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ABSTRACT 
 
 
 Hedgehog (HH) signaling is an evolutionary conserved pathway that is indispensable for 
embryonic development and adult tissue homeostasis. GLI proteins are the transcriptional 
effector molecules of the HH signaling pathway that act in the nucleus to both activate and 
repress HH target gene expression. GLI proteins traffic between multiple subcellular 
compartments including the nucleus, cytoplasm, and primary cilium. Disruption in GLI 
trafficking results in defects in GLI protein activity, yet the mechanisms regulating these 
trafficking events are unclear. Kinesin-2 motor complexes, namely the heterotrimeric 
KIF3A/KIF3B/KAP3 complex and the homodimeric KIF17 complex, regulate both ciliary and 
non-ciliary transport of protein cargo, but whether these motor complexes regulate GLI proteins 
directly has not been tested. To examine a role for the heterotrimeric KIF3A/KIF3B/KAP3 
kinesin-2 motor complex in regulating GLI activity, I performed a series of structure-function 
analyses using biochemical, cell signaling and in vivo approaches that define novel, specific 
interactions between GLI proteins and two components of this complex, KAP3 and KIF3A. I 
find that all three mammalian GLI proteins interact with KAP3 and map specific interaction sites 
in both proteins. Further, I find that GLI proteins interact selectively with KIF3A, but not KIF3B 
and that GLI interacts synergistically with KAP3 and KIF3A. Using a combination of cell 
signaling assays and chicken in ovo electroporations, I demonstrate that KAP3 interactions 
restrict GLI activator, but not GLI repressor function. These data suggest that GLI interactions 
with KIF3A/KIF3B/KAP3 complexes are essential for proper GLI transcriptional activity.  
	  	  xi	  
Further, I provide evidence that homodimeric KIF17 interacts with all mammalian GLI proteins 
and that GLI1 protein expression is decreased in cells stably expressing a dominant-negative 
version of KIF17. Finally, I show that KIF17 and GLI proteins are expressed in overlapping cell 
layers in the developing cerebellum, and that Kif17-/- mice display smaller cerebella. These data 
suggest a model in which KIF17 is playing a tissue-specific role in regulating HH signaling 
through interactions with GLI proteins.  Together, my findings define novel interactions between 
GLI proteins and two distinct kinesin-2 motor complexes and further demonstrate that these 
interactions are required for proper GLI transcriptional activity.
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CHAPTER I: 
 
Introduction 
 
Complex regulation of GLI proteins, the effector molecules of the Hedgehog 
signaling pathway 
 
1.1 Abstract  
 Hedgehog (HH) signaling plays indispensible and diverse roles in regulating vertebrate 
embryonic development. GLI proteins are the effector molecules of the HH signaling pathway, 
modulating HH target gene transcription. Understanding the mechanisms that regulate GLI 
protein function is essential to treating severe developmental defects and adult cancers that arise 
from defects in GLI protein function. Within the mammalian GLI family of transcription factors, 
there are three vertebrate GLI proteins, GLI1-3. Here, I discuss how vertebrate HH signaling is 
regulated, specifically at the level of GLI proteins, and how GLI proteins function as molecular 
“switches” to activate and repress HH target gene expression. Our understanding of HH signal 
transduction drastically changed with the discovery that primary cilia, once thought to be 
vestigial structures, play essential roles in regulating HH signaling. With this discovery came the 
finding that GLI proteins traffic in and out of primary cilia, and that these trafficking events are 
necessary for proper GLI protein function. In Chapter I, I review how primary cilia and 
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intraflagellar trafficking (IFT) proteins regulate GLI protein ciliary localization and function. 
Finally, GLI proteins traffic between multiple subcellular compartments including the nucleus, 
cytoplasm, and primary cilia. How these trafficking events are coordinated, and what molecules 
regulate these trafficking events is not well understood. Thus far, two kinesin motor families, 
kinesin-4 and kinesin-2, have been implicated in regulating HH signaling. In the final section of 
Chapter I, I discuss how kinesin-4 family members, KIF7 and KIF27, regulate GLI proteins and 
provide justification for why I dedicate my doctoral work to understanding a role for kinesin-2 
motor complexes, namely the heterotrimeric KIF3A/KIF3B/KAP3A and the homodimeric 
KIF17, in regulating GLI protein function. 
 
1.2 Hedgehog signaling: pathway regulation from a “GLI” point of view 
1.2.1 Identification of GLI proteins as effector molecules of the Hedgehog signaling pathway 
 Vertebrate HH signaling initiates when secreted HH ligands bind to the twelve-pass 
transmembrane receptor Patched (PTCH1) (Allen et al., 2011; Stone et al., 1996; Marigo et al., 
1996a) and to the co-receptors GAS1, CDON, and BOC (Allen et al., 2011); this relieves 
inhibition of Smoothened (SMO), a seven-pass transmembrane GPCR-like protein that initiates a 
signal transduction cascade culminating in modulation of the GLI family of zinc-finger 
transcription factors (GLI1-3) (Hui and Angers, 2011) (Figure 1.1). The first human GLI gene, 
GLI1, was amplified from a glioblastoma (Kinzler et al., 1987) and subsequent GLI family 
members, GLI2 and GLI3, were identified based on sequence similarity (J M Ruppert, 1988). 
Additional studies revealed that each GLI family member contains a highly conserved zinc-
finger DNA-binding domain and is closely related to the Kruppel family of zinc-finger proteins 
(Kinzler et al., 1988). This finding suggested that, like other Kruppel family members, GLI 
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proteins could play important roles in regulating embryonic development. Further support for 
GLI proteins as transcription factors came when researchers observed that GLI1 is 
predominantly localized to the nucleus in tumor cells where it binds specific DNA sequences 
(Kinzler and Vogelstein, 1990).  
 Early expression analysis of GLI1-3 showing that Gli1, Gli2, and Gli3 are expressed in 
both overlapping and distinct tissues during mouse embryonic development provided further 
evidence that GLI proteins may function in embryonic development (Hui et al., 1994). 
Interestingly, just prior to this expression analysis by Hui and colleagues, reports emerged 
showing that extra-toes (Xt) mutant mice display mutations in Gli3 and that these mice are 
phenotypically similar to human patients suffering from Greig cephalopolysyndactyly syndrome, 
a syndrome in which GLI3 was suggested to be the candidate gene (Vortkamp et al., 1991; Hui 
and Joyner, 1993). Together, these studies identified GLI proteins as zinc-finger transcription 
factors that are required for proper embryonic development and are unregulated in human 
cancers.  
 A decade after the discovery of the Hh gene in Drosophila (Nüsslein-Volhard and 
Wieschaus, 1980) it was determined that HH was a secreted signaling molecule that plays an 
important role in patterning embryos (Mohler and Vani, 1992; Lee et al., 1992; Tabata et al., 
1992). Later it was revealed that three HH ligands exist in mice, Sonic Hedgehog (SHH), Indian 
Hedgehog (IHH), and Desert Hedgehog (DHH), demonstrating that, like GLI proteins, these 
molecules have been expanded in vertebrates (Echelard et al., 1993; Riddle et al., 1993; Krauss 
et al., 1993; Roelink et al., 1994). In Drosophila, Cubitus interruptus (ci) encodes the fly 
homolog of the vertebrate GLI genes and acts downstream of all other identified HH pathway 
components in flies to regulate HH target gene transcription (Domínguez et al., 1996; Alexandre 
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et al., 1996; Ingham, 1998; Orenic et al., 1990; Hepker et al., 1997; Slusarski et al., 1995). In 
parallel to these findings, roles for GLI proteins as regulators of HH signaling in mice were 
starting to surface. GLI1 was the first identified as a mediator of HH signaling because, unlike 
GLI2 and GLI3, GLI1 is expressed close to SHH ligand-expressing cells during gastrulation and 
neurulation (Sasaki et al., 1997; Lee et al., 1997; Hui et al., 1994; Platt et al., 1997). In addition 
to being expressed in close proximity to HH-ligand, misexpression of GLI1 mimicked the effects 
of ectopic HH-signaling in ventral progenitor cells within the neural tube (Hynes et al., 1997; 
Lee et al., 1997). In contrast to GLI1, GLI3 is down-regulated in the posterior mesenchyme of 
chick limb buds in an area where Shh is expressed, suggesting that, unlike GLI1, GLI3 represses 
HH activity (Marigo et al., 1996b). This idea was further supported in mice, where loss of Gli3 
results in ectopic Shh expression (Masuya et al., 1997; Büscher et al., 1997). Shortly after GLI1 
and GLI3 were implicated as regulators of the HH signaling pathway, evidence that the third GLI 
family member, GLI2, was also regulating HH signaling came from a study that showed that 
HH-responsive genes, Ptch1 and Gli1, are down-regulated in mice lacking Gli2 (Ding et al., 
1998). These authors and others, go on to show that that GLI2 is essential for high level but not 
low level HH signal transduction in the developing neural tube (Ding et al., 1998; Altaba, 1998).  
 Taken together, these studies implicated, for the first time, GLI1, GLI2, and GLI3 in 
regulating vertebrate HH signal transduction and further suggested that these proteins function as 
the transcriptional regulators of a highly conserved signaling pathway that plays important roles 
regulating multiple developmental processes. 
   
1.2.2 GLI proteins display distinct and overlapping function as transcriptional activators and 
transcriptional repressors 
	  	  5	  
 With the realization that GLI1, GLI2, and GLI3 all regulate vertebrate HH transduction, 
came many studies dedicated to deciphering the mechanisms regulating GLI protein 
transcriptional activity. Evidence that GLI proteins could function as both transcriptional 
activators and transcriptional repressors was suggested by early reports in Drosophila showing 
that the GLI homolog, Ci, functions as both a transcriptional repressor and a transcriptional 
activator (Domínguez et al., 1996). Insight into vertebrate GLI protein function came with 
structure-function experiments in cultured cells showing that GLI3, like the Drosophila homolog 
Ci, contains both an N-terminal repressor and C-terminal activation domains, where as, GLI1 
contains only the C-terminal activation domain (Dai et al., 1999) (Figure 1.2). Dai et al. further 
demonstrated that GLI3, but not GLI1, is processed into a transcriptional repressor and that in 
the presence of recombinant SHH ligand this processing event is inhibited, allowing full-length 
GLI3 to directly bind and activate the GLI1 promoter (Dai et al., 1999). These data suggested 
that Gli1 is a direct target of the HH signaling pathway and that GLI3 can function as an 
activator and a repressor to mediate Hh signaling. However, the observation by these authors that 
Gli1 mRNA is still present in Gli3 homozygous mutant embryos provided an additional reason to 
investigate whether GLI2 could also regulate HH signaling as a transcriptional activator during 
vertebrate embryogenesis (Dai et al., 1999). In support of this, studies in Gli2 and Gli3 double 
mutant mice suggested that GLI2 and GLI3 play both specific and redundant roles during 
skeletal development (Mo et al., 1997). Analysis of GLI2 transcriptional activity showed that 
like GLI3, GLI2 contains both transcriptional activation and repressor domains, (Sasaki et al., 
1999) (Figure 1.2). Further, these authors showed that full-length GLI2 and GLI3 function as 
weak activators, and that deletion of the N-terminal repression domain significantly increases the 
transcriptional activation function of both GLI2 and GLI3 (Sasaki et al., 1999). Together these 
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studies highlight GLI2 and GLI3 as the major effector molecules of the HH signaling pathway.  
 In contrast, to GLI2 and GLI3, GLI1 lacks a transcriptional repressor domain and is not 
processed, but instead is transcriptionally upregulated by GLI2 and GLI3 to propagate the HH 
signal once the pathway is activated (Bai et al., 2004). Unlike Drosophila, where Ci functions as 
the sole transcriptional activator and repressor in the HH signaling pathway, this function has 
been divided between GLI1, GLI2 and GLI3 in vertebrates. After the discovery that GLI1-3 all 
contain activation domains and that GLI2 and GLI3 contain additional repressor domains, the 
next major goal was to address the extent to which these vertebrate GLIs play overlapping and 
distinct roles as transcriptional activators and repressors during embryonic development.   
 Although GLI2 and GLI3 are the major effector molecules of HH signaling, all three 
vertebrate GLI proteins play overlapping activator roles. For example, during lung, trachea, and 
esophagus formation mutant mice lacking GLI2 display stenosis of the esophagus and trachea in 
addition to lung hypoplasia (Motoyama et al., 1998). Removing one copy of Gli3 in a Gli2-/- 
mouse exacerbates these defects and complete loss of GLI3 in the same Gli2-/- mouse results in 
complete loss of the lung, trachea, and esophagus (Motoyama et al., 1998). In addition to foregut 
formation, HH-dependent neural tube patterning involves GLI1, GLI2, and GLI3 activator 
functions (Bai et al., 2004). SHH ligand is secreted from the notochord and later from the ventral 
most floor plate cells of the neural tube setting up a gradient of HH signaling that is important for 
specifying ventral progenitor cell populations (Figure 1.3). Strikingly, Gli1-/- mice do not display 
developmental defects or decreased HH signaling, unless one copy of Gli2 is removed from the 
Gli1-/- background (Park et al., 2000; Bai et al., 2002). However, Gli1-/-;Gli2-/- mutant mice 
display slight defects in floor plate and V3 interneuron progenitor cells that require the highest 
level of HH signaling, suggesting that GLI1 enhances the activator function of GLI2 in these 
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most ventral cell types (Bai et al., 2004). Consistent with GLI3 functioning as a transcriptional 
repressor of HH signaling, Gli3-/- mice display dorsal expansion of V0-V2 indicative of over 
active HH signaling (Persson et al., 2002). While loss of Gli3 in mice results in phenotypes 
resembling ectopic HH signaling, Bai and colleagues showed that in the ventral neural tube GLI3 
functions as an activator and can induce some floor plate and V3 interneurons; however, unlike 
GLI2, GLI3 activator activity is dependent on Gli1 transcription (Bai et al., 2004). 
 Together, these studies highlight overlapping roles for GLI proteins as transcriptional 
activators in multiple developmental contexts. While GLI2 and GLI3 can both act as 
transcriptional activators and repressors, GLI3 appears to be playing the major transcriptional 
repressor role in regulating HH target genes in vivo. However, reports of GLI2 functioning as a 
transcriptional repressor have been reported both in vivo and in cell culture (Buttitta et al., 2003a; 
Pan et al., 2006; McDermott et al., 2005). Further, loss of both GLI2 and GLI3 results in 
complete loss of HH signaling suggesting that GLI2 and GLI3 mediate most if not all of HH 
target genes transcription including upregulation of the third GLI family member, GLI1 (Buttitta 
et al., 2003b; Motoyama et al., 2015; Bai et al., 2004). These studies underscore an exciting 
example of evolutionary sub-functionalization where the once bipartite transcriptional function 
of the Drosophila GLI homolog, Ci, is now divided between all three mammalian GLI proteins 
that perform both overlapping and distinct functions in modulating HH transcriptional activity.  
 
1.2.3 GLI protein processing and degradation: A complex process involving protein kinase A 
(PKA) 
 Post-translational modification of GLI proteins is a complex and highly regulated process 
that involves many different molecules. Even today, a complete understanding of the 
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mechanisms and molecules involved in regulating GLI protein function are not complete. As a 
result of the high level of HH pathway conservation between vertebrates and invertebrates, work 
in Drosophila has shaped our understanding and provided the groundwork for elucidating the 
mechanisms involved in vertebrate GLI protein processing and degradation. In particular, a study 
by Aza-Blanc and colleagues beautifully demonstrated that the Drosophila GLI homolog, Ci, is 
proteolytically cleaved into a repressor in the absence of HH ligand (Aza-Blanc et al., 1997). 
Shortly after this discovery, it was determined that extensive phosphorylation by several Ser/Thr 
kinases including protein kinase A (PKA), glycogen synthase kinase 3 (GSK3), and casein 
kinase I (CKI) family members leads to recruitment of the F-box containing protein Slimb/β-
TrCP, a substrate-specific receptor of the SCF-type E3 ubiquitin ligase (Jia et al., 2005; Jiang 
and Struhl, 1998; Jia et al., 2002; Wang et al., 1999; Price and Kalderon, 2002; Smelkinson and 
Kalderon, 2006; Chen et al., 1999). A protein degradation domain (PDD) is further required for 
proper partial Ci processing by the proteasome (Figure 1.2), a process that is inhibited in Ci 
mutants lacking the PDD (Tian et al., 2005; Méthot and Basler, 1999).  
 Roles for PKA in regulating vertebrate HH signaling have also been reported 
(Hammerschmidt et al., 1996; Epstein et al., 1996). Similar to Ci, GLI3 is phosphorylated by 
PKA at the first four PKA sites (P1-P4) in its C-terminus adjacent to the CK1 and GSK3 sites 
(black asterisks in Fig 1.2). Following these phosphorylation events full-length GLI3 is 
ubiquinated by the SCFβTrCP ubiquitin E3 ligase and subsequently processed by the proteasome 
into an N-terminal repressor (Wang et al., 2000a; Wang and Li, 2006; Tempé et al., 2006). 
Interestingly, GLI2 is also phosphorylated by PKA at the same sites as GLI3; in addition to a 
small fraction being processed into a N-terminal repressor, GLI2 is mostly destabilized resulting 
in degradation (Pan et al., 2009; 2006). Like Ci, both GLI2 and GLI3 contain a PDD that is 
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important for proteosomal degradation; however this domain is less potent in GLI2 (Pan and 
Wang, 2007). This destabilization of GLI2 in the absence of HH signaling partially explains why 
GLI3 functions as the major transcriptional repressor of the HH pathway, albeit GLI2 repressor 
activity is suggested to play minor roles in both neural tube and somite development (Buttitta et 
al., 2003b; Pan et al., 2009). In contrast, GLI1 lacks complete conservation of the conserved 
PKA phosphorylation residues, PDD, and is not processed in to a transcriptional repressor (Pan 
and Wang, 2007; Price and Kalderon, 2002) (Figure 1.2). 
 The role for PKA in initiation GLI2/3 repressor processing has been studied in great 
detail; however, positive regulation of GLI function by PKA has also been reported (Kaesler et 
al., 2000; Niewiadomski et al., 2013). In addition to the highly conserved PKA phosphorylation 
residues P1-P6 in GLI2 and GLI3 that are required for processing and degradation of GLI2 and 
GLI3, Niewiadomski et al. identified additional partial consensus PKA clusters, (Pc-g cluster, 
Figure 1.2) that are conserved between all vertebrate GLI proteins, as well as Ci, and are 
required for full activation of GLI2/3 transcriptional activators (Niewiadomski et al., 2014). In 
reporter assays, cells stably expressing versions of GLI2 where the Pc-g clusters are mutated to 
nonphosphorylatable or phosphomimetic residues showed 40% less and significantly more 
activity, respectively (Niewiadomski et al., 2014). In contrast to the P1-P6 residues, the Pc-g 
residues are completely conserved in GLI1, however their role in mediating GLI1 activation has 
not been tested. Interestingly, it is reported that additional residues within GLI1 are 
phosphorylated by PKA, and mutating these residues has both positive and negative functional 
consequences on GLI1 transcriptional activity (Kaesler et al., 2000). While more studies are 
necessary to fully understand the complex regulation of GLI proteins by PKA, it is clear that 
PKA controls both GLI processing and transcriptional activation. 
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 In addition to SCFβTrCP–mediated GLI processing and degradation, additional E3 
ubiquitin ligases regulate the turnover of GLI proteins. For example, in Drosophila, levels of 
full-length Ci are controlled by the substrate-specific receptor for the Cul3-based E3 ubiquitin 
ligase Hib (Kent et al., 2006; Zhang et al., 2006). In flies, Loss of Hib leads to an accumulation 
of Ci, where as overexpression of Hib reduces Ci levels and inhibits HH signaling (Kent et al., 
2006). Similar to Hib, the mammalian homolog, SPOP (speckle-type POZ protein), interacts 
with GLI2 and GLI3 to promote their ubiquitin-mediated processing and degradation (Chen et 
al., 2009; Zhang et al., 2009). In contrast, GLI1 is not a strong substrate for SPOP (Chen et al., 
2009; Zhang et al., 2009), but instead is recruited to the E3 ubiquitin ligase, Itch,  by the adaptor 
protein, Numb (Di Marcotullio et al., 2010). Together, these studies highlight several key protein 
components that regulate GLI protein processing and degradation, and further emphasize the 
complex regulation of GLI protein levels during embryonic development. 
 
1.2.4 Suppressor of fused (Sufu): a vertebrate specific regulator of GLI protein function 
 In addition to PKA, suppressor of fused (SUFU) is another highly conserved HH pathway 
component that negatively regulates the HH signaling pathway (Preat, 1992). Loss-of-function 
mutations in Sufu suppress the phenotype in flies containing mutations in Fu, a serine-threonine 
kinase that is important for HH signaling downstream of Smo in Drosophila HH signaling (Preat 
et al., 1990; 1993; Thérond et al., 1993).Interestingly, while loss of SUFU is flies has no 
noticeable consequence in the absence of other mutations, Sufu-/- mice die in utero by E9.5 with 
severe developmental defects indicative of overactive HH signaling similar to those observed in 
Ptch1-/- mice that display constitutive HH pathway activation (Svärd et al., 2006).  Like Ptch1-/- 
mice, Sufu-/- mice develop a ventralized neural tube and have deformed cephalic regions 
	  	  11	  
including an open fore-, mid-, and hindbrains (Svärd et al., 2006). An earlier study identified an 
SYGH motif present in all mammalian GLI proteins that is required for SUFU binding– mutation 
of this motif in GLI1 results in constitutive GLI1 nuclear localization (Dunaeva et al., 
2003)(Figure 1.2). Similarly, mouse embryonic fibroblasts (MEFs) lacking SUFU show 
increased nuclear localization of GLI1 (Svärd et al., 2006). A more mechanistic understanding of 
how of SUFU regulates GLI proteins came in a study by Humke et al. where they eloquently 
show that in the absence of HH signaling SUFU promotes GLI3 processing into its repressor 
form and that initiation of HH signaling promotes the dissociation of the SUFU-GLI3 complex 
and nuclear localization of full-length GLI3 (Humke et al., 2010). Interestingly, activation of 
PKA prevents the dissociation of the GLI3-SUFU complex, thus preventing nuclear localization 
and transcriptional activity of full-length GLI3 (Humke et al., 2010). SUFU also forms 
complexes with GLI2, and like SUFU-GLI3 complexes, HH signaling promotes the dissociation 
of SUFU from GLI2 (Humke et al., 2010).  
 Further studies showed that loss of SUFU results in destabilization of full-length but not 
C-terminally processed repressor versions of GLI2 and GLI3, where as overexpression of SUFU 
stabilizes both GLI2 and GLI3 (Wang et al., 2010). In this same study, Wang and colleagues 
demonstrated that knockdown of SPOP in Sufu-/- MEFS rescues full-length GLI2 and GLI3 
levels, and consistent with this result, overexpression of SPOP promotes GLI2 and GLI3 
processing and degradation (Wang et al., 2010). An earlier study demonstrated that SUFU 
interacts with GLI proteins through an additional C-terminal motif (Merchant et al., 2004)(Figure 
1.2) and Wang and colleagues further showed that SUFU and SPOP compete for the same 
binding sites within the N- and C-termini of GLI3 and a C-terminal region of GLI2. Strikingly, 
expression of a constitutive GLI3 repressor in Sufu-/- mice mostly rescues the ventralized neural 
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tube, suggesting that C-terminally processed GLI3 repressor functions independently of SUFU 
(Wang et al., 2010). 
 Together, these studies demonstrate that SUFU is a negative regulator of HH signaling 
that interacts with full-length GLI proteins to promote their processing and degradation in 
addition to stabilizing and preventing their nuclear localization in a HH dependent manner. 
Further, dissociation of SUFU-GLI complexes is inhibited by PKA and depends on the presence 
of primary cilia, microtubule-based organelles that are implicated in regulating HH signaling 
(see below). 
 
1.3 Regulation of GLI protein function by primary cilia 
 
1.3.1 Link between vertebrate HH signaling and primary cilia   
 The discovery that vertebrate HH signaling requires primary cilia has drastically changed 
the dogma of HH signal transduction (Huangfu et al., 2003). Primary cilia are microtubule-based 
extensions of the cell surface that were once thought to be vestigial structures in vertebrates; 
however, now we know that these subcellular organelles regulate many important developmental 
processes including HH signaling (Goetz and Anderson, 2010). Intraflagellar transport (IFT) is a 
highly regulated process involving IFT particles (A and B) that are trafficked along a 
microtubule-based axoneme by anterograde (kinesin-2) and retrograde (dynein) motor proteins 
(Goetz and Anderson, 2010) (Figure 1.4). The first piece of evidence demonstrating that 
vertebrate HH signaling depends on primary cilia came from a forward-genetic screen in mice 
designed to identify mutations that disrupt embryonic development (Huangfu et al., 2003). 
Interestingly, many of the mutant embryos discovered in this screen had mutations in IFT 
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components, which resulted in phenotypes similar to those seen in HH mutants, in particular 
defects in HH-dependent neural patterning (Huangfu et al., 2003; Goetz and Anderson, 2010). 
In-depth investigations into the IFT mutants identified by Anderson and colleagues, initiated a 
large body of research dedicated to understanding how primary cilia regulate HH signaling and 
the subsequent discovery that several core HH pathway components localize to primary cilia 
both in the absence and presence of HH signaling, including the GLI proteins (Rohatgi et al., 
2007; Corbit et al., 2005; Haycraft et al., 2005) (Figure 1.5). Mutations in several IFT 
components, including the anterograde motor (Kif3a), retrograde motor (Dync2h1), IFT A 
(Ift122, Ift172,), and IFT B (Ift88, Ift27, Ift25) complexes causes defects in GLI accumulation at 
the ciliary tip and correlates with defective HH signaling (Takeda et al., 1999; Ocbina et al., 
2011; Huangfu and Anderson, 2005; Qin et al., 2011; Keady et al., 2012; Gorivodsky et al., 
2009; Huangfu et al., 2003; Yang et al., 2015; Haycraft et al., 2005; Liu et al., 2005). In many 
cases these IFT mutations correlate with HH loss-of-function, in particular in the neural tube 
where defects in Gli activator function results in misspecification of ventral neuronal progenitor 
cells (Huangfu and Anderson, 2005; Huangfu et al., 2003). However, in some cases mutations in 
IFT components display apparent gain-of-function HH phenotypes, particularly in the mouse 
limb where defects in GLI3 repressor processing result in improper digit specification (Haycraft 
et al., 2005; Liu et al., 2005). While defects in IFT machinery perturb HH signaling and GLI 
function, how IFT components interact with and regulate GLI proteins is not well characterized.  
  
1.3.2 Ciliary regulation of GLI protein processing and activation 
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 All three mammalian GLI proteins localize to primary cilia, but not the proteolytically 
processed GLI3 repressor (Haycraft et al., 2005). GLI2 and GLI3 cycle through cilia at low 
levels in the absence of HH signaling, and within minutes after HH stimulation, both full-length 
GLI2 and GLI3 accumulate at the tips of primary cilia in a SMO and microtubule-dependent 
manner (Kim et al., 2009; Wen et al., 2010; Chen et al., 2009) (Figure 1.5). These studies 
confirmed that full length GLI2 and GLI3, but not their C-terminally truncated repressor 
versions, are enriched at ciliary tips. Further, defects in ciliogenesis disrupt GLI3 processing and 
full-length GLI2 activation which results in digit formation and neural tube defects (Haycraft et 
al., 2005; Liu et al., 2005). While these studies implicated primary cilia in regulating GLI 
processing and activation, whether GLI ciliary localization is required for this regulation and 
how the protein regulators of GLI transcriptional activity, namely SUFU and PKA, fit into the 
cilia-centric HH model had yet to be elucidated.  
 Insights into these mechanisms came with the finding that SUFU traffics in complex with 
GLI proteins through the primary cilia in a GLI-dependent manner (Haycraft et al., 2005; Zeng 
et al., 2010) (Figure 1.5). HH stimulation promotes the ciliary accumulation and subsequent 
dissociation of GLI2-SUFU and GLI3-SUFU complexes, a process dependent on primary cilia 
(Humke et al., 2010; Tukachinsky et al., 2010).  However, constitutive activation of GLI proteins 
in the absence of SUFU is independent of primary cilia (Jia et al., 2009; Chen et al., 2009). 
Furthermore, PKA localizes near the basal body at the base of the cilium and loss of PKA causes 
an increase in GLI2 at the tips of primary cilia (Tuson et al., 2011; Barzi et al., 2009; 
Tukachinsky et al., 2010; Zeng et al., 2010) (Figure 1.5). Also, HH mediated dissociation of 
GLI-SUFU complexes is inhibited in cells lacking primary cilia or with overactive PKA, 
suggesting that GLI-SUFU complexes dissociate at the cilium in response to PKA inactivation 
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(Humke et al., 2010; Tukachinsky et al., 2010). In combination with the finding that cilia 
localization of GLI2 and GLI3 is not affected by loss of the conserved P1-4 PKA 
phosphorylation sites (Zeng et al., 2010), these data suggest that PKA modifies GLI proteins at 
the base of the cilium upon ciliary exit (Tuson et al., 2011). Together, these studies support a 
mechanism by which trafficking of the GLI-SUFU complexes within primary cilia controls the 
accessibility of these complexes to PKA phosphorylation upon ciliary exit. Since full-length, but 
not repressor versions of GLI2 and GLI3 are localized to the primary cilia (Wen et al., 2010; 
Haycraft et al., 2005), this further supports a model where in the absence of HH ligand, GLI2-
SUFU and GLI3-SUFU complexes traffic through cilia at low levels where they are modified 
into a PKA substrate which results in GLI processing and degradation. HH pathway activation 
promotes ciliary dissociation of GLI2 and GLI3 from SUFU where they now avoid PKA 
mediated processing and degradation leading to activation of full-length transcriptional activators 
that can then localize to the nucleus and upregulate HH target gene transcription (Figure 1.5).  
 Many question still remain unresolved. For instance, the specific post-translational 
modifications that the GLI-SUFU complexes receive in the cilium, and whether these complexes 
dissociate within the primary cilia are still unresolved. In addition, HH pathway activation in the 
absence of PKA is dependent on primary cilia (Tuson et al., 2011), leaving open the possibility 
that additional cilium-dependent mechanisms exist downstream PKA inhibition that allow full 
activation of GLI proteins.  
 Interestingly, domains required for GLI2 cilia localization have been identified and 
deleting these domains prevents GLI2 cilia localization, separation form SUFU, and subsequent 
activation, supporting the model proposed above (Santos and Reiter, 2014; Liu et al., 2015). 
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Important to note, in the process of generating a mutant GLI2 allele lacking the cilia localization 
domain, Liu and colleagues additionally eliminate the conserved P1-P6 PKA residues and show 
that this GLI2 variant fails to activate Hh signaling (Liu et al., 2015). This is in contrast to a 
recent study that showed that stably expressing a version of GLI2 lacking the P1-P6 PKA sites 
highly activates HH signaling (Niewiadomski et al., 2014). These contrasting findings suggest 
that even a version of GLI2 insensitive to PKA phosphorylation that results in processing and 
degradation must traffic to the primary cilia to become fully active highlighting the possibility 
that primary cilia regulate GLI protein transcriptional activation through additional mechanisms.   
 Roles for primary cilia in negatively and positively regulating GLI protein function have 
been recently reported in human disease (Wong et al., 2009; Han et al., 2009). More specifically, 
Wong et al. demonstrate that tumors initiated by overactive Smo depend on primary cilia for 
facilitating positive signals through GLI activators and for suppressing negative signals through 
processing of GLI repressors (Wong et al., 2009).  Future studies are required to fully understand 
how primary cilia regulate GLI protein activity and the importance of this regulation in HH-
dependent tumorigenesis. 
  
1.4 Kinesin motor regulation of GLI protein function 
1.4.1 Complex regulation of GLI proteins by the kinesin-4 motor protein, KIF7 
 Despite the remarkably high level of pathway conservation shared between invertebrate 
and vertebrate HH signal transduction, Drosophila do not require primary cilia for proper HH 
signaling. This raises a fascinating question:  Why does vertebrate HH signaling depend on 
primary cilia? A possible answer to this question may reside with the kinesin-4 motor family 
member, KIF7. Prior studies in Drosophila identified Costal 2 (Cos2) as a kinesin-like protein 
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that regulates HH signal transduction via direct interactions with the Drosophila GLI homolog 
Ci (Sisson et al., 1997; Robbins et al., 1997). Cos2 functions both positively and negatively to 
transduce the HH signal from the transmembrane receptors, Ptc and Smo, to the Gli transcription 
factor, Ci (Wang and Holmgren, 1999; Wang et al., 2000b; Wang and Jiang, 2004; Ruel et al., 
2003). In the absence of Hh ligand, Cos2 scaffolds a complex containing the Fu kinase and Ci to 
microtubules resulting in recruitment of protein kinases and processing of Ci into a truncated 
repressor (Zhao et al., 2005). Upon Hh ligand stimulation, Cos2 no longer scaffolds Ci for 
processing, but instead forms a complex with Smo which allows predominance of full-length Ci 
activator and subsequent upregulation of HH target genes (Zhao et al., 2007; Ruel et al., 2003).  
 More recent studies in vertebrates identified a similar role for the Cos2 vertebrate 
homologue, KIF7, in the regulation of GLI protein function (Liem et al., 2009; Endoh-
Yamagami et al., 2009; Cheung et al., 2009). In vertebrates, two Cos2 homologs exist, KIF7 and 
KIF27, both of which interact with GLI proteins (Endoh-Yamagami et al., 2009; Cheung et al., 
2009; Maurya et al., 2013; Marks and Kalderon, 2011; Katoh and Katoh, 2004); however 
whether KIF27 regulates HH signaling and GLI protein activity is still unresolved. In contrast to 
KIF27, several studies have shown that mice lacking KIF7 display mild ectopic HH phenotypes 
due the dual role for KIF7 in both promoting and antagonizing GLI activity (Maurya et al., 2013; 
Hsu et al., 2011; Li et al., 2012). In fact, due to the mild ectopic HH phenotypes observed in 
mice lacking KIF7, an early report suggested that KIF7 is dispensable for vertebrate HH 
signaling (Varjosalo et al., 2006).  
 In Drosophila, point mutations in the motor domain of Cos2 disrupt its microtubule 
dependent motility thereby inhibiting its ability to repress HH signaling (Farzan et al., 2008; Ho 
et al., 2005). Similar results are observed in vertebrates where Kif7maki mice (harboring a L130P 
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mutation in the conserved motor domain) show mild ectopic activation of HH target genes (Liem 
et al., 2009).  In this study, Kif7maki mice display expanded motor neuron and NKX2.2+ domains, 
however, Gli2 Kif7maki double mutants the motor neuron domain is not expanded dorsally and the 
floor plate and NKX2.2 domains are absent (Liem et al., 2009). This suggests that the expanded 
motor neuron and NKX2.2+ domains seen in the mutant mice are a result of increased GLI2 
activity. In addition, Kif7maki mice display preaxial polydactyly and defects in GLI3 processing 
likely contributing to the greater expansion of ventral progenitor domains seen in Gli3 Kif7maki 
double mutants compared to Gli3 mutants alone. Further, while Smo single mutants die by 
embryonic day 9.5 (E9.5) and fail to specify any ventral neuronal cell populations, Smo;Kif7maki 
double mutants survive to E10.5 and partially specify both NKX2.2 and motor neuron cells, 
suggesting that the loss of Kif7 function in Smo null mice partially rescues GLI activation. Along 
with a partial rescue in mice lacking the major HH signal transduction component SMO, 
Ptch1;Kif7maki double mutants also partially rescue the severe phenotypes displayed by mice 
lacking the major Hh negative regulator, PTCH1 (Liem et al., 2009). Through a careful analysis, 
Anderson and colleagues showed that not only does KIF7 regulate HH signaling, but it does so 
by both positively and negatively regulating GLI activity through a mechanism that requires 
primary cilia (Liem et al., 2009). Together with other studies, the current paradigm is that, 
similar to Cos2, KIF7 promotes HH signaling through dissociation of SUFU-GLI complexes, but 
unique to vertebrates, controls the ciliary localization of GLI proteins in a tissue-specific manner 
(Hsu et al., 2011; Maurya et al., 2013; Endoh-Yamagami et al., 2009; Liem et al., 2009). While 
the KIF7-GLI interaction sites have not been precisely mapped, GLI proteins appear to interact 
with KIF7 via multiple domains, including an N-terminal motif (Marks and Kalderon, 2011).  
	  	  19	  
 KIF7 localizes to the tips of primary cilia in response to HH stimulation, and mutations 
that disrupt the motor domain of KIF7 perturb both KIF7 and GLI protein accumulation at the 
ciliary tip (Hsu et al., 2011; Liem et al., 2009). These experiments raised the possibility that 
KIF7 could act as an anterograde motor to directly traffic GLI-SUFU complexes. However, 
detailed investigation by Anderson and colleagues showed that KIF7 does not possess plus-end-
directed microtubule motoring capabilities, but instead functions to organize the ciliary tip 
compartment through the regulation of microtubule dynamics (He et al., 2014). Further, the 
effects of KIF7 are controlled by PPFIA1- and PP2A-mediated regulation of KIF7 
phosphorylation (Liu et al., 2014). These results suggest that either the loss of KIF7 (He et al., 
2014), or altered KIF7 phosphorylation (Liu et al., 2014), affects the ciliary localization and 
activity of GLI proteins due to disorganization of the ciliary tip. This supports the idea that the 
ectopic activation of the HH pathway observed in mice defective in KIF7 function could result 
from ectopic GLI-SUFU complexes away from the ciliary tip, where they inappropriately 
dissociate in the absence of HH signaling.   
 Whether KIF7-mediated dissociation of the GLI-SUFU complexes requires the direct 
interaction of KIF7 for its negative and positive roles in regulating GLI activity requires further 
studies, but regardless, KIF7 shares at least some conserved functional roles in regulating HH 
signal transduction with its Drosophila homolog, Cos2. It is interesting to postulate that the 
intimate relationship between vertebrate HH signaling and primary cilia may be at least partly 
due to the evolutionary conserved role of KIF7 and Cos2 in sculpting microtubules. Lastly, the 
finding that KIF7 does not possess plus-end-directed microtubule motoring capabilities leaves a 
gap in our understanding of how GLI proteins are trafficked to the tips of primary cilia. A major 
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unresolved question remains: What motor proteins regulate plus-end-directed GLI trafficking 
within the primary cilia? 
 
1.4.2 Role of kinesin-2 motors in the regulation of HH signaling  
 The kinesin-2 motors are a functionally diverse subgroup of the kinesin superfamily that 
mediate plus-end-directed trafficking events both within and outside of primary cilia (Scholey, 
2013). Within the kinesin-2 family, three motor complexes exist: (1) a heterotrimeric 
KIF3A/KIF3B/KAP3 complex, (2) a heterotrimeric KIF3A/KIF3C/KAP3 complex, and (3) a 
homodimeric KIF17 complex (Figure 1.6). Multiple roles for kinesin-2 motor proteins in 
regulating cell processes and embryonic development have been reported, including 
intraflagellar transport and cilium assembly, opsin transport in photoreceptor development, and 
axonal and cytoplasmic organelle transport (Scholey, 2013; Hirokawa, 2000).  
 The heterotrimeric KIF3A/KIF3B/KAP3 is the most studied member of the kinesin-2 
motor family and is known for its roles in intraflagellar transport and cilia assembly (Scholey, 
2013; Hirokawa et al., 2009; Hirokawa, 2000; Nonaka et al., 1998; Takeda et al., 2000). In fact, 
mice with mutations in Kif3A, Kif3B, or the kinesin-associated protein, Kap3 (Kifap3) 
(Yamazaki et al., 1996), die by mid-gestation due to defects in left-asymmetry as a result of 
defects in ciliogenesis (Takeda et al., 1999; Nonaka et al., 1998; Hirokawa, 2000; Teng et al., 
2005). Similar to KIF3B, KIF3C forms an additional complex with KIF3A and KAP3 (Figure 
1.6); however KIF3C is dispensable for normal embryonic development and functions in distinct 
tissues (Yang and Goldstein, 1998; Muresan et al., 1998). Interestingly, KIF3C also forms a 
distinct complex from KIF3A and KAP3 (Muresan et al., 1998), but how this heterotrimeric 
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KIF3A/KIF3C/KAP3 complex regulates plus-end-directed microtubule trafficking requires more 
studies.  
 Initial investigations into the mechanisms that regulate heterotrimeric kinesin-2 complex 
assembly and function in vertebrates suggested that KIF3A and KIF3B interact with cargo via 
the armadillo repeats of KAP3 (Takeda et al., 2000; Yamazaki et al., 1996; Gindhart and 
Goldstein, 1996), yet examples also exist where KIF3A interacts with cargo independently of 
KAP3 (Huang et al., 2011; Tanuma et al., 2008; Phang et al., 2014). For example, the TRIM 
protein RNF33 interacts with KIF3A and KIF3B in mouse testis in the absence of KAP3 (Huang 
et al., 2011). Further, two isoforms of KAP3 exist, KAP3A and KAP3B, but how these isoforms 
differ in both their interactions with KIF3A, KIF3B and protein cargos is unknown (Yamazaki et 
al., 1996). While it is clear that the heterotrimeric KIF3A/KIF3B/KAP3 complex regulates 
important cellular processes, the mechanism by which this complex interacts with and regulates 
cargo trafficking requires additional experiments. 
 Interestingly, mice lacking KIF3A and KIF3B display phenotypes indicative of disrupted 
HH signaling, including craniofacial abnormalities, loss of ventral progenitor cells in the 
developing neural tube, and excessive bone and cartilage formation during mouse skeletogenesis 
(Takeda et al., 1999; Huangfu et al., 2003; Nonaka et al., 1998; Koyama et al., 2007). These 
findings suggest that members of the heterotrimeric kinesin-2 complex play important roles in 
HH-dependent tissue patterning, but whether this regulation is through direct interactions and 
trafficking of HH components remains unclear. Unfortunately, teasing apart a functional role for 
KIF3A, KIF3B, and KAP3 in directly regulating HH signaling is complicated by the fact that 
genetic manipulation of either complex member causes defects in ciliogenesis.  
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  In contrast to the heterotrimeric KIF3A/KIF3B/KAP3 kinesin-2 complex, the 
homodimeric KIF17 complex is dispensable for normal ciliogenesis and has not been implicated 
in HH signaling (Wong-Riley and Besharse, 2012). While mice lacking KIF17 are viable and 
appear anatomically normal, loss of KIF17 leads to neuronal dysfunction in mice and is 
associated with schizophrenia in humans (Yin et al., 2011; Wong-Riley and Besharse, 2012; 
Tarabeux et al., 2010; Setou et al., 2000). Furthermore, recent studies have revealed that KIF17 
functions in a diverse range of distinct cell processes, including dendritic transport of 
neurotransmitters and mRNA, intraflagellar transport in the specialized vertebrate photoreceptor 
and olfactory sensory cilia, and stabilization of microtubule polarity (Guillaud et al., 2003; Jaulin 
and Kreitzer, 2010; Yin et al., 2012; Setou et al., 2000; Yin et al., 2011; Insinna et al., 2008; 
2009; Takano et al., 2007; Jenkins et al., 2006). Further, structure-function experiments 
discovered that KIF17 contains a sequence within the C-terminal tail that mediates both its 
nuclear and ciliary entry (Dishinger et al., 2010). Interestingly, KIF17 interacts with and 
regulates the delivery of signaling molecules to primary cilia (Jenkins et al., 2006). For example, 
KIF17 delivers cyclic nucleotide-gated channels to the ciliary membrane in MDCK kidney 
epithelial cells (Jenkins et al., 2006). Similar to KIF17, KAP3 also shuttles between the nuclear 
and ciliary compartments in sea urchin embryos (Morris et al., 2004); however, whether KAP3 
localizes to the nucleus in vertebrates requires further investigation. Together these studies 
suggest that, similar to GLI proteins, members of both the heterotrimeric and homodimeric 
kinesin-2 complexes localize to both cilia and nuclear compartments. 
  Both the heterotrimeric KIF3A/KIF3B/KAP3 and the homodimeric KIF17 motor 
complex are expressed in multiple neuronal tissues where they play indispensible roles in 
regulating plus-end-directed microtubule cargo transport. GLI proteins, like the kinesin-2 
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complexes, are also highly expressed in many different neuronal tissues where they function to 
transduce HH signaling during embryonic and postnatal neurological processes (Ruiz i Altaba et 
al., 2002). Although kinesin-2 motors have been implicated as regulators of HH signaling for 
over a decade, whether these motors directly regulate HH signaling through interactions with 
GLI proteins, or other HH components, has not been assessed.   
  
1.5 Conclusion 
 Vertebrate GLI proteins undergo extensive regulation both in the presence and absence of 
HH signaling to ensure that HH target genes are properly regulated. In Drosophila, the GLI 
homolog Ci functions as both a transcriptional activator and repressor, whereas these duties have 
been split between three mammalian GLI proteins, GLI1, GLI2 and GLI3. Processing and 
activation of GLI proteins is a highly regulated process that requires modifications by and 
interactions with many different proteins, including SUFU, PKA, and KIF7. Recent studies 
indicate that the interactions between SUFU, PKA, and KIF7 and GLIs are further modulated by 
their localization to primary cilia. Despite the large body of evidence that suggest GLI trafficking 
to cilia is required for proper transcriptional activity, the mechanisms that regulate these 
trafficking events remain unknown.   
 Like GLI proteins, kinesin-2 protein complexes, namely the heterotrimeric 
KIF3A/KIF3B/KAP3 and homodimeric KIF17 complex, localize to multiple subcellular 
compartments where they regulate plus-end-directed microtubule trafficking. This in 
combination with the finding that KIF7 lacks plus-end-directed motoring capabilities makes 
kinesin-2 motor complexes presumptive candidates for regulating GLI subcellular trafficking; 
thus I dedicated my doctoral research to assessing a role for both the heterotrimeric 
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KIF3A/KIF3B/KAP3 and the homodimeric KIF17 complexes in regulating GLI protein 
trafficking and function.  
 A difficult problem still remains: How do you assess a role for the KIF3A/KIF3B/KAP3 
complex in regulating Gli proteins away from its function in ciliogenesis?  In Chapter II, I tackle 
this problem by performing a series of structure-function analyses to define novel, specific 
interactions between GLI proteins and components of the heterotrimeric complex. Using a 
combination of cell signaling assays and chicken in ovo electroporations, I test the significance 
of these interactions on GLI transcriptional activity. In Chapter III, I investigate a role for the 
homodimeric KIF17 complex in regulating GLI protein activity. Here, I take a biochemical 
approach to assess physicals interactions between KIF17 and each of mammalian GLI proteins. 
Further, I examine a functional role for KIF17 in regulating GLI protein function and subcellular 
localization in cells expressing a version of KIF17 that lacks the conserved motor domain. 
Lastly, I take advantage of the viability of Kif17-/- mice and thoroughly assess both the 
expression of KIF17 during HH-dependent cerebellar development and the consequences of 
cerebellar proliferation in the absence of KIF17.  
  
 
 
 
 
 
 
 
	  	  25	  
1.6 Figures 
 
 
Figure 1.1. Schematic of the vertebrate Hedgehog (HH) signaling pathway.  
(Left) In the absence of HH signaling, PTCH1 constitutively inhibits the activity of SMO, a key 
transducer of the HH signaling pathway. This leads to processing of GLI transcription factors 
into transcriptional repressors that restrict HH target gene expression, including Ptch1 and Gli1. 
(Right) HH ligand binding to PTCH1 and the co-receptors, GAS1, CDON, and BOC relieves 
PTCH1 inhibition of SMO leading to processing of GLI transcription factors into transcriptional 
activators that bind DNA and activate HH target gene transcription. 
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Figure 1.2. Schematic representation of domains and motifs in GLI proteins.  
Structural domains and modification sites within Drosophila GLI protein, Cubitus interruptus 
(Ci) and mouse GLI1, GLI2, and GLI3 are represented. Figure adapted from (Hui and Angers, 
2011) 
 
	  	  27	  
 
Figure 1.3. A gradient of SHH signaling specifies distinct neuronal progenitor domains in 
the ventral neural tube. In the developing spinal cord, SHH secreted from the notochord and 
later the floor plate establishes a gradient of HH ligand within the ventral neural tube. This 
gradient induces (Class II; Nkx6.1, Olig2, Nkx2.2, FoxA2, Dbx1, Dbx2) and represses (Class I; 
Pax7, Pax3) HH target genes in a concentration-dependent manner. Combinatorial expression of 
these transcription factors along the dorsal-ventral axis specifies 5 distinct ventral neuronal 
progenitor domains. 
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Figure 1.4. Intraflagellar trafficking in primary cilia. 
Cargo is transported from the base to the tip of primary (anterograde trafficking) along the 
microtubule axoneme by kinesin-2 motor proteins along with intraflagellar transport A (IFT A) 
and IFT B complexes. The dynein motor (which consist of cytoplasmic dynein 2 heavy chain 1 
(DYNC2H1) and cytoplasmic dynein 2 light chain 1 (DYNC2LI1)) mediates the return of IFT 
complexes to the base of primary cilia (retrograde trafficking) complexes. Figure adapted from 
(Goetz and Anderson, 2010). 
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Figure 1.5. Ciliary trafficking of vertebrate HH signaling pathway components. (Left) In the 
absence of HH signaling, GLI2 and GLI3 cycle through cilia at low levels and are subsequently 
phosphorylated by PKA, CKI and GSK3β upon ciliary exit. This leads to their proteolytic 
cleavage to generate the repressor forms, GLI2R and GLI3R, respectively. (Right) In the 
presence of HH signaling, SMO is activated and accumulates in primary cilia. The activation of 
SMO results in increased ciliary accumulation of SUFU-GLI2 and SUFU-GLI3 complexes, 
dissociation of the GLI–SUFU complex, and the transport of full-length, activated GLI2 and 
GLI3 proteins from the cilia to the nucleus bypassing proteolytic processing.  
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Figure 1.6. Kinesin-2 motor protein complexes.  
Schematic representation of the three kinesin-2 motor protein complexes: (1) heterotrimeric 
KIF3A/KIF3B/KAP3, (2) heterotrimeric KIF3A/KIF3C/KAP3, and (3) the homodimeric KIF17 
complex. Figure adapted from (Verhey and Hammond, 2009).  
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CHAPTER II: 
 
 
 
The Heterotrimeric Kinesin-2 Complex Interacts with and Regulates GLI 
Protein Function 
 
2.1 Abstract 
 GLI transport to the primary cilium and nucleus is required for proper HH signaling; 
however, the mechanisms that mediate these trafficking events are poorly understood. Kinesin-2 
motor proteins regulate ciliary transport of cargo, yet their role in GLI protein function remains 
unexplored. To examine a role for the heterotrimeric KIF3A/KIF3B/KAP3 kinesin-2 motor 
complex in regulating GLI activity, we performed a series of structure-function analyses using 
biochemical, cell signaling and in vivo approaches that define novel, specific interactions 
between GLI proteins and two components of this complex, KAP3 and KIF3A. We find that all 
three mammalian GLI proteins interact with KAP3 and map specific interaction sites in both 
proteins. Further, we find that GLI proteins interact selectively with KIF3A, but not KIF3B and 
that GLI interacts synergistically with KAP3 and KIF3A. Using a combination of cell signaling 
assays and chicken in ovo electroporations, we demonstrate that KAP3 interactions restrict GLI 
activator, but not GLI repressor function. These data suggest that GLI interactions with 
KIF3A/KIF3B/KAP3 complexes are essential for proper GLI transcriptional activity. 
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2.2 Introduction 
 Hedgehog (HH) signaling is an evolutionarily conserved pathway that is indispensible for 
embryonic development and functions in adult tissue homeostasis, renewal, and regeneration 
(reviewed in (McMahon et al., 2003; Briscoe and Thérond, 2013). Vertebrate HH signaling 
initiates when secreted HH ligands bind to the twelve-pass transmembrane receptor Patched 
(PTCH1) (Stone et al., 1996; Marigo et al., 1996) and to the co-receptors GAS1, CDON, and 
BOC (Allen et al., 2011); this relieves inhibition of Smoothened (SMO), a seven-pass 
transmembrane GPCR-like protein that initiates a signal transduction cascade culminating in 
modulation of the GLI family of zinc-finger transcription factors (GLI1-3) (Hui and Angers, 
2011). As effector molecules of the HH pathway, GLI proteins act in the nucleus to both activate 
and repress HH target gene expression (Ruiz i Altaba, 2011; Sasaki et al., 1999; Stamataki, 2005; 
Vokes et al., 2007).  
 There are three mammalian GLI proteins– GLI1, which functions exclusively as a 
transcriptional activator and is dispensable for mammalian development (Bai et al., 2002), GLI2, 
the main transcriptional activator of the HH pathway (Ding et al., 1998; Bai et al., 2002), and 
GLI3, which acts primarily as a transcriptional repressor (Altaba, 1999; Bai et al., 2004). GLI2 
and GLI3 both contain N-terminal repressor and C-terminal activation domains that regulate 
their function (Sasaki et al., 1999; Aza-Blanc et al., 2000; Stamataki, 2005). In the absence of 
HH signaling, GLI2 and GLI3 are proteolytically processed into N-terminal repressors that 
inhibit HH target gene transcription (Wang et al., 2000). Conversely, HH ligand stimulation 
promotes the accumulation of full-length GLI2 and GLI3 that activate HH target gene 
transcription (Pan et al., 2006). 
	  	  46	  
 Recent studies indicate a significant role for primary cilia in the regulation of GLI protein 
processing and function (reviewed by Nozawa et al., 2013).  GLI2 and GLI3 constitutively 
traffic through primary cilia at low levels (Haycraft et al., 2005; Norman et al., 2009) while HH 
pathway activation promotes GLI2 and GLI3 accumulation at the tips of primary cilia (Endoh-
Yamagami et al., 2009; Wen et al., 2010); this correlates with the accumulation of full-length 
GLI proteins that activate HH target gene transcription. Notably, all mammalian GLI proteins 
traffic to primary cilia (Haycraft et al., 2005), and disruption of ciliogenesis affects both 
processing and function of GLI2 and GLI3, which results in digit formation and neural tube 
patterning defects  (Haycraft et al., 2005; Liu et al., 2005). Despite their implication in GLI 
protein regulation, the mechanisms by which primary cilia regulate GLI activity and processing 
are not well understood.   
 Intraflagellar transport (IFT) complexes are responsible for cilia formation, maintenance, 
and trafficking of cargo within primary cilia (reviewed by Pedersen and Rosenbaum, 2008). 
These complexes consist of IFT particles (A and B) that are trafficked along microtubule-based 
axonemes by anterograde (kinesin-2) and retrograde (dynein) motor proteins (reviewed by Goetz 
and Anderson, 2010). Roles for these various IFT components in GLI protein ciliary trafficking 
are starting to emerge. For example, mutations in genes that encode for components of retrograde 
motors (Dync2h1), IFT A complexes (Ift122), or IFT B complexes (Ift25) cause GLI protein 
mislocalization at ciliary tips that correlates with aberrant HH signaling (Ocbina et al., 2011; Qin 
et al., 2011; Keady et al., 2012). While these studies indicate a role for IFT particles and 
retrograde motors in GLI processing and function, the mechanisms of how GLI proteins are 
trafficked within and between subcellular compartments remains largely unexplored.    
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 One outstanding question is: what regulates the intracellular trafficking of GLI proteins 
between the cytoplasm, nucleus, and primary cilium? The KIF3A/KIF3B/KAP3 heterotrimeric 
complex is an evolutionarily conserved kinesin-2 motor that mediates plus-end-directed protein 
transport along microtubules and plays important functional roles in both ciliary and intracellular 
transport (reviewed by Scholey, 2013; Cole et al., 1993; Wedaman, 1996). Mutations in Kif3a, 
Kif3b, or the non-motor component, kinesin-associated protein (Kifap3; referred to hereafter as 
Kap3) cause ciliary defects that lead to mid-gestation lethality and randomization in left-right 
asymmetry (Takeda et al., 1999; Hirokawa, 2000; Nonaka et al., 1998). Mice lacking KIF3A also 
display aberrant neural tube patterning similar to phenotypes seen in mice containing mutations 
that prevent HH pathway activation (Huangfu et al., 2003). Previous work in vertebrates 
identified KAP3 as an armadillo repeat-containing protein that forms a heterotrimeric complex 
with KIF3A and KIF3B and scaffolds cargo to the motors (Yamazaki et al., 1995; 1996). Similar 
to Kif3a and Kif3b mutant mice, Kap3 mutant mice die during mid-gestation (Teng et al., 2005) 
due to the central role of the heterotrimeric kinesin-2 complex in ciliogenesis (reviewed in 
(Scholey, 2013). Further, it is this critical role for KIF3A, KIF3B, and KAP3 in ciliogenesis that 
complicates the use of genetics to address their role in HH signaling and explains why a role for 
these molecules in regulating GLI protein activity has remained elusive.  
 In order to dissect the role of the KIF3A/KIF3B/KAP3 complex in directly regulating 
GLI protein trafficking and function independent of its role in ciliogenesis, we employed a 
combination of biochemical, cell signaling, and in vivo approaches to define novel interactions 
between GLI proteins and members of the kinesin-2 motor complex. Specifically we 
demonstrate that both KAP3 and KIF3A, but not KIF3B interact with GLI proteins and map the 
site of these interactions between all three proteins. Further, using cell signaling assays and 
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chicken in ovo electroporations we find that KAP3 restricts GLI activator, but not GLI repressor 
function. Together, these data identify novel, selective physical interactions between kinesin-2 
motor complex components that specifically regulate GLI protein function. 
 
2.3 Results 
KAP3 localizes with GLI2 and GLI3 in different subcellular compartments 
 To determine whether the heterotrimeric KIF3A/KIF3B/KAP3 complex co-localizes with 
GLI proteins, we initially compared the distribution of endogenous GLI2 and GLI3 with 
endogenous KAP3 in mouse embryonic fibroblasts (MEFs) (Figure 2.1). In wildtype MEFs, both 
GLI2 and GLI3 localize to multiple subcellular compartments including the nucleus, cytoplasm, 
and the tips of primary cilia (Figure 2.1A and Figure 2.1B, top rows). Similar to GLI2 and GLI3, 
KAP3 localizes to multiple subcellular compartments and co-localizes with GLI2 and GLI3 
within the tips of primary cilia  (Figure 2.1A and Figure 2.1B, top rows, white arrows). While 
GLI2 and GLI3 co-localize with KAP3 largely at the tips of primary cilia in wildtype MEFs, co-
localization is observed along the entire length of the cilium in Dync2h1 mutant MEFs that are 
defective in retrograde ciliary trafficking (Figure 2.1A, middle row and Figure 2.1B, bottom 
row;(Ocbina et al., 2011). Further, KAP3 localizes to primary cilia in Gli2-/-;Gli3-/- MEFs 
suggesting that endogenous KAP3 ciliary localization is independent of GLI2 and GLI3 (Figure 
2.1A, bottom row).  
 In addition to assessing endogenous co-localization, we also compared the distribution of 
endogenous GLI2 and GLI3 with epitope-tagged KAP3A (KAP3A::HA) in HH-responsive 
NIH/3T3 fibroblasts (Figure 2.1; Figure 2.2). Similar to what we observe in MEFs, endogenous 
GLI2 and GLI3 localize to multiple subcellular compartments including the cytoplasm, nucleus, 
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and primary cilium (Figure 2.1A and Figure 2.2A, top row). Similarly, KAP3A::HA localizes to 
multiple subcellular compartments and co-localizes with endogenous GLI2 and GLI3 in primary 
cilia (Figure2.1A and Figure 2.2A, white arrows).  More importantly, KAP3A::HA distribution 
is similar to endogenous KAP3 confirming that KAP3A::HA localizes to the same subcellular 
compartments as endogenous KAP3 (Compare Figure 2.1A and Figure 2.2A).  
 To confirm the specificity of the endogenous GLI2 and GLI3 antibodies in NIH/3T3 cells 
and to assess whether KAP3A::HA ciliary localization requires GLI2 and/or GLI3, we examined 
KAP3A::HA localization in Gli2-/-;Gli3-/- MEFs (Figure 2.3A and Figure 2.2A, bottom rows). In 
Gli2-/-;Gli3-/- MEFs, no GLI2 or GLI3 antibody signal is detected however KAP3A::HA still 
localizes to primary cilia (Figure 2.3A and Figure 2.2A, bottom rows). These data indicate that 
like endogenous KAP3, KAP3A::HA localizes to primary cilia independently of GLI2 and GLI3. 
 To further assess GLI2/KAP3A co-localization, we expressed an epitope-tagged version 
of GLI2 (MYC::GLI2) in NIH/3T3 cells (Figure 2.2B). MYC::GLI2 localizes to both the nucleus 
and cytoplasm and co-localizes with KAP3A::HA in these subcellular compartments (Figure 
2.2B).  These data suggest that in addition to primary cilia, GLI2 can co-localize with KAP3 in 
the cytoplasm and nucleus when expressed at similar levels. 
 
KAP3A and KAP3B specifically interact with all full-length mammalian GLI proteins 
 To investigate whether KAP3 proteins physically interact with GLI2, we performed co-
immunoprecipitation experiments in COS-7 cells. Two isoforms of mammalian KAP3 exist– 
KAP3A and KAP3B (Yamazaki et al., 1996). KAP3A is a 792 amino acid protein containing 
nine armadillo repeats (Yamazaki et al., 1996). KAP3B is an alternatively spliced isoform of 
KAP3A that contains a 66 base pair insertion immediately downstream of the codon for amino 
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acid 757, generating a truncated 772 amino acid protein (Yamazaki et al., 1996). COS-7 cells 
were co-transfected with MYC::GLI2 and either KAP3A::HA or KAP3B:HA followed by 
immunoprecipitation and western blot analysis (Figure 2.3, B and C). We find that both 
KAP3A::HA and KAP3B::HA co-precipitate with MYC::GLI2 (Figure 2.3B). Similarly, 
immunoprecipitation of either KAP3A::HA or KAP3B::HA also co-precipitates MYC::GLI2 
(Figure 2.3C). Notably, both KAP3A::HA and KAP3B::HA appear to be stabilized in the 
presence of GLI2 (Figure 2.3, B and C, cf. KAP3 expression in lysates from cells transfected 
with KAP3 alone and lysates co-transfected with KAP3 and GLI2). In contrast, KAP3A and 
KAP3B do not interact significantly with the structurally related, zinc finger containing 
transcription factor, ZIC1 (Figure 2.4A). Overall, these data suggest that GLI2 specifically 
interacts with both isoforms of KAP3.  
 The physical association of GLI2 with KAP3A and KAP3B prompted us to ask whether 
KAP3A and KAP3B also interact with the other full-length mammalian GLI proteins, namely 
GLI1 and GLI3. Similarly to GLI2, we find that KAP3A co-precipitates with either GLI1 or 
GLI3 (Figure 2.3D, top panels) and that immunoprecipitation of KAP3A also co-precipitates 
GLI1 and GLI3 (Figure 2.3D, middle panels). We also find that KAP3B co-precipitates with 
GLI1 and GLI3 (Figure 2.3E). Taken together, these data indicate that KAP3A and KAP3B 
physically interact specifically with all three mammalian GLI proteins. 
 To determine whether the interaction between GLI and KAP3 proteins is direct, we 
purified FLAG-tagged GLI1 and FLAG-tagged KAP3A from cell lysates (Figure 2.3F) and 
performed immunoprecipitation experiments using an antibody directed against endogenous 
KAP3 (Figure 2.3G). We find that purified FLAG::GLI1 co-precipitates with purified 
KAP3A::FLAG (Figure 2.3G). In contrast, purified GFP::FLAG does not co-precipitate with 
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KAP3A (Figure 2.3G). These results suggest that GLI proteins interact directly and specifically 
with KAP3. 
 
GLI2 selectively interacts with kinesin-2 motors and synergistically binds KIF3A and KAP3A 
 The mechanism by which KAP3 facilitates cargo binding as part of the KIF3A/KIF3B 
motor complex is not well understood, and whether this complex is involved in transport of the 
GLI proteins has yet to be addressed. Previous work indicates that KIF3A/KIF3B can exist as a 
separate heterodimeric complex that can bind cargo in the absence of KAP3 (Huang et al., 2011; 
Yamazaki et al., 1995; 1996), suggesting that kinesin-2 motors may use multiple mechanisms to 
associate with cargo. To test whether KIF3A and KIF3B themselves can interact with GLI 
proteins, we performed immunoprecipitation studies in COS-7 cells transfected with 
MYC::GLI2 and either KIF3A::HA or KIF3B::HA (Figure 2.5A). As a control, we performed 
similar experiments in COS-7 cells expressing KAP3A::FLAG and either KIF3A::HA or 
KIF3B::HA (Figure 2.5A).  
 Surprisingly, immunoprecipitation of GLI2 co-precipitates KIF3A, but not KIF3B 
(Figure 2.5A, top panels). In contrast, both KIF3A and KIF3B co-precipitate with KAP3 (Figure 
2.5A, middle panels). Importantly, KIF3A and KIF3B are expressed at equal levels in cell 
lysates, indicating that protein expression is not an explanation for this discrepancy (Figure 2.5A, 
lower panels). Quantitation of these interactions over three separate experiments indicates that 
nearly 25 times as much KIF3A precipitates with GLI2 compared to KIF3B (Figure 2.5B), while 
relatively equal amounts of KIF3A and KIF3B interact with KAP3 (KIF3A:KIF3B ~1; Figure 
2.5B). Together these data suggest that GLI2 can interact with kinesin-2 motors, and that GLI2 
preferentially interacts with KIF3A. 
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 Since the majority of KAP3 in the cell associates with KIF3A/KIF3B (Yamazaki et al., 
1995; Yamazaki et al., 1996), we examined whether the co-expression of KAP3A with KIF3A or 
KIF3B would promote interactions with GLI2. We immunoprecipitated MYC::GLI2 from COS-
7 cells expressing KAP3A::FLAG and either KIF3A::HA (Figure 2.5C) or KIF3B::HA (Figure 
3D).  Strikingly, co-expression of KAP3A and KIF3A results in significantly more co-
precipitation of both proteins with GLI2 compared to expression of either protein individually 
(Figure 2.5C; top panel, cf. lane 5 and lane 8; second panel, cf. lane 6 and lane 8). In stark 
contrast, co-expression of KAP3A and KIF3B does not enhance the amount of KIF3B (Figure 
2.5D; top panel, cf. lane 5 and lane 8) or KAP3A (Figure 2.5D; second panel, cf. lane 6 and lane 
8) that co-precipitates with GLI2. Taken together, these data suggest that GLI2 preferentially 
interacts with KIF3A compared to KIF3B and that co-expression of KIF3A and KAP3A 
promotes synergistic interactions of both proteins with GLI2.  
 
The armadillo repeats in KAP3 mediate interactions with GLI2 
 We next performed a complementary set of biochemical experiments to determine the 
regions within KAP3A and KIF3A that are required to interact with GLI proteins. Previous work 
indicates that KAP3A interacts with cargo proteins via its armadillo repeats (Gindhart and 
Goldstein, 1996; Jimbo et al., 2002; Morris et al., 2004; Brown et al., 2005); however, whether 
KAP3A interacts with GLI proteins in a similar manner is unclear. To test this, we generated two 
epitope-tagged, truncated versions of KAP3A (KAP3AΔC::HA and KAP3AΔN::HA; Figure 
2.5E). These constructs alternately delete over 100 amino acids C-terminal (KAP3∆C) or N-
terminal (KAP3∆N) of the centrally-located armadillo repeats of KAP3. Immunoprecipitation of 
GLI2 co-precipitates full-length KAP3A, KAP3A∆C, and KAP3A∆N (Figure 2.5F). These data 
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are consistent with the notion that the armadillo repeats in KAP3A mediate interactions with 
GLI2. Attempts to identify specific armadillo repeats in KAP3 that are required to interact with 
GLI proteins were hindered by poor expression of these constructs, thus precluding further 
analysis (data not shown). 
 
The N-terminal motor domain of KIF3A is dispensable for interactions with GLI2 
 To map the domain within KIF3A that mediates interactions with GLI proteins, we 
immunoprecipitated MYC::GLI2 from cells expressing either KIF3A::HA or a version of KIF3A 
that lacks the conserved N-terminal motor domain, DNKIF3A::HA (Figure 2.5G). KIF3A and 
DNKIF3A both co-precipitate with GLI2, albeit less strongly when compared to KAP3A (Figure 
2.5H, top panels). Notably DNKIF3A is expressed at lower levels than full-length KIF3A, which 
may explain the quantitative difference in GLI2 association (Figure 2.5H, bottom panels). 
Regardless, these data indicate that the motor domain of KIF3A is dispensable for interactions 
with GLI2.   
 
KAP3A interacts with constitutive GLI repressor, but not constitutive GLI activator 
 Given that GLI1-3 interact with KAP3, we sought to identify the domains within the GLI 
proteins that mediate binding to KAP3. Specifically, we examined the requirements for the N- 
and C-termini of the GLI proteins in KAP3 interactions (Figure 2.6). Here we took advantage of 
the high degree of sequence conservation shared between mammalian GLI2 and GLI3 proteins. 
GLI2 and GLI3 contain a conserved amino-terminal transcriptional repressor domain, and a 
carboxy–terminal transcriptional activation domain (Sasaki et al., 1999). We generated two 
construct: one that encodes an epitope-tagged, C-terminal truncated GLI3 (MYC::GLI3R) that 
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functions as a constitutive transcriptional repressor (Meyer and Roelink, 2003) and a second that 
encodes an epitope-tagged, N-terminal truncated, constitutively active GLI2 (MYC::GLI2ΔN; 
(Roessler et al., 2005); Figure 2.6A).  
 To confirm the activity of these constructs, we tested their function in a cell-based HH 
reporter assay. Consistent with previous reports, full-length GLI2 induces an approximately a 12-
fold increase in HH-dependent luciferase expression in NIH/3T3 fibroblasts compared to no 
treatment (Kim et al., 2009); Figure 2.6B). This is similar to the level of induction observed 
when cells are exposed to NSHH-conditioned medium (Figure 2.6B). Importantly, we observed a 
synergistic induction of luciferase activity (~ 40-fold induction) when Gli2-transfected cells were 
also treated with NSHH-conditioned medium (Figure 2.6B). These results confirm that 
MYC::GLI2 functions to activate HH-dependent transcription in NIH/3T3 cells.  
 In contrast to full-length GLI2, expression of constitutively active MYC::GLI2ΔN results 
in approximately 90-fold induction of luciferase activity (Figure 2.6C). These results support 
previous studies (Roessler et al., 2005; Sasaki et al., 1999) and confirm that MYC::GLI2ΔN 
functions to activate HH signaling at high levels in mammalian cells. To determine the 
requirement for the N-terminal domain of GLI2 in mediating KAP3 binding, we performed 
additional co-immunoprecipitation studies (Figure 2.6D). Surprisingly, while full-length GLI2 
and GLI2∆N are expressed at similar levels in cell lysates and are precipitated equivalently, 
KAP3A only co-precipitates with full-length GLI2 and does not significantly interact with 
GLI2∆N (Figure 2.6D). These data suggest that the amino-terminal domain of GLI2 is required 
to interact with KAP3 proteins. 
 We next tested MYC::GLI3R activity in luciferase assays and compared its function to 
full-length MYC::GLI3 (Figure 2.6F). Unlike GLI2, full-length GLI3 does not induce significant 
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HH pathway activity in the absence of ligand treatment (Figure 2.6F). Further, treatment of cells 
expressing full-length GLI3 with NSHH-conditioned medium does not significantly induce 
luciferase activity beyond that observed with NSHH treatment alone (Figure 2.6F). These data 
are consistent with the current paradigm that GLI3 functions mainly as a transcriptional repressor 
in vivo (Wang et al., 2000). In contrast, MYC::GLI3R induces a small, but significant decrease 
in luciferase induction when compared to no treatment in the absence of HH ligand treatment 
(Figure 2.6F). Similarly, MYC::GLI3R significantly decreases NSHH-mediated luciferase 
induction (Figure 2.6F). These data confirm that MYC::GLI3R functions as a transcriptional 
repressor in cell signaling assays.  
 We performed immunoprecipitation studies with full-length GLI3 and GLI3R to assess 
interactions with KAP3A (Figure 2.6G). Similarly to Figure 2, KAP3A co-precipitates with full-
length GLI3. Importantly, KAP3A also co-precipitates with GLI3R (Figure 2.6G). These data 
suggest that the N-terminus of GLI3 is sufficient to mediate physical interactions with KAP3A. 
Notably, immunofluorescence localization data demonstrate that GLI3R is localized exclusively 
to the nucleus (Figure 2.7). Taken together, these results further suggest that there is a common 
N-terminal domain in GLI2 and GLI3 that promotes interactions with KAP3.  
 
The N-terminus of GLI2 interacts with KAP3A 
 To more precisely map the domains within the GLI proteins that interact with KAP3A, 
we generated a series of epitope-tagged, N-terminal truncated versions of GLI2 (Figure 2.8A). 
GLI2ΔN, which fails to appreciably interact with KAP3A (Figure 2.6D), lacks the amino-
terminal 328 amino acids of GLI2 (Roessler et al., 2005). Therefore, we generated 
MYC::GLI2154-1586 to determine if amino acids 154 to 328 mediate KAP3 binding. Similar to 
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GLI2∆N, and in contrast to full-length GLI2, immunoprecipitation of MYC::GLI2154-1586 fails to 
co-precipitate KAP3A (Figure 2.8B). We employed this strategy iteratively, generating 
MYC::GLI261-1586 to assess whether amino acids 61 to 153 mediate GLI2 interactions with 
KAP3A. Importantly, GLI261-1586 does co-precipitate similar amounts of KAP3A as compared to 
full-length GLI2 (Figure 2.8B). These data suggest that GLI2 interacts with KAP3A via an N-
terminal motif that lies between amino acids 61 and 153. 
 To test the functional significance of this interaction, we again utilized luciferase reporter 
assays in HH-responsive NIH/3T3 cells (Figure 2.8C). While expression of full-length GLI2 
promotes a small but significant increase in luciferase activity, GLI2154-1586 induces an 
approximately 70-fold increase in luciferase activity, similar to the induction observed with 
GLI2∆N (cf. Figure 2.6C and 2.8C). In contrast GLI261-1586 promotes much lower levels of 
signaling (approximately 12-fold) which is similar to the induction observed with full-length 
GLI2 (Figure 2.8C). These data correlate GLI binding to KAP3 with reduced HH pathway 
activity. 
 Having narrowed the KAP3-binding domain in GLI2 to less than 100 amino acids, we 
generated two additional constructs to more finely map this interaction. We first generated 
GLI2108-1586, and similar to GLI2ΔN, GLI2108-1586 does not co-precipitate KAP3A as effectively 
as full-length GLI2 or GLI261-1586 (Figure 2.8D). These data suggest that amino acids 61 to 108 
are necessary to interact with KAP3A. Therefore, we also deleted these amino acids from full-
length GLI2 (GLI2∆61-108; Figure 2.8A). GLI2∆61-108 does not effectively co-precipitate KAP3A 
compared to full-length GLI2 (Figure 2.8D), confirming that amino acids 61-108 are essential 
for GLI2 interactions with KAP3.  
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 To further test the correlation between GLI-KAP3 interactions and reduced HH pathway 
activity (Figure 2.8C), we examined whether deletion of the domain responsible for KAP3 
binding might result in higher GLI activity. Indeed, GLI2Δ61-108 promotes approximately three-
fold greater luciferase induction than full-length GLI2 in cell signaling assays (Figure 2.8E). 
Together, these data identify an interaction between GLI2 and KAP3A that is mediated by 47 
amino acids within the N-terminus of GLI2 that acts to restrict GLI2 activity.  
 
KAP3A interactions with GLI3 do not alter GLI repressor function  
 To test whether the KAP3-binding domain identified in GLI2 could also mediate 
interactions between GLI3 and KAP3A, we generated a MYC::GLI3R∆134-182 construct that 
deletes the analogous motif in GLI3 (Figure 2.9A). Similar to GLI2∆61-108 (Figure 2.8D), 
GLI3R∆134-182 does not effectively co-precipitate KAP3A compared to full-length GLI3 and 
GLI3R (Figure 2.9B), demonstrating that the 47 amino acid KAP3-binding domain is conserved 
between GLI2 and GLI3.   
 We also compared the repressor function of GLI3R to GLI3R∆134-182 in the presence of 
NSHH-mediated luciferase induction (Figure 2.9C). Surprisingly, and in stark contrast to the 
transcriptional activation data obtained with GLI2, GLI3R and GLI3R∆134-182 are equally 
effective in repressing HH pathway activation (from approximately 4.5 fold to 1.5 fold) 
suggesting that perturbing the interaction between GLI3R and KAP3 does not alter GLI3 
repressor activity (Figure 2.9C). Taken together, these data indicate that the KAP3-binding 
domain is conserved between GLI2 and GLI3, and that KAP3-binding selectively restricts GLI 
activator, but not GLI repressor function. 
 
	  	  58	  
KAP3 interactions with GLI2 restrict HH pathway activation in vivo 
 To extend the observation that KAP3-GLI interactions selectively restrict GLI activator 
but not GLI repressor function, we utilized chicken in ovo neural tube electroporations (Figure 
2.10). Here, we can assess the consequences of GLI function on the expression of endogenous 
HH targets to readout different levels of HH pathway activation, including those targets (e.g. 
NKX2.2) that exclusively require GLI activator function for their expression (Bai et al., 2004; 
Bai and Joyner, 2001; Bai et al., 2002; Oosterveen et al., 2012; Peterson et al., 2012). 
 Electroporation of empty vector (pCIG) does not alter expression of the low level HH 
pathway target, NKX6.1 (Figure 2.10A). In contrast, electroporation of Gli2 promotes cell 
autonomous, ectopic NKX6.1 expression, as does electroporation of a KAP-binding deficient 
Gli2 construct (Gli2∆61-108) and constitutively active Gli2∆N (Figure 2.10A). Strikingly, GLI2 is 
not sufficient to promote ectopic NKX2.2 expression in the developing neural tube, while 
expression of a KAP3-binding deficient GLI2 (GLI2∆61-108) does induce cell autonomous 
NKX2.2 expression, similar to what is observed with expression of constitutively active GLI2ΔN 
(Figure 2.10B). Notably, ectopic NKX2.2+ cells are detected even in the dorsal most aspect of 
the chicken neural tube (Figure 2.10B, arrows).  
 To test whether KAP3-binding deficient GLI3R (GLI3R∆134-182) is sufficient to repress 
endogenous HH target genes in the developing chicken neural tube, we electroporated GLI3R 
and GLI3R∆134-182 and assessed PAX7 expression (Figure 2.11). While HH signaling 
normally restricts PAX7 expression to the dorsal neural tube, electroporation of GLI3R results in 
ventral expansion of PAX7 even in the ventral most aspect of the neural tube (Figure 2.11A, top 
row, white arrows). Similar to GLI3R, the KAP3-binding deficient GLI3R (GLI3R∆134-182) 
induces ectopic PAX7 expression throughout the ventral neural tube (Figure 2.11A, bottom row, 
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white arrows). Together, these data support the notion that KAP3-binding restricts the activator, 
but not repressor function of the GLI proteins.  
 
2.4 Discussion 
GLI proteins physically interact with the heterotrimeric kinesin-2 motor complex  
 Tightly regulated trafficking and processing of GLI proteins are vital for proper HH 
signaling (Haycraft et al., 2005; Kim et al., 2009). However, the mechanisms that regulate GLI 
protein function remain poorly understood. Here we present evidence that the heterotrimeric 
KIF3A/KIF3B/KAP3 kinesin-2 motor complex selectively regulates GLI activator function 
through multiple physical interactions (Figure 2.12A). Specifically, we find that all three 
mammalian GLI proteins physically interact with the kinesin-associated protein, KAP3. Further, 
we demonstrate that GLI2 and GLI3 interact with KAP3 via a conserved N-terminal 47 amino 
acid domain that restricts GLI activator, but not GLI repressor function. We also map the GLI 
binding site in KAP3 to the conserved armadillo repeats that mediate interactions with other 
KAP3 cargo proteins (Gindhart and Goldstein, 1996; Jimbo et al., 2002; Phang et al., 2014). In 
addition, we find that GLI proteins selectively interact with the KIF3A kinesin-2 motor 
component, but not appreciably with KIF3B. Strikingly, GLI proteins interact synergistically 
with KIF3A and KAP3, forming a robust complex that suggests GLI protein function is 
regulated by multiple interactions with the kinesin-2 motor complex. To our knowledge, this 
study provides the first evidence that GLI proteins physically interact with plus-end-directed 
kinesin-2 motor proteins, despite their implication in HH signaling for over a decade (Takeda et 
al., 1999; Huangfu et al., 2003). These results are of particular significance given that ciliary 
transport of cargo is currently believed to be largely mediated by interactions with IFT particles 
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(Scholey, 2003; Bhogaraju et al., 2013; Qin et al., 2004). However, our data suggest a novel 
paradigm where direct interactions of kinesin-2 motors with GLI protein cargo can regulate their 
trafficking and function. Notably, these results are consistent with recent work suggesting that 
kinesin-2 motors also mediate the anterograde trafficking of dynein proteins independently of 
IFT particles (Hao et al., 2011). Further studies are needed to elucidate whether ciliary 
trafficking of GLI proteins occurs independently of IFT and BBSome protein interactions. 
 
Complex regulation of GLI protein processing and activity 
 Multiple proteins modulate GLI transcriptional activity to control the output of HH 
signaling. Suppressor of Fused (SUFU) represses HH signaling by binding GLI proteins and 
preventing their nuclear transport (Kogerman et al., 1999; Barnfield et al., 2005). SUFU-GLI 
complexes traffic to primary cilia in response to HH stimulation, a process necessary for 
dissociation of the complex and subsequent nuclear translocation of GLI proteins (Tukachinsky 
et al., 2010), but the mechanisms that control complex assembly/disassembly are unclear. Here 
we show that KAP3 interacts with GLI2 and GLI3 and co-localizes with these proteins in 
primary cilia. KAP3 may control GLI activity through effects on SUFU-GLI complex formation. 
However, interactions between KAP3 and the constitutively nuclear localized GLI3R also 
suggest a role for KAP3 at the level of nuclear trafficking. It is plausible that the 
KIF3A/KIF3B/KAP3 complex controls both the nuclear and ciliary trafficking of GLI proteins, 
but further experiments are required to elucidate these mechanisms. It will be of particular 
interest to test whether KAP3 affects SUFU-GLI interactions and the requirement for cilia in this 
process. 
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KAP3 interactions with GLI proteins specifically regulate GLI activator function 
 We demonstrate that a conserved 47 amino acid domain in GLI2 and GLI3 mediates 
KAP3 interactions, and that deletion of this domain from GLI2 results in increased 
transcriptional activity. Notably this motif encompasses a portion of a previously identified N-
terminal repressor domain (Sasaki et al., 1999). As a result, one possibility is that the increase in 
GLI2 activity is simply due to loss of this poorly defined repressor domain. However, two key 
findings argue against this notion. First, elimination of the analogous domain in GLI3 does not 
alter GLI3 repressor function, suggesting that this domain does not possess general repressive 
activity. Second, electroporation of a KAP-binding deficient Gli2 construct in the developing 
chicken neural tube induces ectopic NKX2.2 expression, which requires GLI activator function 
and cannot be induced simply by the loss of GLI repression (Matise et al., 1998; Bai et al., 
2004). Together, these data support a novel paradigm where GLI-KAP3 interactions selectively 
restrict the activator, but not the repressor function of GLI proteins.  
 These observations are similar to SUFU regulation of GLI proteins, where GLI3 
repressor can function independently of SUFU (Wang et al., 2010).  In these studies, SUFU 
interacts with both GLI2 and GLI3, however GLI3 repressor is able to rescue the ventralized 
neural tube phenotype in Sufu-/- embryos (Wang et al., 2010). It is interesting to speculate that, 
similar to SUFU, KAP3 may regulate GLI activator proteins during transit to the nucleus, 
although the nature of GLI, KAP3 and SUFU interplay will require further study. 
  
Regulation of GLI function by kinesin proteins 
 Initial studies in Drosophila identified Cos2 as a kinesin-related protein that controls HH 
signaling through interactions with Ci, the Drosophila homologue of GLI (Sisson et al., 1997; 
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Robbins et al., 1997). More recent studies in vertebrates identified a similar role for the Cos2 
homologue, Kif7, in the regulation of GLI protein function (Liem et al., 2009; Endoh-Yamagami 
et al., 2009; Cheung et al., 2009). In particular, KIF7, and the structurally related kinesin KIF27, 
both interact with GLI proteins (Endoh-Yamagami et al., 2009; Cheung et al., 2009; Maurya et 
al., 2013; Marks and Kalderon, 2011), while KIF7 specifically functions to both promote and 
antagonize GLI activity (Maurya et al., 2013; Hsu et al., 2011; Li et al., 2012). KIF7 promotes 
HH signaling through dissociation of SUFU-GLI complexes, and controls the ciliary localization 
of GLI proteins in a tissue-specific manner (Hsu et al., 2011; Maurya et al., 2013; Endoh-
Yamagami et al., 2009). While the KIF7-GLI interaction sites have not been precisely mapped, 
GLI proteins appear to interact with KIF7 via multiple domains, including an N-terminal motif 
(Marks and Kalderon, 2011). One hypothesis is that KAP3 competes for KIF7 binding to GLI 
proteins, thus limiting dissociation of GLI-SUFU complexes and restricting GLI protein 
function. Interestingly, KIF7 functions to organize the ciliary tip compartment through the 
regulation of microtubule dynamics (He et al., 2014). Further, the effects of KIF7 are controlled 
by PPFIA1- and PP2A-mediated regulation of KIF7 phosphorylation (Liu et al., 2014).These 
results suggest that either the loss of KIF7 (He et al., 2014), or altered KIF7 phosphorylation 
(Liu et al., 2014), affects the ciliary localization and activity of GLI proteins. However, given 
that KIF7 does not possess plus-end-directed microtubule motor activity (He et al., 2014), one 
possibility is that KAP3-GLI protein interactions are disrupted in Kif7 mutant cells due to the 
disorganized ciliary tip compartments. It will be particularly important to test these interactions 
in cells with different KIF7 expression levels and phosphorylation states, and to assess the role of 
KIF7 in mediating kinesin-2 interactions with GLI proteins. 
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 Our data indicate that, in addition to KIF7 and KIF27, GLI proteins also interact with 
KIF3A, suggesting that multiple kinesin proteins control GLI function. That KIF3A interacts 
with GLI proteins independently of KAP3 has precedence in the literature. For example, the 
TRIM protein RNF33 interacts with KIF3A and KIF3B in mouse testis (Huang et al., 2011). 
Additionally, the protein phosphatases DUSP26 and POPX2 interact with both KIF3 and KAP3 
proteins (Tanuma et al., 2008; Phang et al., 2014). These data also raise the question of whether 
GLI proteins interact with yet additional kinesin proteins. Our results indicate that GLI2 
preferentially interacts with KIF3A, but not KIF3B, analogous to earlier data demonstrating 
selective interactions of GLI2 with KIF7 and KIF27 (Cheung et al., 2009). Future studies will be 
required to determine whether GLI proteins interact with: 1) additional kinesin-2 motors, 
including KIF3C and KIF17 (Yang et al., 2001; Yang and Goldstein, 1998; Insinna et al., 2008; 
Snow et al., 2004), 2) other kinesin motors implicated in ciliary trafficking (Morsci and Barr, 
2011), and 3) non-ciliary kinesin motors (Hirokawa et al., 2009). 
 In addition to kinesin-2 motors and their adaptor proteins, intraflagellar transport (IFT) 
particles, such as IFT25 and IFT122, also regulate GLI ciliary localization (Qin et al., 2011; 
Keady et al., 2012). However, whether this is mediated by physical interactions between GLI and 
IFT particles remains unexplored, and whether KAP3 interacts directly with these IFT particles 
has not been tested. One possibility is that, along with KAP3, IFT particles interact with GLI 
proteins to mediate ciliary GLI trafficking. In addition to their role in ciliary trafficking, IFT 
particles also function in trafficking outside of the primary cilium (reviewed by Baldari and 
Rosenbaum, 2010). For example, IFT particles traffic T-cell receptors to the immune synapse 
(Finetti et al., 2009). Future studies will determine whether IFT particles interact with GLI 
proteins and the consequences of these interactions on GLI processing and activity.  
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 In summary, despite the indirect role of KIF3A/KIF3B/KAP3 in HH signaling due to 
their role in ciliogenesis, our knowledge of whether these motors control HH signaling directly 
through interactions with HH pathway components has remained unexplored. Here we identify 
GLI proteins as novel cargo of the heterotrimeric kinesin-2 motor complex that physically 
interact with KAP3 and selectively interact with KIF3A, but not KIF3B. Based on our data we 
propose a model (Figure 2.12B) where GLI proteins interact with kinesin-2 motors via 
synergisitic interactions with KAP3 and KIF3A that selectively restrict GLI activator, but not 
GLI repressor function. We postulate that kinesin-2 motors may regulate: 1) anterograde GLI 
trafficking to ciliary tips, 2) GLI trafficking to the nucleus following ciliary transport, or 3) GLI 
transport to other cellular compartments (Figure 2.12B). While the precise molecular mechanism 
awaits elucidation, our findings identify a direct role for the kinesin-2 motor protein complex in 
HH signaling through physical interactions with GLI proteins that selectively regulate GLI 
transcriptional activity. 
 
2.5 Materials and Methods  
DNA Constructs 
 To generate 6X MYC-tagged constructs mGli1, hGli2, hGli2ΔN, hGli2280-1586, hGli2262-
1586, hGli2218-1586, hGli2154-1586, hGli2108-1586, hGli261-1586, hGli3, and hGli3R cDNAs were cloned 
into pCDNA3 using standard molecular biology techniques. To generate a version of hGLI2 
lacking amino acids 61-108 (hGli2∆61-108), we amplified hGli2 using forward  (5’-
TCTTGCCACCATTCCATGCGGCTGGCCCTGGGGAGTCCCC- 3’) and reverse (5’-	  
GGGGACTCCCCAGGGCCAGCCGCATGGAATGGTGGCAAGA-3’) mutagenesis primers. 
To generate a version of hGLI3R lacking amino acids 134-182 (hGLI3RΔ134-182) we amplified 
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hGLI3R using forward (5'-TTTTCCCTGCCTTCCATCCTACTGCTGCTTCCGAGTCTCC-3’) 
and reverse (5'-GGAGACTCGGAAGCAGCAGTAGGATGGAAGGCAGGGAAAA- 3’) 
mutagenesis primers. Hemagglutinin (HA)-tagged hKap3a, hKap3b, hKif3a, hDNkif3a, mKif3b, 
Flag (FLAG)-tagged hKap3a, HA-tagged hGli2∆N and 6X MYC-tagged hGli2 and hGli2Δ61-108 
cDNAs were cloned into pCIG (Megason and McMahon, 2002).  
 
Immunoprecipitation and Western Blot Analysis 
 COS-7 cells were transiently transfected with the relevant DNA constructs using 
Lipofectamine 2000 (Invitrogen, Cat. #11668). The cells were lysed 48 hr after transfection in 
HEPES lysis buffer (25mM HEPES pH 7.4, 115mM KOAc, 5mM NaOAc, 5mM MgCl2, 0.5mM 
EGTA, and 1% TX-100) containing protease inhibitor (Roche, Cat. #11836153001). Cell lysates 
were then subjected to centrifugation at 14,000 x g for 15 min to remove the insoluble fraction 
and protein concentrations were determined using a BCA Assay Kit (Pierce, Cat. #23225). Cell 
lysates (1mg) were then pre-cleared with Protein G agarose beads (Roche, Cat. #11719416001) 
for 1 hr at 4°C. MYC- or HA-tagged proteins were immunoprecipitated from pre-cleared lysates 
using either anti-MYC (1:150; Santa Cruz, Cat. #sc-40) or anti-HA (1:300; Covance, Cat. 
#MMS-101) antibodies for 2 hr at 4°C. Following immunoprecipitation, the lysates were 
incubated with Protein G agarose beads for 1 hr at 4°C. The Protein G agarose beads were 
washed 5 x 8 min in HEPES lysis buffer and re-suspended in 30 µl of 1x PBS and 6x Laemmli 
buffer. The samples were boiled for 10 minutes and proteins were separated using SDS-PAGE 
and analyzed by western blotting. Anti-MYC (1:1000) and anti-HA (1:1000) primary antibodies, 
peroxidase-conjugated AffiniPure goat anti-mouse light chain secondary antibody (1:50,000; 
Jackson ImmunoResearch, Cat. # 115-035-174), and a Konica Minolta SRX-101A medical film 
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processor were used to visualize tagged proteins. Western blots were quantified using ImageJ 
software. 
 
Purification and immunoprecipitation of FLAG-tagged proteins 
 For purification of GFP::FLAG, KAP3A::FLAG, and FLAG::GLI1, COS-7 cells were 
transfected with the appropriate DNA expression constructs. At 48 hr post-transfection, cells 
were harvested via lysis in a solution containing 50mM HEPES (pH 7.5), 150 mM NaCl, 1% 
Triton X-100, and a protease inhibitor cocktail. Lysates were centrifuged at 16,000 x g for 15 
min. The resulting supernatant was mixed with anti-FLAG M2 agarose beads (Sigma-Aldrich) 
and incubated for 2 hr at 4°C. After extensive washes in lysis buffer, bound proteins were eluted 
from the beads with two 20 min incubations with 300 µg/ml of 3X FLAG peptide (ApexBio) at 
25°C. Post elution lysates were subjected to SDS-PAGE and analyzed by Gel Code Blue staining 
(Thermo Scientific). Equal amounts of the eluted FLAG-tagged proteins were combined and 
KAP3A-FLAG was immunoprecipitated from lysates using mouse anti-KAP3 (BD Biosciences) 
and the same immunoprecipitation methods described above. A mouse Anti-FLAG antibody 
(1:1000, Sigma-Aldrich), peroxidase-conjugated AffiniPure goat anti-mouse light chain 
secondary antibody (1:50,000; Jackson ImmunoResearch), and a Konica Minolta SRX-101A 
medical film processor were used to visualize tagged proteins. 
 
Cell Culture and Luciferase Assays 
 NIH/3T3 cells were cultured at 37°C, 5% CO2, 95% humidity in Dulbecco’s modified 
eagle medium (DMEM; Gibco, Cat. #11965-092) containing 10% bovine calf serum (ATCC; 
Cat. #30-2030) and penicillin/streptomycin/glutamine (Gibco, Cat. #10378-016). Luciferase 
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assays were performed by plating 2.5 x 104 cells/well in 24 well plates. The next day cells were 
co-transfected using Lipofectamine 2000 with the DNA constructs indicated in each experiment 
in addition to Ptc∆136-GL3 (Chen et al., 1999; Nybakken et al., 2005) and pSV-Beta-
galactosidase (Promega) constructs to report HH pathway activation and normalize transfections, 
respectively. Cells were changed to low-serum media (DMEM supplemented with 0.5% bovine 
calf serum and penicillin/streptomycin/glutamine) 48 hr after transfection and cultured at 37°C in 
5%C02 for an additional 48 hr.  NSHH-conditioned medium was added immediately after low-
serum change where relevant to activate the HH pathway. Cells were harvested and luciferase 
and beta-galactosidase activities were measured using Luciferase Assay System (Promega Cat. # 
E1501) and BetaFluor β-gal assay kit (Novagen, Cat. #70979-3). Multiple assays were 
performed and each sample was assayed in triplicate. 
 
Immunofluorescence staining 
 NIH/3T3 fibroblasts were seeded at a density of 1.5 x 105 cells/well in 6 well plates. Cells 
were transfected 24 hr later with either empty vector (pCIG) or with a DNA construct encoding 
KAP3::HA using Lipofectamine 2000. Cells were grown in low-serum media starting 8 hr after 
transfection, fixed 48 hr post-transfection in 4% paraformaldehyde for 10 min at room 
temperature, and permeabilized with a 5 min incubation in 0.2% Triton X-100 in PBS. 
Immunostaining was performed using the following primary antibodies: mouse anti-acetylated 
tubulin (1:2500; Sigma), rabbit anti-gamma tubulin (1:2500; Sigma), mouse anti-KAP3 (1:500; 
BD Biosciences), rabbit anti-ARL13B (1:500; Proteintech), mouse anti-HA (1:1000; Covance), 
guinea pig anti-GLI2 (1:300; a gift from Dr. J.T. Eggenschwiler, University of Georgia), mouse 
anti-GLI3 (1:1000; obtained from Dr. S.J. Scales, Genentech). The following secondary 
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antibodies were used at a dilution of 1:500:  Alexa 488 goat anti-guinea pig IgG, Alexa 488 goat 
anti-mouse IgG2b, Alexa 555 goat anti-mouse IgG1, Alexa 633 goat anti-rabbit IgG. To 
visualize nuclei, DAPI (Invitrogen) was incubated for 5 min at a dilution of 1:30,000. Cells were 
imaged using a Leica Upright SP5X White Light Laser Confocal Microscope. Images were 
processed using Adobe Photoshop and Illustrator. 
 
Chick in ovo neural tube electroporations and immunostaining 
 Electroporations were performed as previously described (Allen et al., 2011). In brief, 
DNA (1.0 µg/µl) was injected into the neural tubes of Hamburger-Hamilton stage 10-12 chicken 
embryos with 50 ng/µl Fast Green. Embryos were dissected after 48 hours and fixed in 4% PFA 
for immunofluorescent analysis. The following antibodies were used for neural tube 
immunostaining: mouse IgG1 anti-NKX6.1 [1:20, Developmental Studies Hybridoma Bank 
(DSHB)], mouse IgG1 anti-PAX7 (1:20, DSHB), mouse IgG2b anti-NKX2.2 (1:20, DSHB). 
Nuclei were visualized using DAPI (1:30,000, Molecular Probes). Alexa 555 secondary 
antibodies (1:500, Molecular Probes) were visualized on a Leica Upright SP5X Light Laser 
Confocal Microscope. Images were processed using Adobe Photoshop and Illustrator. 
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2.8 Figures  
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Figure 2.1. Endogenous KAP3 and GLI proteins localize to primary cilia. 
(A) Antibody detection of endogenous GLI2 (green) and KAP3 (red) in wild-type (top row), 
Dync2h1lln/lln (middle row), or Gli2-/-;Gli3-/- MEFs (bottom row). Primary cilia are identified with 
antibodies against acetylated tubulin (AcTub; grey). (B) Antibody detection of endogenous GLI3 
(green) and KAP3 (red) in wild-type (top row) and Dync2h1lln/lln (middle row) MEFs (bottom 
row). Primary cilia are identified with antibodies against ARL13B (ARL13B; grey). Scale bar, 
10 µm. Arrows denote localization of KAP3A and GLI2 or GLI3 in primary cilia. 
 
 
 
Figure 2.2. KAP3A co-localizes with mammalian GLI proteins. 
 (A) Antibody detection of endogenous GLI3 in NIH/3T3 cells (top row; green) or Gli2-/-;Gli3-/- 
MEFs (bottom row; green) expressing HA-tagged KAP3A (KAP3::HA). Primary cilia are 
identified using antibodies directed against ARL13B (ARL13B; grey). DAPI denotes nuclei 
(blue). Insets represent high magnification images of primary cilia. Scale bar, 10µm. (B) 
Antibody detection of MYC::GLI2 (green) and KAP3A::HA (red) in NIH/3T3 cells.  DAPI 
(blue) identifies nuclei. Scale bar, 10µm. 
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Figure 2.3. KAP3 localizes and interacts with mammalian GLI proteins. 
(A) Antibody detection of endogenous GLI2 in NIH/3T3 cells (top row; green) or Gli2-/-;Gli3-/- 
MEFs (bottom row; green) expressing HA-tagged KAP3A (KAP3::HA; red). Primary cilia are 
identified using antibodies directed against acetylated tubulin (AcTub; grey). DAPI denotes 
nuclei (blue). Insets represent high magnification images of primary cilia. Scale bar, 10 µm. 
Arrows denote co-localization of KAP3A and GLI2 in primary cilia. (B) Immunoprecipitation of 
MYC-tagged GLI2 (MYC::GLI2) from COS-7 cells expressing either HA-tagged KAP3A 
(KAP3A::HA) or KAP3B (KAP3B::HA). (C) Immunoprecipitation of KAP3A::HA or 
KAP3B::HA from COS-7 cells co-expressing MYC::GLI2. (D) Immunoprecipitation of 
MYC::GLI1-3 or KAP3A::HA from COS-7 cells co-expressing MYC::GLI1-3 and/or 
KAP3A::HA. (E) Immunoprecipitation of MYC::GLI1-3 from COS-7 cells co-expressing 
MYC::GLI1-3, and/or KAP3B::HA. Immunoprecipitates (IP) and whole cell lysates (WCL) were 
subjected to SDS-PAGE and western blot analysis (IB) using antibodies directed against MYC 
(α-MYC) and HA (α-HA). Antibody detection of Beta-Tubulin (α-Beta-Tubulin) was used to 
confirm equal loading across lanes. (F) Gel Code Blue detection of affinity purified 
KAP3A::FLAG, FLAG::GLI1, and GFP::FLAG from COS-7 cell lysates. Asterisks (*) denote 
FLAG antibody heavy and light chains eluted from the FLAG agarose beads. (G) 
Immunoprecipitation (top blots) of purified KAP3A::FLAG using an endogenous KAP3 
antibody (IP: α-KAP3) followed by western blot analysis with anti-FLAG antibody (IB: α-
FLAG) to detect KAP3A::FLAG, FLAG::GLI1 or GFP::FLAG. 10% of the inputs (bottom blots) 
were visualized by western blot analysis to confirm equal protein levels. The molecular weights 
(in kDa) of protein standards are indicated at the left of each blot. 
 
 
 
 
 
Figure 2.4.  KAP3A does not interact with ZIC1. 
(A) Immunoprecipitation of MYC-tagged GLI2 (MYC::GLI2) or MYC-tagged ZIC1 
(MYC::ZIC1) from COS-7 cells expressing HA-tagged KAP3A (KAP3A::HA). 
Immunoprecipitates (IP) and whole cell lysates (WCL) were subjected to SDS-PAGE and 
western blot analysis (IB) using antibodies directed against MYC (α-MYC) and HA (α-HA). 
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Antibody detection of Beta-Tubulin (α-Beta-Tubulin) was used to confirm equal loading across 
lanes. The molecular weights (in kDa) of protein standards are indicated at the left of each blot. 
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Figure 2.5. GLI2 selectively interacts with kinesin-2 motors and synergistically binds the 
tail domain of KIF3A and the armadillo repeats of KAP3A. (A) Immunoprecipitation of 
MYC::GLI2 or KAP3A::FLAG from COS-7 cells expressing KIF3A::HA or KIF3B::HA. (B) 
Quantitation of the ratio of KIF3A:KIF3B that co-precipitates with either MYC::GLI2 or 
KAP3A::FLAG. Error bars represent the mean +/- S.D. of the band densities from three separate 
experiments; a p-value of 0.0008 indicates a significant difference in the KIF3A:KIF3B ratio that 
co-precipitates with MYC::GLI2 compared to KAP3A::FLAG (Student’s unpaired t-test). (C) 
Immunoprecipitation of MYC::GLI2 from COS-7cells expressing KIF3A::HA and/or 
KAP3A::FLAG. (D) Immunoprecipitation of MYC::GLI2 from COS-7 cells expressing 
KIF3B::HA and/or KAP3A::FLAG. Immunoprecipitates (IP) and whole cell lysates (WCL) were 
subjected to SDS-PAGE and western blot analysis (IB) using antibodies directed against MYC 
(α-MYC) and HA (α-HA). Antibody detection of Beta-Tubulin (α-Beta-Tubulin) was used to 
confirm equal loading across lanes. (E) Graphic representation of full-length and truncated 
human KAP3A proteins. KAP3A contains highly conserved armadillo repeats (dark blue), a 
KAP3A-specific sequence (gold), and an HA-tag at the C-terminus (purple). (F) 
Immunoprecipitation of MYC::GLI2 from COS-7 cells expressing KAP3A::HA, 
KAP3AΔC::HA, or KAP3AΔN::HA. (G) Graphic representation of full-length and truncated 
human KIF3A proteins. KIF3A contains a highly conserved motor domain (blue), a rod domain 
(grey), a cargo-binding tail domain (pink), and an HA-tag at the C-terminus (purple). (H) 
Immunoprecipitation of MYC::GLI2 from COS-7 cells expressing KAP3A::HA, KIF3A::HA, or 
DNKIF3A::HA. Immunoprecipitates (IP) and whole cell lysates (WCL) were subjected to SDS-
PAGE and western blot analysis (IB) using antibodies directed against MYC (α-MYC) and HA 
(α-HA). Antibody detection of Beta-Tubulin (α-Beta-Tubulin) was used to confirm equal 
loading across lanes. The molecular weights (in kDa) of protein standards are indicated at the left 
of each blot.  
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Figure 2.6. The N-termini of GLI2 and GLI3 interact with KAP3A. 
(A) Graphic representation of full-length and truncated human GLI2 proteins. A 6X MYC 
epitope tag (purple) is present at the N-terminus of each GLI2 protein. Highly conserved GLI2 
protein sequences include a transcriptional repressor domain (red, absent from hGLI2ΔN), SUFU 
binding site (orange, absent from hGLI2ΔN), five zinc-finger DNA binding domains (dark blue), 
phosphorylation cluster (light blue) and a transcriptional activation domain (green). (B) 
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Luciferase activity readout of HH signaling following treatment of NIH/3T3 fibroblasts with 
NSHH after transfection with either empty vector (No Treatment) or Gli2-pCDNA3 (Gli2). HH 
pathway activity is measured as fold luciferase induction. Error bars represent the mean +/- S.D. 
for triplicate samples from a single experiment and are representative of three independent 
experiments; p-values are indicated above the relevant treatment groups (Student’s unpaired t-
test). (C) Comparison of HH pathway activity in NIH/3T3 cells expressing hGLI2 or hGLI2ΔN. 
(D) Immunoprecipitation of MYC::GLI2 or MYC::GLI2ΔN from COS-7 cells co-expressing 
KAP3A::HA. Immunoprecipitates (IP) and whole cell lysates (WCL) were subjected to SDS-
PAGE and western blot analysis (IB) using antibodies directed against MYC (α-MYC) and HA 
(α-HA). Antibody detection of Beta-Tubulin (α-Beta-Tubulin) was used to confirm equal 
loading across lanes. The molecular weights (in kDa) of protein standards are indicated at the left 
of each blot. (E) Graphic representation of full-length and truncated human GLI3 proteins. (F) 
Luciferase activity readout of HH signaling following treatment of NIH/3T3 fibroblasts with 
NSHH after transfection with either empty vector (No Treatment), Gli3-pCDNA3 (Gli3), or 
Gli3R-pCDNA3 (Gli3R).  HH pathway activity is measured as fold luciferase induction. Error 
bars represent the mean +/- S.D. for triplicate samples in a single experiment and are 
representative of three independent experiments; p-values are indicated above the relevant 
treatment groups (Student’s unpaired t-test). n.s., not significant (p>0.05). (G) 
Immunoprecipitation of MYC::GLI3 or MYC::GLI3R from COS-7 cells co-expressing 
KAP3A::HA. 
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Figure 2.7.  Subcellular localization of MYC-tagged GLI constructs in NIH/3T3 cells. 
(A) Localization of MYC::GLI1, MYC::GLI2, MYC::GLI3, MYC::GLI3R, and MYC::GLI2ΔN 
in NIH/3T3 cells (green). Primary cilia are identified using antibodies directed against acetylated 
tubulin (AcTub; grey). DAPI denotes nuclei (blue). (B) Summary of subcellular localization of 
MYC-tagged GLI constructs (N=20 cells). Scale bar, 30µm. 
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Figure 2.8. GLI2 interacts with KAP3A via an N-terminal domain that restricts GLI2 
function.(A) Graphic representation of full-length and truncated human GLI2 proteins. (B) 
Immunoprecipitation of MYC::GLI2, MYC::GLI2ΔN, MYC::GLI2154-1586 or MYC::GLI261-1586 
from COS-7 cells expressing KAP3A::HA. (C) Luciferase activity readout of HH signaling after 
transfection with either empty vector (No Treatment), Gli2, Gli2154-1586 or Gli261-1586. HH 
pathway activity is measured as fold luciferase induction. Error bars represent the mean +/- S.D. 
for triplicate samples in a single experiment and are representative of three independent 
experiments; p-values are indicated above the relevant treatment groups (Student’s unpaired t-
test). (D) Immunoprecipitation of MYC::GLI2, MYC::GLI2ΔN, MYC::GLI2108-1586, 
MYC::GLI261-1586, or GLI2 Δ 61-108 from COS-7 cells expressing KAP3A::HA. 
Immunoprecipitates (IP) and whole cell lysates (WCL) were subjected to SDS-PAGE and 
western blot analysis (IB) using antibodies directed against MYC (α-MYC) and HA (α-HA). 
Antibody detection of Beta-Tubulin (α-Beta-Tubulin) was used to confirm equal loading across 
lanes. The molecular weights (in kDa) of protein standards are indicated at the left of each blot. 
(E) Comparison of full-length GLI2 and GLI2Δ61-108 activity in HH-responsive NIH/3T3 cells. 
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Figure 2.9. KAP3A interacts with an N-terminal GLI3 domain that does not alter GLI 
repressor function. (A) Graphic representation of full-length and truncated human GLI3 
proteins. (B) Immunoprecipitation of MYC::GLI3, MYC::GLI3R, or MYC::GLI3R∆134-182 
from COS-7 cells expressing KAP3A::HA. (C) Luciferase activity readout of HH signaling after 
transfection with either empty vector (No Treatment), Gli3R or Gli3∆134-182. HH pathway activity 
is measured as fold luciferase induction. Error bars represent the mean +/- S.D. for triplicate 
samples in a single experiment and are representative of three independent experiments; p-values 
are indicated above the relevant treatment groups (Student’s unpaired t-test). 
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Figure 2.10. KAP3 binding restricts GLI2 activity in vivo. 
(A) Transverse sections of Hamburger-Hamilton stage 21-22 chicken neural tubes electroporated 
with pCIG (top row), Gli2 (upper row), Gli2∆61-108 (lower row), or Gli2∆N (bottom row) were 
stained with antibodies raised against NKX6.1 (red). GFP expressing cells (green) denote 
electroporated cells. DAPI marks nuclei. Arrows indicate ectopic expression of NKX6.1. (B) 
Transverse sections of Hamburger-Hamilton stage 21-22 chicken neural tubes stained with 
antibodies raised against NKX2.2 (red). GFP expressing cells (green) denote electroporated cells. 
DAPI marks nuclei. Arrows indicate ectopic NKX2.2 expression. Scale bar, 100µm 
 
 
 
 
Figure 2.11. KAP3 binding does not alter GLI3R activity in vivo. 
(A) Transverse sections of Hamburger-Hamilton stage 21-22 chicken neural tubes electroporated 
with Gli3R (top row) or Gli3∆134-182 (bottom row) stained with antibodies raised against 
PAX7 (red). GFP expressing cells (green) denote electroporated cells. DAPI marks nuclei. 
Arrows indicate ectopic PAX7 expression. Scale bar, 100µm. 
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Figure 2.12. Model of GLI/kinesin-2 complex interactions and subcellular localization. 
(A) Schematic summary of biochemical interactions between GLI proteins (blue), KAP3 (grey), 
KIF3A (dark green), and KIF3B (yellow). Truncated versions of GLI proteins, GLI2ΔN and 
GLI3R, are represented in light green and red, respectively. Plus (+) and minus (-) represent the 
relative strength of interaction based on the immunoprecipitation studies with (-) indicating no 
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interaction and (++++) denoting the strongest interaction. (B) Graphic representation of the 
functional consequence of the KAP3-GLI interaction on GLI activator (green) and subcellular 
localization of the GLI (blue)/KAP3 (grey)/KIF3A (dark green)/ KIF3B (yellow) complex. The 
primary cilium is represented by microtubules (brown) extending from basal bodies (grey) with 
the ciliary barrier depicted by thin black lines. Plus (+) and minus (-) depict microtubule 
directionality. Question marks denote putative plus-end trafficking roles for 
KIF3A/KIF3B/KAP3 in regulating GLI proteins based on biochemical, immunofluorescence and 
signaling studies.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	  87	  
2.9 References 
 
Allen, B.L., J.Y. Song, L. Izzi, I.W. Althaus, J.-S. Kang, F. Charron, R.S. Krauss, and A.P. 
McMahon. 2011. Overlapping Roles and Collective Requirement for the Coreceptors GAS1, 
CDO, and BOC in SHH Pathway Function. Developmental Cell. 20:775–787. 
doi:10.1016/j.devcel.2011.04.018. 
Altaba, A.R.I. 1999. Gli proteins encode context-dependent positive and negative functions: 
implications for development and disease. Development. 
Aza-Blanc, P., H.Y. Lin, A. Ruiz i Altaba, and T.B. Kornberg. 2000. Expression of the 
vertebrate Gli proteins in Drosophila reveals a distribution of activator and repressor 
activities. Development. 127:4293–4301. 
Bai, C.B., and A.L. Joyner. 2001. Gli1 can rescue the in vivo function of Gli2. Development. 
128:5161–5172. 
Bai, C.B., D. Stephen, and A.L. Joyner. 2004. All mouse ventral spinal cord patterning by 
hedgehog is Gli dependent and involves an activator function of Gli3. Developmental Cell. 
6:103–115. 
Bai, C.B., W. Auerbach, J.S. Lee, D. Stephen, and A.L. Joyner. 2002. Gli2, but not Gli1, is 
required for initial Shh signaling and ectopic activation of the Shh pathway. Development. 
Baldari, C.T., and J. Rosenbaum. 2010. Intraflagellar transport: it's not just for cilia anymore. 
Current opinion in cell biology. 
Barnfield, P.C., X. Zhang, V. Thanabalasingham, M. Yoshida, and C.-C. Hui. 2005. Negative 
regulation of Gli1 and Gli2 activator function by Suppressor of fused through multiple 
mechanisms. Differentiation. 73:397–405. doi:10.1111/j.1432-0436.2005.00042.x. 
Bhogaraju, S., B.D. Engel, and E. Lorentzen. 2013. Intraflagellar transport complex structure and 
cargo interactions. Cilia. 2:10. doi:10.1186/2046-2530-2-10. 
Briscoe, J., and P.P. Thérond. 2013. The mechanisms of Hedgehog signalling and its roles in 
development and disease. Nat Rev Mol Cell Biol. 
Brown, C.L., K.C. Maier, T. Stauber, L.M. Ginkel, L. Wordeman, I. Vernos, and T.A. Schroer. 
2005. Kinesin-2 is a motor for late endosomes and lysosomes. Traffic. 6:1114–1124. 
doi:10.1111/j.1600-0854.2005.00347.x. 
Chen, C.H., D.P. von Kessler, W. Park, B. Wang, Y. Ma, and P.A. Beachy. 1999. Nuclear 
trafficking of Cubitus interruptus in the transcriptional regulation of Hedgehog target gene 
expression. Cell. 98:305–316. 
Cheung, H.O.-L., X. Zhang, A. Ribeiro, R. Mo, S. Makino, V. Puviindran, K.K.L. Law, J. 
Briscoe, and C.-C. Hui. 2009. The Kinesin Protein Kif7 Is a Critical Regulator of Gli 
Transcription Factors in Mammalian Hedgehog Signaling. Sci Signal. 2:ra29. 
	  	  88	  
doi:10.1126/scisignal.2000405. 
Cole, D.G., S.W. Chinn, K.P. Wedaman, K. Hall, and T. Vuong. 1993. Novel heterotrimeric 
kinesin-related protein purified from sea urchin eggs. Nature. 
Ding, Q., J. Motoyama, S. Gasca, R. Mo, H. Sasaki, J. Rossant, and C.C. Hui. 1998. Diminished 
Sonic hedgehog signaling and lack of floor plate differentiation in Gli2 mutant mice. 
Endoh-Yamagami, S., M. Evangelista, D. Wilson, X. Wen, J.-W. Theunissen, K. Phamluong, M. 
Davis, S.J. Scales, M.J. Solloway, F.J. de Sauvage, and A.S. Peterson. 2009. The 
Mammalian Cos2 Homolog Kif7 Plays an Essential Role in Modulating Hh Signal 
Transduction during Development. Current Biology. 19:1320–1326. 
doi:10.1016/j.cub.2009.06.046. 
Finetti, F., S.R. Paccani, M.G. Riparbelli, and E. Giacomello. 2009. Intraflagellar transport is 
required for polarized recycling of the TCR/CD3 complex to the immune synapse. Nature 
cell …. 
Gindhart, J.G., and L.S. Goldstein. 1996. Armadillo repeats in the SpKAP115 subunit of kinesin-
II. Trends Cell Biol. 6:415–416. 
Goetz, S.C., and K.V. Anderson. 2010. The primary cilium: a signalling centre during vertebrate 
development. Nat. Rev. Genet. 11:331–344. doi:10.1038/nrg2774. 
Hao, L., E. Efimenko, P. Swoboda, and J.M. Scholey. 2011. The retrograde IFT machinery of C. 
elegans cilia: two IFT dynein complexes? PLoS ONE. 6:e20995. 
doi:10.1371/journal.pone.0020995. 
Haycraft, C.J., B. Banizs, Y. Aydin-Son, Q. Zhang, E.J. Michaud, and B.K. Yoder. 2005. Gli2 
and Gli3 localize to cilia and require the intraflagellar transport protein polaris for processing 
and function. PLoS Genet. 1:e53. doi:10.1371/journal.pgen.0010053. 
He, M., R. Subramanian, F. Bangs, T. Omelchenko, K.F. Liem Jr, T.M. Kapoor, and K.V. 
Anderson. 2014. The kinesin-4 protein Kif7 regulates mammalian Hedgehog signalling by 
organizing the cilium tip compartment. Nat. Cell Biol. 16:663–672. 
doi:doi:10.1038/ncb2988. 
Hirokawa, N. 2000. Stirring up Development with the Heterotrimeric Kinesin KIF3. Traffic. 
1:29–34. doi:10.1034/j.1600-0854.2000.010105.x. 
Hirokawa, N., Y. Noda, Y. Tanaka, and S. Niwa. 2009. Kinesin superfamily motor proteins and 
intracellular transport. Nat Rev Mol Cell Biol. 10:682–696. doi:10.1038/nrm2774. 
Hsu, S.-H.C., X. Zhang, C. Yu, Z.J. Li, J.S. Wunder, C.-C. Hui, and B.A. Alman. 2011. Kif7 
promotes hedgehog signaling in growth plate chondrocytes by restricting the inhibitory 
function of Sufu. Development. 138:3791–3801. doi:10.1242/dev.069492. 
Huang, C.-J., C.-C. Huang, and C.-C. Chang. 2011. Association of the testis-specific 
	  	  89	  
TRIM/RBCC protein RNF33/TRIM60 with the cytoplasmic motor proteins KIF3A and 
KIF3B. Mol Cell Biochem. 360:121–131. doi:10.1007/s11010-011-1050-8. 
Huangfu, D., A. Liu, A.S. Rakeman, N.S. Murcia, L. Niswander, and K.V. Anderson. 2003. 
Hedgehog signalling in the mouse requires intraflagellar transport proteins. Nature. 426:83–
87. doi:10.1038/nature02061. 
Hui, C.-C., and S. Angers. 2011. Gli Proteins in Development and Disease. Annu. Rev. Cell Dev. 
Biol. 27:513–537. doi:10.1146/annurev-cellbio-092910-154048. 
Insinna, C., N. Pathak, B. Perkins, and I. Drummond. 2008. The homodimeric kinesin, Kif17, is 
essential for vertebrate photoreceptor sensory outer segment development. Developmental 
…. 
Jimbo, T., Y. Kawasaki, R. Koyama, R. Sato, S. Takada, K. Haraguchi, and T. Akiyama. 2002. 
Identification of a link between the tumour suppressor APC and the kinesin superfamily. 
Nat. Cell Biol. 4:323–327. doi:10.1038/ncb779. 
Keady, B.T., R. Samtani, K. Tobita, M. Tsuchya, J.T. San Agustin, J.A. Follit, J.A. Jonassen, R. 
Subramanian, C.W. Lo, and G.J. Pazour. 2012. IFT25 Links the Signal-Dependent 
Movement of Hedgehog Components to Intraflagellar Transport. Developmental Cell. 
22:940–951. doi:10.1016/j.devcel.2012.04.009. 
Kim, J., M. Kato, and P.A. Beachy. 2009. Gli2 trafficking links Hedgehog-dependent activation 
of Smoothened in the primary cilium to transcriptional activation in the nucleus. Proc. Natl. 
Acad. Sci. U.S.A. 106:21666–21671. doi:10.1073/pnas.0912180106. 
Kogerman, P., T. Grimm, L. Kogerman, D. Krause, A.B. Undén, B. Sandstedt, R. Toftgård, and 
P.G. Zaphiropoulos. 1999. Mammalian suppressor-of-fused modulates nuclear-cytoplasmic 
shuttling of Gli-1. Nat. Cell Biol. 1:312–319. doi:10.1038/13031. 
Li, Z.J., E. Nieuwenhuis, W. Nien, X. Zhang, J. Zhang, V. Puviindran, B.J. Wainwright, P.C.W. 
Kim, and C.-C. Hui. 2012. Kif7 regulates Gli2 through Sufu-dependent and -independent 
functions during skin development and tumorigenesis. Development. 139:4152–4161. 
doi:10.1242/dev.081190. 
Liem, K.F., M. He, P.J.R. Ocbina, and K.V. Anderson. 2009. Mouse Kif7/Costal2 is a cilia-
associated protein that regulates Sonic hedgehog signaling. Proc. Natl. Acad. Sci. U.S.A. 
106:13377–13382. doi:10.1073/pnas.0906944106. 
Liu, A., B. Wang, and L.A. Niswander. 2005. Mouse intraflagellar transport proteins regulate 
both the activator and repressor functions of Gli transcription factors. Development. 
132:3103–3111. doi:10.1242/dev.01894. 
Liu, Y.C., A.L. Couzens, A.R. Deshwar, L.D. B McBroom-Cerajewski, X. Zhang, V. 
Puviindran, I.C. Scott, A.-C. Gingras, C.-C. Hui, and S. Angers. 2014. The PPFIA1-PP2A 
protein complex promotes trafficking of Kif7 to the ciliary tip and Hedgehog signaling. Sci 
Signal. 7:ra117. doi:10.1126/scisignal.2005608. 
	  	  90	  
Marigo, V., R.A. Davey, Y. Zuo, and J.M. Cunningham. 1996. Biochemical evidence that 
patched is the Hedgehog receptor. …. 
Marks, S.A., and D. Kalderon. 2011. Regulation of mammalian Gli proteins by Costal 2 and 
PKA in Drosophila reveals Hedgehog pathway conservation. Development. 138:2533–2542. 
doi:10.1242/dev.063479. 
Matise, M.P., D.J. Epstein, H.L. Park, K.A. Platt, and A.L. Joyner. 1998. Gli2 is required for 
induction of floor plate and adjacent cells, but not most ventral neurons in the mouse central 
nervous system. Development. 125:2759–2770. 
Maurya, A.K., J. Ben, Z. Zhao, R.T.H. Lee, W. Niah, A.S.M. Ng, A. Iyu, W. Yu, S. Elworthy, 
F.J.M. van Eeden, and P.W. Ingham. 2013. Positive and Negative Regulation of Gli Activity 
by Kif7 in the Zebrafish Embryo. PLoS Genet. 9:e1003955. 
doi:10.1371/journal.pgen.1003955. 
McMahon, A.P., P.W. Ingham, and C.J. Tabin. 2003. Developmental roles and clinical 
significance of hedgehog signaling. Curr. Top. Dev. Biol. 53:1–114. 
Megason, S.G., and A.P. McMahon. 2002. A mitogen gradient of dorsal midline Wnts organizes 
growth in the CNS. 
Meyer, N.P., and H. Roelink. 2003. The amino-terminal region of Gli3 antagonizes the Shh 
response and acts in dorsoventral fate specification in the developing spinal cord. Dev. Biol. 
257:343–355. 
Morris, R.L., C.N. English, J.E. Lou, and F.J. Dufort. 2004. Redistribution of the kinesin-II 
subunit KAP from cilia to nuclei during the mitotic and ciliogenic cycles in sea urchin 
embryos. Developmental …. 
Morsci, N.S., and M.M. Barr. 2011. Kinesin-3 KLP-6 regulates intraflagellar transport in male-
specific cilia of Caenorhabditis elegans. Curr. Biol. 21:1239–1244. 
doi:10.1016/j.cub.2011.06.027. 
Nonaka, S., Y. Tanaka, Y. Okada, S. Takeda, A. Harada, Y. Kanai, M. Kido, and N. Hirokawa. 
1998. Randomization of left-right asymmetry due to loss of nodal cilia generating leftward 
flow of extraembryonic fluid in mice lacking KIF3B motor protein. Cell. 95:829–837. 
Norman, R.X., H.W. Ko, V. Huang, C.M. Eun, L.L. Abler, Z. Zhang, X. Sun, and J.T. 
Eggenschwiler. 2009. Tubby-like protein 3 (TULP3) regulates patterning in the mouse 
embryo through inhibition of Hedgehog signaling. Hum. Mol. Genet. 18:1740–1754. 
doi:10.1093/hmg/ddp113. 
Nozawa, Y.I., C. Lin, and P.-T. Chuang. 2013. Hedgehog signaling from the primary cilium to 
the nucleus: an emerging picture of ciliary localization, trafficking and transduction. Curr. 
Opin. Genet. Dev. 23:429–437. doi:10.1016/j.gde.2013.04.008. 
Nybakken, K., S.A. Vokes, T.-Y. Lin, A.P. McMahon, and N. Perrimon. 2005. A genome-wide 
	  	  91	  
RNA interference screen in Drosophila melanogaster cells for new components of the Hh 
signaling pathway. Nat Genet. 37:1323–1332. doi:10.1038/ng1682. 
Ocbina, P.J.R., J.T. Eggenschwiler, I. Moskowitz, and K.V. Anderson. 2011. Complex 
interactions between genes controlling trafficking in primary cilia. Nat Genet. 
doi:10.1038/ng.832. 
Oosterveen, T., S. Kurdija, Z. Alekseenko, C.W. Uhde, M. Bergsland, M. Sandberg, E. 
Andersson, J.M. Dias, J. Muhr, and J. Ericson. 2012. Mechanistic differences in the 
transcriptional interpretation of local and long-range Shh morphogen signaling. 
Developmental Cell. 23:1006–1019. doi:10.1016/j.devcel.2012.09.015. 
Pan, Y., C.B. Bai, A.L. Joyner, and B. Wang. 2006. Sonic hedgehog signaling regulates Gli2 
transcriptional activity by suppressing its processing and degradation. Molecular and 
Cellular Biology. 26:3365–3377. doi:10.1128/MCB.26.9.3365-3377.2006. 
Pedersen, L.B., and J.L. Rosenbaum. 2008. Intraflagellar transport (IFT) role in ciliary assembly, 
resorption and signalling. Curr. Top. Dev. Biol. 85:23–61. doi:10.1016/S0070-
2153(08)00802-8. 
Peterson, K.A., Y. Nishi, W. Ma, A. Vedenko, L. Shokri, X. Zhang, M. McFarlane, J.-M. 
Baizabal, J.P. Junker, A. van Oudenaarden, T. Mikkelsen, B.E. Bernstein, T.L. Bailey, M.L. 
Bulyk, W.H. Wong, and A.P. McMahon. 2012. Neural-specific Sox2 input and differential 
Gli-binding affinity provide context and positional information in Shh-directed neural 
patterning. Genes & Development. 26:2802–2816. doi:10.1101/gad.207142.112. 
Phang, H.-Q., J.-L. Hoon, S.-K. Lai, Y. Zeng, K.-H. Chiam, H.-Y. Li, and C.-G. Koh. 2014. 
POPX2 phosphatase regulates the KIF3 kinesin motor complex. J. Cell. Sci. 127:727–739. 
doi:10.1242/jcs.126482. 
Qin, H., D.R. Diener, S. Geimer, D.G. Cole, and J.L. Rosenbaum. 2004. Intraflagellar transport 
(IFT) cargo: IFT transports flagellar precursors to the tip and turnover products to the cell 
body. J. Cell Biol. 164:255–266. doi:10.1083/jcb.200308132. 
Qin, J., Y. Lin, R.X. Norman, H.W. Ko, and J.T. Eggenschwiler. 2011. Intraflagellar transport 
protein 122 antagonizes Sonic Hedgehog signaling and controls ciliary localization of 
pathway components. Proceedings of the …. 
Robbins, D.J., K.E. Nybakken, R. Kobayashi, and J.C. Sisson. 1997. Hedgehog elicits signal 
transduction by means of a large complex containing the kinesin-related protein costal2. 
Cell. 
Roessler, E., A.N. Ermilov, D.K. Grange, A. Wang, M. Grachtchouk, A.A. Dlugosz, and M. 
Muenke. 2005. A previously unidentified amino-terminal domain regulates transcriptional 
activity of wild-type and disease-associated human GLI2. Hum. Mol. Genet. 14:2181–2188. 
doi:10.1093/hmg/ddi222. 
Ruiz i Altaba, A. 2011. Hedgehog Signaling and the Gli Code in Stem Cells, Cancer, and 
	  	  92	  
Metastases. Sci Signal. 4:pt9. doi:10.1126/scisignal.2002540. 
Sasaki, H., Y. Nishizaki, C. Hui, M. Nakafuku, and H. Kondoh. 1999. Regulation of Gli2 and 
Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as 
primary mediators of Shh signaling. Development. 126:3915–3924. 
Scholey, J.M. 2003. Intraflagellar transport. Annu. Rev. Cell Dev. Biol. 19:423–443. 
doi:10.1146/annurev.cellbio.19.111401.091318. 
Scholey, J.M. 2013. Kinesin-2: A Family of Heterotrimeric and Homodimeric Motors with 
Diverse Intracellular Transport Functions. Annu. Rev. Cell Dev. Biol. 
Sisson, J.C., K.S. Ho, K. Suyama, and M.P. Scott. 1997. Costal2, a novel kinesin-related protein 
in the Hedgehog signaling pathway. Cell. 
Snow, J.J., G. Ou, A.L. Gunnarson, M.R.S. Walker, H.M. Zhou, I. Brust-Mascher, and J.M. 
Scholey. 2004. Two anterograde intraflagellar transport motors cooperate to build sensory 
cilia on C. elegans neurons. Nat. Cell Biol. 6:1109–1113. doi:10.1038/ncb1186. 
Stamataki, D. 2005. A gradient of Gli activity mediates graded Sonic Hedgehog signaling in the 
neural tube. Genes & Development. 19:626–641. doi:10.1101/gad.325905. 
Stone, D.M., M. Hynes, M. Armanini, T.A. Swanson, and Q. Gu. 1996. The tumour-suppressor 
gene patched encodes a candidate receptor for Sonic hedgehog. Nature. 
Takeda, S., Y. Yonekawa, Y. Tanaka, Y. Okada, S. Nonaka, and N. Hirokawa. 1999. Left-right 
asymmetry and kinesin superfamily protein KIF3A: new insights in determination of 
laterality and mesoderm induction by kif3A-/- mice analysis. J. Cell Biol. 145:825–836. 
Tanuma, N., M. Nomura, M. Ikeda, I. Kasugai, Y. Tsubaki, K. Takagaki, T. Kawamura, Y. 
Yamashita, I. Sato, M. Sato, R. Katakura, K. Kikuchi, and H. Shima. 2008. Protein 
phosphatase Dusp26 associates with KIF3 motor and promotes N-cadherin-mediated cell–
cell adhesion. Oncogene. 28:752–761. doi:10.1038/onc.2008.431. 
Teng, J., T. Rai, Y. Tanaka, Y. Takei, T. Nakata, M. Hirasawa, A.B. Kulkarni, and N. Hirokawa. 
2005. The KIF3 motor transports N-cadherin and organizes the developing neuroepithelium. 
Nat. Cell Biol. 7:474–482. doi:10.1038/ncb1249. 
Tukachinsky, H., L.V. Lopez, and A. Salic. 2010. A mechanism for vertebrate Hedgehog 
signaling: recruitment to cilia and dissociation of SuFu-Gli protein complexes. J. Cell Biol. 
191:415–428. doi:10.1083/jcb.201004108. 
Vokes, S.A., H. Ji, S. McCuine, T. Tenzen, S. Giles, S. Zhong, W.J.R. Longabaugh, E.H. 
Davidson, W.H. Wong, and A.P. McMahon. 2007. Genomic characterization of Gli-activator 
targets in sonic hedgehog-mediated neural patterning. Development. 134:1977–1989. 
doi:10.1242/dev.001966. 
Wang, B., J.F. Fallon, and P.A. Beachy. 2000. Hedgehog-regulated processing of Gli3 produces 
	  	  93	  
an anterior/posterior repressor gradient in the developing vertebrate limb. Cell. 100:423–434. 
Wang, C., Y. Pan, and B. Wang. 2010. Suppressor of fused and Spop regulate the stability, 
processing and function of Gli2 and Gli3 full-length activators but not their repressors. 
Wedaman, K.P. 1996. Sequence and submolecular localization of the 115-kD accessory subunit 
of the heterotrimeric kinesin-II (KRP85/95) complex. J. Cell Biol. 132:371–380. 
doi:10.1083/jcb.132.3.371. 
Wen, X., C.K. Lai, M. Evangelista, J.A. Hongo, F.J. de Sauvage, and S.J. Scales. 2010. Kinetics 
of Hedgehog-Dependent Full-Length Gli3 Accumulation in Primary Cilia and Subsequent 
Degradation. Molecular and Cellular Biology. 30:1910–1922. doi:10.1128/MCB.01089-09. 
Yamazaki, H., T. Nakata, Y. Okada, and N. Hirokawa. 1995. KIF3A/B: a heterodimeric kinesin 
superfamily protein that works as a microtubule plus end-directed motor for membrane 
organelle transport. J. Cell Biol. 130:1387–1399. 
Yamazaki, H., T. Nakata, Y. Okada, and N. Hirokawa. 1996. Cloning and characterization of 
KAP3: a novel kinesin superfamily-associated protein of KIF3A/3B. Proc. Natl. Acad. Sci. 
U.S.A. 93:8443–8448. 
Yang, Z., and L.S. Goldstein. 1998. Characterization of the KIF3C neural kinesin-like motor 
from mouse. Mol. Biol. Cell. 9:249–261. 
Yang, Z., E.A. Roberts, and L.S. Goldstein. 2001. Functional analysis of mouse kinesin motor 
Kif3C. Molecular and Cellular Biology. 21:5306–5311. doi:10.1128/MCB.21.16.5306-
5311.2001. 	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	  94	  
 
 
 
 
 
CHAPTER III: 
 
 
 
Investigation of KIF17 interactions with GLI proteins and its role in 
regulating Hedgehog signaling 
 
3.1 Abstract 
 GLI (Glioblasoma) proteins are the transcriptional effector molecules of the Hedgehog 
(HH) signaling pathway that function to activate and repress Hedgehog (HH) target gene 
expression. GLI proteins traffic between multiple subcellular compartments including the 
cytoplasm, nucleus, and primary cilium. Disrupting GLI intracellular trafficking results in 
defects in GLI protein activity; however, the mechanisms regulating GLI protein trafficking are 
incomplete. Kinesin-2 motor proteins regulate both ciliary and non-ciliary transport of cargo and 
have been implicated in HH signaling for over a decade, but how these motor complexes regulate 
GLI proteins directly is still unclear. In Chapter II, I identified direct interactions between 
heterotrimeric kinesin-2 motor complexes and GLI proteins that selectively restrict GLI activator 
function. Here I examine a role for the homodimeric kinesin-2 motor, KIF17, in regulating GLI 
activity. Using a combination of biochemical, cell signaling, and in vivo experimental 
approaches I show that KIF17 co-localizes and interacts with GLI proteins. Further, I show that 
GLI1 protein expression is decreased in cells stably expressing a dominant-negative version of 
KIF17. Finally, I provide evidence that KIF17 and GLI are expressed in overlapping cell layers 
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in the developing cerebellum, and that Kif17-/- mice have smaller cerebella. These data suggest a 
model in which KIF17 is playing a tissue specific role in regulating HH signaling through 
interactions with GLI proteins. 
 
3.2 Introduction 
 GLI proteins are the transcriptional effector molecules of the Hedgehog (HH) signaling 
pathway (Hui and Angers, 2011). Among the three mammalian GLI proteins, GLI2 and GLI3 are 
the first responders to the HH signal. GLI2 and GLI3 both contain N-terminal repressor and C-
terminal activation domains that modulate their function (Sasaki et al., 1999; Aza-Blanc et al., 
2000; Stamataki, 2005). In the absence of HH signaling, GLI2 and GLI3 are proteolytically 
processed into N-terminal repressors that inhibit HH target gene transcription (Sasaki et al., 
1999; Wang et al., 2000; Aza-Blanc et al., 2000; Stamataki, 2005). Conversely, HH ligand 
stimulation promotes the accumulation of full-length GLI2 and GLI3 that activate HH target 
gene transcription (Pan et al., 2006). Once activated, GLI2 and GLI3 induce expression of the 
third GLI protein family member, GLI1, which functions exclusively as a transcriptional 
activator that is dispensable for mammalian development (Bai et al., 2002).  
 GLI2 and GLI3 are indispensible for normal development and adult tissue homeostasis 
(reviewed by Hui and Angers, 2011). Despite the importance of GLI2 and GLI3 in embryonic 
development, the mechanisms regulating their protein function are incomplete. Over the past 
decade, several studies have shown that all mammalian GLI proteins localize to primary cilia in a 
regulated process and that this localization is enriched in the presence of HH signaling (Haycraft 
et al., 2005; Liu et al., 2005; Chen et al., 2009; Wen et al., 2010; Zeng et al., 2010). Loss of 
primary cilia, or mutations that prevent GLI2 and/or GLI3 proteins from trafficking to primary 
	  	  96	  
cilia, cause defects in both GLI processing and activation (Haycraft et al., 2005; Liu et al., 2005; 
2015; Santos and Reiter, 2014). Although an increasing body of evidence now suggest that GLI 
protein ciliary trafficking is essential for proper GLI function, a major question remains 
unresolved:  What molecules directly regulate GLI protein trafficking, and to what extent do 
these molecules affect GLI protein function? 
 Intraflagellar transport (IFT) complexes traffic cargo within primary cilia through 
interactions with microtubule-based anterograde (kinesin-2) and retrograde (dynein) motor 
proteins (Pedersen and Rosenbaum, 2008; Goetz and Anderson, 2010). Although mutations in 
genes that encode for components of retrograde motors (Dync2h1), IFT A complexes (Ift122), or 
IFT B complexes (Ift25 and Ift27) disrupt GLI protein ciliary localization and correlate with 
aberrant HH signaling (Ocbina et al., 2011; Qin et al., 2011; Keady et al., 2012; Yang et al.), the 
mechanisms of how GLI proteins are trafficked within and between subcellular compartments 
remain poorly understood.   
 Kinesin-2 motor proteins traffic protein cargos toward the plus-ends of microtubules both 
in the cytoplasm and within primary cilia making them presumptive candidates for directly 
regulating GLI protein trafficking. Within the kinesin-2 motor protein family there are two major 
motor complexes:  a heterotrimeric complex consisting of KIF3A, KIF3B and the kinesin-
associated protein, KAP3; and second, a homodimeric KIF17 motor complex (Scholey, 2013). I 
recently demonstrated that the heterotrimeric KIF3A/KIF3B/KAP3 motor complex directly 
interacts with and regulates GLI transcriptional activity (Carpenter et al., 2015). More 
specifically, I show that all mammalian GLI proteins interact with KAP3 and that this interaction 
is important for regulating the transcriptional activation of GLI2, but is dispensable for GLI3 
repressor function. (Carpenter et al., 2015). While this study implicates the heterotrimeric 
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KIF3A/KIF3B/KAP3 motor complex in directly regulating GLI transcriptional activity, a role for 
the homodimeric KIF17 motor complex has not been addressed. Here, I investigate a role for 
KIF17 in interacting with and regulating GLI protein trafficking and function, specifically in 
HH-dependent cerebellar proliferation.  
 Kif17-/- mice are viable, fertile and display a grossly normal body plan (our own 
observations and (Setou et al., 2000). However, recent studies have revealed that loss of KIF17 
leads to neurological defects including impaired learning and memory in mice and is associated 
with schizophrenia in humans (Wong-Riley and Besharse, 2012; Tarabeux et al., 2010; Yin et 
al., 2012). KIF17 is abundantly expressed in neuronal tissue and plays important roles in 
regulating NMDA receptor subunit 2B (NR2B) in hippocampal dendrites, cyclic nucleotide–
gated (CNG) channels in olfactory sensory cilia, and microtubule stabilization in epithelial cells 
(Setou et al., 2000; Yin et al., 2012; Jaulin and Kreitzer, 2010). Similar to KIF17, GLI proteins 
are expressed in multiple neuronal tissues and play important roles in regulating brain growth 
and development ((Ruiz i Altaba et al., 2002). Whether KIF17 and GLI proteins are expressed in 
the same neuronal tissues is unknown, and whether KIF17, like the heterotrimeric 
KIF3A/KIF3B/KAP3 motor complex, can physically interact with GLI proteins and regulate 
their function has yet to be tested. Here, I use a combination of biochemical, cell culture, and in 
vivo mouse genetic experimental approaches to show that KIF17 co-localizes and interacts with 
all mammalian GLI proteins. In addition, I provide evidence that GLI1 protein expression is 
decreased in cells stably expressing a dominant-negative version of KIF17 (DNKIF17) that lacks 
the motor domain. Finally, I show that KIF17 and GLI proteins are expressed in overlapping cell 
layers in the developing cerebellum, and that Kif17-/- mice have smaller cerebella.  
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3.3 Results 
KIF17 co-localizes with GLI proteins in vitro 
 To initially assess whether GLI proteins co-localize with KIF17, I compared the cellular 
distribution of an epitope-tagged KIF17 (KIF17::HA) with endogenous GLI2 and GLI3 in 
NIH/3T3 cells (Figure 3.1). Consistent with previous work, KIF17::HA localizes to multiple 
subcellular compartments including the cytoplasm, nucleus, and primary cilia (Verhey and 
Hammond, 2009; Dishinger et al., 2010)(Figure 3.1A and 3.1B). Similarly, endogenous GLI2 
and GLI3 distribute across multiple cellular compartments and co-localize with KIF17::HA in 
primary cilia (Figure 3.1A and Figure 3.1B). These data suggest that, like KAP3, KIF17 co-
localizes with GLI proteins in primary cilia.  
 Since KIF17 and GLI proteins localize to the same subcellular compartments, we 
performed co-immunoprecipitation experiments in COS-7 cells to determine whether KIF17 and 
GLI proteins physically interact (Figure 3.2). COS-7 cells were co-transfected with MYC::GLI2 
and KIF17::HA followed by immunoprecipitation and western blot analysis (Figure 3.2A). I find 
that KIF17::HA co-precipitates with MYC::GLI2 (Figure 3.2A). The physical association of 
GLI2 with KIF17 prompted me to assess whether KIF17 interacts with the other full-length 
mammalian proteins, GLI1 and GLI3. Similar to GLI2, I find that KIF17 co-precipitates with 
both GLI1 and GLI3 (Figure 3.2B). Taken together, these data indicate that KIF17 physically 
interacts with all three mammalian GLI proteins. 
 
DNKIF17 does not disturb ciliary localization of GLI2 and GLI3 
 Motorless KIF17 and KIF3A proteins are predicted to exert dominant-negative effects on 
kinesin-2 dependent cargo trafficking (Brown et al., 2005; Jiang et al., 2015; Guillaud et al., 
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2003). To determine whether GLI localization is perturbed in the presence of motorless KIF17, I 
generated NIH/3T3 Flp-In cells (Sauer, 1994) stably expressing EGFP-tagged full-length KIF17 
(KIF17::EGFP), dominant-negative KIF17 (DNKIF17::EGFP), and dominant-negative KIF3A 
(DNKIFA::EGFP). Similar to transiently transfected KIF17::HA, KIF17::EGFP localizes to 
multiple subcellular compartments including the cytoplasm and nucleus (compare Figure 3.1A 
and 3.1B to Figure 3.3A and 3.3B, top rows). However, unlike KIF17::HA, KIF17::EGFP is not 
detected in primary cilia (Figure 3.3A, top rows, white arrows). While KIF17::EGFP is absent 
from primary cilia, endogenous GLI2 and GLI3 localize normally to the tips of primary cilia 
(Figure 3.3A and 3.3B, top rows, white arrow).   
 I next assessed localization of endogenous GLI2 and GLI3 in cells expressing a 
dominant-negative version of KIF17, DNKIF17::EGFP, which lacks the conserved motor 
domain (Figure 3.3A and 3.3B, middle rows). Similar to KIF17::EGFP, DNKIF17::EGFP 
localizes to nuclear and cytoplasmic compartments (Figure 3.3A and 3.3B, middle rows). 
However, in contrast to KIF17::EGFP, DNKIF17::EGFP co-localizes with GLI2 and GLI3 in the 
tips of primary cilia (Figure 3.3A and 3.3B, middle rows, white arrows). In addition to 
DNKIF17::EGFP, I assessed GLI2 and GLI3 localization in a NIH/3T3 Flp-In cells stably 
expressing dominant-negative KIF3A (DNKIF3A::EGFP; Figure 3.3A and 3.3B, bottom rows). 
NIH/3T3 cells expressing motorless KIF3A have been reported to display defects in HH 
signaling due to perturbed ciliogenesis (Kim et al., 2009). Similar to DNKIF17, 
DNKIF3A::EGFP localizes to the nucleus and cytoplasm (Figure 3.3A and 3.3B, bottom rows). 
In contrast to what has been previously reported (Kim et al., 2009), primary cilia appear to be 
normal in these cells, and DNKIF3A::EGFP co-localizes with GLI2 and GLI3 in the tips of 
primary cilia (Figure 3.3A and 3.3B, bottom rows, white arrows). Taken together, these data 
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suggest that stably expressing low levels of either DNKIF17 or DNKIF3A does not disrupt 
endogenous GLI2 and GLI3 ciliary localization and that both DNKIF17 and DNKIF3A co-
localize with GLI2 and GLI3 at the tips of primary cilia. 
   
GLI1 expression is decreased in cells expressing DNKIF17 
 Despite no obvious defects in GLI2 and GLI3 trafficking in cells expressing DNKIF17 
and DNKIF3A, I was curious whether HH target gene expression and GLI3 processing were 
affected in these cell lines. To assess HH-responsiveness, I analyzed GLI1 protein expression via 
western blotting and quantified our findings (Figure 3.4A and Figure 3.4B). After 48 hours of 
SAG treatment to activate the HH signaling pathway (REF- for SAG), GLI1 protein expression 
was similar between the parental NIH/3T3 Flp-In cells and in cells expressing full-length 
KIF17::EGFP (Figure 3.4A, lanes 1 and 2; quantified in Figure 3.4B). In contrast to the parental 
cells, cells expressing DNKIF17::EGFP show reduced GLI1 protein expression (Figure 3.4A, 
compare lanes 1 vs. 3; quantified in Figure 3.4B). Similar to DNKIF17::EGFP expressing cells, 
DNKIF3A::EGFP cells show reduced GLI1 expression compared to the parental cells (Figure 
3.4A, compare lanes 1 vs. 4; quantified in Figure 3.4B). 
 Decreased GLI1 expression levels in cells expressing DNKIF17 and DNKIF3A prompted 
me to test whether this could be explained by defects in GLI3 processing. To examine GLI3 
processing in cells expressing DNKIF17 and DNKIF3A, I assessed GLI3 full-length (GLI3FL) 
and GLI3 repressor (GLI3R) protein levels in each cell line (Fig 3.4C). GLI3FL and GLI3R 
levels are similar between parental cells and cells expressing KIF17::EGFP, DNKIF17::EGFP, 
and DNKIF3A::EGFP (Figure3.4C). Importantly, the apparently decreased level of GLI3FL in 
KIF17::EGFP-expressing cells observed in this experiment (Figure 3.4C, compare lane 2 to lane 
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4) is more similar to parent cells in repeated experiments (data not shown). Overall, these data 
suggest that GLI1 protein expression levels are decreased in cells stably expressing DNKIF17 
and DNKIF3A; however, this decrease cannot be explained by altered GLI3 processing. 
 
KIF17 is dispensable for HH-dependent neural patterning 
 Due to defects in GLI1 protein expression in cells expressing DNKIF17, I assessed 
whether loss of KIF17 affects HH-dependent neural tube patterning. To do this, I performed 
immunofluorescence experiments on Kif17-/- neural tubes at E10.5 (Figure 3.5A). Using a 
combination of dorsal and ventral neural progenitor markers, I show that both Kif17+/- (Figure 
3.5A, left panels) and Kif17-/- (Figure 3.5A, right panels) neural tubes show no apparent defects 
in neural patterning and are indistinguishable from wildtype E10.5 neural tubes (data not shown).   
 The lack of phenotype in Kif17-/- E10.5 neural tubes prompted me to determine whether 
KIF17 is expressed in E10.5 embryos. To assess KIF17 expression in E10.5 embryos, I 
performed whole-mount X-Gal staining on Kif17+/+, Kif17+/-, and Kif17-/- embryos (Figure 3.5B). 
No X-Gal staining was observed in either Kif17+/- or Kif17-/- at E10.5 (Figure 3.5B). These data 
suggest that KIF17 is dispensable for HH-dependent neural patterning, likely due to a lack of 
Kif17 expression in the developing neural tube. 
 
KIF17 is expressed in the developing cerebellum 
 Previous reports on vertebrate KIF17 expression showed high-level mRNA expression in 
adult mouse brain tissue (Setou et al., 2000). This led me to test where KIF17 is expressed in 
adult mouse brains. To do so, I performed whole-mount X-Gal staining on Kif17+/+ (Figure 3.6A, 
left panel) and Kif17+/- (Figure 3.6A, right panel) adult mouse brains. Specific X-Gal staining in 
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Kif17+/- brains is observed in multiple compartments including the cerebral cortex (Cx), thalamus 
(Th), and cerebellum (Cb) (Figure 3.6A, right panel).  
 In mice, cerebellar proliferation continues up to 2 to 3 weeks after birth and is dependent 
on HH signaling (Wechsler-Reya and Scott, 1999). This prompted me to perform a more detailed 
time course of Kif17 expression to determine whether Kif17 is also expressed in the developing 
cerebellum during this time frame (Figure 3.6B). At P4, no X-Gal staining is observed in 
Kif17+/+, Kif17+/-, or Kif17-/- cerebella; however, specific staining is present in the adjacent 
ependymal cell lining in Kif17+/-and Kif17-/- (Figure 3.6Bi, middle and bottom panels, black 
asterisk). By P8, X-Gal is detectable in the posterior most lobules of both Kif17+/- and Kif17-/- 
cerebellum with stronger X-Gal staining observed in Kif17-/- cerebellum (Figure 3.6Bii, middle 
and bottom panels, black arrows). From P14 to P21, X-Gal staining intensifies in Kif17+/- and 
Kif17-/- cerebella, and is also present at lower levels in every lobe of the cerebellum (Figure 
3.6Biii and 3.6Biv, middle and bottom panels). Taken together, these data suggest that KIF17 is 
expressed during postnatal cerebellar development. 
 
KIF17 and GLI proteins co-localize in Purkinje cell layer   
 GLI proteins interact with KIF17 in vitro and are expressed in distinct layers of the 
cerebellum (Figure 3.2; (Corrales et al., 2004). This prompted me to determine if KIF17 and 
GLIs are expressed in overlapping cell layers within the developing cerebellum. By performing 
X-Gal staining on P21 Kif17-/- cerebellum sections, I found that X-Gal staining is present in a 
cell layer located between the inner granule layer (IGL) and external granule layer (EGL) 
presumed to be the Purkinje cell layer (PCL) (Figure 3.7A). Co-staining with a Purkinje cell 
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marker (LIM1/2) and an antibody against β-Galactosidase (β-Gal) confirmed that KIF17 is 
expressed in the PCL (Figure 3.7B, bottom panels, inset).  
 Both GLI1 and GLI2 are expressed in the PCL by P21 (Corrales et al., 2004). To confirm 
these reports and to determine whether KIF17 and GLI proteins display overlapping expression 
in the PCL, I performed whole-mount X-Gal staining on Kif17+/-, Gli1+/-, and Gli2+/- P21 
cerebellum (Fig 3.8A). X-Gal staining on Gli1+/- cerebella at P21 showed that, similar to KIF17 
expression, GLI1 expression is restricted to the PCL (Figure 3.8A, compare top and middle 
panels, dotted line in insets). In both Kif17+/- and Gli1+/-, X-Gal staining is strongest in the PCL; 
however, lower levels of X-Gal are also present in the molecular cell layer (MCL) in Kif17+/-  
animals (Figure 3.8A, top panel, inset). No X-Gal staining is observed in the EGL of either 
Kif17+/- or Gli1+/- cerebella. Similar to Kif17+/- and Gli1+/-, X-Gal staining is strongest in the PCL 
of Gli2+/- cerebella at P21 (Figure 3.8A, compare top, middle, and bottom panels, dotted line in 
insets). However, unlike Kif17+/- and Gli1+/-, X-Gal staining in Gli2+/- cerebella are also present 
in the IGL (Figure 3.8A, bottom panel, inset). Taken together, these data suggest that Kif17, 
Gli1, and Gli2 display distinct and overlapping expression in the developing cerebellum. 
Interestingly, Kif17, Gli1, and Gli2 all display overlapping expression in the PCL. 
 
Mice lacking KIF17 display decreased cerebellum size 
 During the process of analyzing KIF17 expression in the developing cerebellum, I 
noticed Kif17-/- cerebella appeared smaller compared to wildtype littermates. This observation 
prompted me to compare the size of wildtype vs. Kif17-/- adult cerebella (Figure 3.9A). I 
confirmed my initial observations that Kif17-/- cerebella are smaller compared to wildtype 
cerebella (Figure 3.9A, compare dotted line in left panels vs. dotted line in right panels). These 
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data, though preliminary, suggest that cerebellum development is perturbed in mice lacking 
KIF17. 
 
3.4 Discussion 
GLI proteins interact with multiple kinesin-2 motor complexes  
 Here I provide evidence that the homodimeric KIF17 motor complex interacts with all 
mammalian GLI proteins. These data are interesting in light of my recent work showing that the 
heterotrimeric KIF3A/KIF3B/KAP3 complex also interacts with all mammalian GLI proteins 
(Carpenter et al., 2015). Taking these two studies together, my data suggest a model in which 
both kinesin-2 motor complexes share GLI proteins as cargo. KAP3 interacts with GLI proteins 
directly in the absence of IFT particles (Carpenter et al., 2015), but whether KIF17 binds GLI 
proteins directly has yet to be tested. It is possible that KIF17 may interact with GLI proteins via 
IFT particles or some unknown protein scaffolds. In support of this idea, it has been reported that 
immunoprecipitation of either KIF17 or KIF3A/KIF3B/KAP3 motor complexes from mouse 
retinal extracts co-immunoprecipitates equal amounts of an IFT complex B protein, IFT88 
(Insinna et al., 2009). In the same study, the authors further show that immunoprecipitation of 
KIF17 co-immunoprecipitates KIF3A, KIF3B, and KAP3, suggesting that in addition to 
interacting with IFT88, KIF17 also interacts with a complex containing KIF3A/KIF3B and 
KAP3 (Insinna et al., 2009). More experiments are required to test whether KIF17 and GLI 
proteins form separate complexes from KIF3A/KIF3B/KAP3 and whether these interactions are 
direct. To my knowledge, the finding that both kinesin-2 motor complexes interact with GLI 
proteins provides a rare example where the homodimeric KIF17 and heterotrimeric 
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KIF3A/KIF3B/KAP3 motor complexes interact redundantly with a protein cargo other than IFT 
protein machinery. 
  
DNKIF17 perturbs GLI1 expression, but does not alter GLI cilia localization 
 KIF17 localizes with GLI2 and GLI3 in primary cilia when transiently transfected in 
NIH/3T3 cells; however, I do not detect co-localization of KIF17 with either GLI2 or GLI3 in 
primary cilia when KIF17 is stably expressed at lower levels. This contrasting finding is likely 
due to the fact cells stably expressing KIF17 simply do not have enough KIF17 protein in the 
primary cilia to detect using our standard immunofluorescence protocol. To assess whether 
KIF17 is trafficking through primary cilia at barely detectable levels, one approach would be to 
assess whether KIF17 accumulates in primary cilia in Dync2h lln/lln mouse embryonic fibroblasts 
(MEFs) (Ocbina et al., 2011) that are defective in retrograde trafficking of ciliary proteins. 
However, further experiments are required to test this possibility.  
 In contrast to full-length KIF17, DNKIF17 co-localizes with GLI2 and GLI3 at the tips of 
primary cilia. I also observe an increase in DNKIF17 nuclear localization compared to cells 
stably expressing full-length KIF17. These observations are consistent with published studies 
showing that C-terminal truncated versions of KIF17 display increased nuclear localization due 
to exposure of an N-terminal sequence that interacts with import protein, Importin-β2, and is 
important for both cilia and nuclear localization of KIF17 (Dishinger et al., 2010).  It is possible 
that without the motor domain, DNKIF17 is localized to both the nuclear and ciliary 
compartments via interactions with other proteins, like Importin- β2 for example. Regardless, 
GLI2 and GLI3 localize to primary cilia normally in the presence of stably expressed DNKIF17.  
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 Transiently expressing DNKIF3A in NIH/3T3 cells causes defects ciliogenesis (Kim et 
al., 2009) and our unpublished observations); however, I show that NIH/3T3 cells stably 
expressing low levels of DNKIF3A display no defects in ciliogenesis and that DNKIF3A 
localizes to the tips of cilia. Further, stable expression of DNKIF3A does not alter GLI2 and 
GLI3 cilia localization. Despite no affects on GLI2 and Gli3 cilia localization, I find that GLI1 
protein expression is significantly decreased in cells stably expressing DNKIF3A and DNKIF17. 
The defect in GLI1 expression could not be explained by defects in GLI3 processing as neither 
DNKIF17 nor DNKIF3A expressing cells display defects in GLI3 processing. One possibility is 
that DNKIF17 and DNKIF3A disrupt non-ciliary GLI protein trafficking. Evidence in support of 
this comes from a study where specifically disrupting non-ciliary dynamic microtubules by 
nocodazole (Noc) treatment decreases HH transcriptional response in a dose dependent manner 
(Tukachinsky et al., 2010). More studies are needed to determine how DNKIF17 regulates GLI1 
protein expression and if this is consistent with other HH target proteins, like PTCH1.   
 
KIF17 co-expresses with GLI proteins in Purkinje cell layer of the developing cerebellum 
 HH signaling is required for proper cerebellar development and GLI2 is the major 
activator driving HH-dependent cerebellar proliferation (Corrales et al., 2004; 2006; Wechsler-
Reya and Scott, 1999; Blaess et al., 2006). Here I show that KIF17 is expressed in the posterior 
lobes of the developing cerebellum by P8 and that this expression is detected broadly throughout 
the cerebellum by P21. At P21, KIF17 is expressed in the Purkinje cell layer (PCL) along with 
GLI1 and GLI2. While co-localization with Purkinje cells (PCs) marker, LIM1/2, shows that 
KIF17 is expressed in PCs, whether GLI1 and GLI2 are present in PCs at P21 is not clear. It has 
been reported that in GLI1 and GLI2 cerebella at P5 and P10, respectively that both GLI1 and 
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GLI2 are expressed in Bergman glia cells (BG) that are present along with PCs within PCL 
(Corrales et al., 2004); however, whether they overlap with KIF17 in PCs with KIF17 at P21 has 
not been tested. BG are intimately associated with PCs in the PCL and are important for 
regulating PC structure in the adult cerebellum (Yamada and Watanabe, 2002). A more in-depth 
analysis of KIF17 expression by co-staining with BG markers is required to confirm that KIF17 
expression is indeed restricted to PCs. Regardless, why GLI proteins are co-expressed with 
KIF17 in the PCL in adult cerebellum and whether KIF17 and GLI proteins are involved in 
maintenance of BG and/or PCs provide important questions to investigate. It will also be 
important to assess a role for KIF17 in regulating HH-dependent cerebellar development by 
performing cerebellar granule cell progenitor (CGNP) cell proliferation assays (Izzi et al., 2011). 
 While more experiments are needed to confirm whether KIF17 is regulating HH-
dependent cerebellar development, I show here that mice lacking KIF17 display smaller 
cerebellum. Interestingly, I further show that KIF17 is expressed during the time window of HH-
dependent cerebellar proliferation and in the same cell layers as the major activators driving 
cerebellum proliferation, GLI proteins. As a whole, this investigation supports a model that 
implicates yet another kinesin-2 motor, KIF17, in the regulation of HH signaling via interactions 
with GLI proteins.   
 
3.5 Materials and Methods 
DNA Constructs 
Hemagglutinin (HA)-tagged hKIF17 and hKIF3A constructs and variants were generated from 
full-length human KIF17 cDNA (provided by Kristen J. Verhey, University of Michigan Ann 
Arbor, MI).  Briefly, full-length hKIF17 (cDNA, base pairs) 1 to 3,081; protein, amino acis 1-
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1027), hDNKIF17 (cDNA, base pairs 1,393 to 3,081; protein, amino acids 464-1027) and 
hDNKif3A (cDNA, base pairs 1,033 to 2,106; protein, amino acids 345-702)-were cloned into 
pGIG (Megason and McMahon, 2002) using standard molecular biology techniques. To generate 
6X MYC-tagged Gli constructs, mGli1, hGli2, hGli3 were cloned into pCDNA3 as previously 
described (Carpenter et al., 2015).  
 
Immunoprecipitation and Western Blot Analysis 
COS-7 cells were transiently transfected with the relevant DNA constructs using Lipofectamine 
2000 (Invitrogen, Cat. #11668). The cells were lysed 48 hr after transfection in HEPES lysis 
buffer (25mM HEPES pH 7.4, 115mM KOAc, 5mM NaOAc, 5mM MgCl2, 0.5mM EGTA, and 
1% TX-100) containing protease inhibitor (Roche, Cat. #11836153001). Cell lysates were then 
subjected to centrifugation at 14,000 x g for 15 min to remove the insoluble fraction and protein 
concentrations were determined using a BCA Assay Kit (Pierce, Cat. #23225). Cell lysates 
(1mg) were then pre-cleared with Protein G agarose beads (Roche, Cat. #11719416001) for 1 hr 
at 4°C. MYC- or HA-tagged proteins were immunoprecipitated from pre-cleared lysates using 
either anti-MYC (1:150; Santa Cruz, Cat. #sc-40) or anti-HA (1:300; Covance, Cat. #MMS-101) 
antibodies for 2 hr at 4°C. Following immunoprecipitation, the lysates were incubated with 
Protein G agarose beads for 1 hr at 4°C. The Protein G agarose beads were washed 5 x 8 min in 
HEPES lysis buffer and re-suspended in 30 µl of 1x PBS and 6x Laemmli buffer. The samples 
were boiled for 10 minutes and proteins were separated using SDS-PAGE and analyzed by 
western blotting. Anti-MYC (1:1000) and anti-HA (1:1000) primary antibodies, peroxidase-
conjugated AffiniPure goat anti-mouse light chain secondary antibody (1:50,000; Jackson 
ImmunoResearch, Cat. # 115-035-174), and a Konica Minolta SRX-101A medical film 
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processor were used to visualize tagged proteins. For detecting endogenous GLI1 and GLI3, 
whole cell lysates were collected in RIPA lysis buffer (50mM Tris pH 7.2, 150mM NaCl, 0.1% 
SDS, 1% TX-100, 1% sodium deoxycholate, 5mM EDTA) containing protease inhibitor. HH 
signaling was stimulated by adding 300 nM SAG in low serum for 48 hrs. Anti-GLI1  (Cell 
Signaling (L42B10), Cat. #2643; 1:1000) and anti-GLI3 (R&D, Cat. # AF3690; 1:200) primary 
antibodies and either peroxidase-conjugated AffiniPure goat anti-mouse light chain secondary 
antibody, or peroxidase-conjugated AffiniPure Donkey anti-goat light chain secondary antibody 
(1:50,000; Jackson ImmunoResearch, Cat. # 705-035-147) were used to detect GLI1 and GLI3, 
respectively. Western blots were quantified using ImageJ software. 
 
Immunofluorescence staining 
NIH/3T3 fibroblasts were seeded at a density of 1.5 x 105 cells/well in 6 well plates. Cells were 
transfected 24 hr later with either empty vector (pCIG) or with a DNA construct encoding 
KIF17::HA using Lipofectamine 2000. Cells were grown in low-serum media starting 8 hr after 
transfection, fixed 48 hr post-transfection in 4% paraformaldehyde for 10 min at room 
temperature, and permeabilized with a 5 min incubation in 0.2% Triton X-100 in PBS.  Neural 
tube and cerebellum immunofluorescence was performed essentially as previously described 
(Allen et al., 2011).  Neural patterning analysis was performed at the forelimb level in E10.5 
embryos. Immunostaining was performed using the following primary antibodies: mouse anti-
acetylated tubulin (1:2500; Sigma), rabbit anti-GFP (1:1000; Invitrogen), rabbit anti-gamma 
tubulin (1:2500; Sigma), rabbit anti-ARL13B (1:500; Proteintech), mouse anti-HA (1:1000; 
Covance), guinea pig anti-GLI2 (1:300; a gift from Dr. J.T. Eggenschwiler, University of 
Georgia), mouse anti-GLI3 (1:1000; obtained from Dr. S.J. Scales, Genentech), mouse IgG1 
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anti-NKX6.1 (1:20, Developmental Studies Hybridoma Bank [DSHB]), mouse IgG2a anti-PAX3 
(1:20, DSHB), rabbit IgG anti-DBX1 (1:1000, gift from Dr. Yasushi Nagakawa), mouse IgG1 
anti-FOXA2 (1:20, DSHB), rabbit IgG anti-FOXA2 (1:500, Cell Signaling), mouse IgG2b anti-
NKX2.2 (1:20, DSHB), rabbit IgG anti-OLIG2 (1:1000, Millipore), rabbit anti- β-Galactosidase 
(1:500, MP Biomedical), mouse IgG1 anti-LIM1/2 (1:20; DSHB) . The following secondary 
antibodies were used at a dilution of 1:500:  Alexa 488 goat anti-guinea pig IgG, Alexa 488 goat 
anti-mouse IgG2b, Alexa 555 goat anti-mouse IgG1, Alexa 633 goat anti-rabbit IgG. To 
visualize nuclei, DAPI (Invitrogen) was incubated for 5 min at a dilution of 1:30,000. Cells and 
neural tube sections were imaged using a Leica Upright SP5X White Light Laser Confocal 
Microscope. Images were processed using Adobe Photoshop and Illustrator. 
 
Stable cell line generation 
Stable NIH/3T3 cells lines expressing low levels of EGFP fused KIF17, DNKIF17, and 
DNKIF3A were generated using the Flp-In method exactly according to the manufacturer’s 
recommendations (Life Technologies). Briefly, NIH/3T3 Flp-In cells were co-transfected with 
pOG44 and the pCDNA5/FRT vector containing KIF17, DNKIF17, or DNKIF3A fused to 
EFGP.  After 48 hrs, the cells were reseeded at low density and the culture media was 
supplemented with Hygromycin B (Invitrogen) for stable integrant selection. Stable cell lines 
were passaged in Hygromycin B supplemented media every other passage to preserve selection 
pressure and prevent silencing of the transgene.  
 
Whole-mount X-Gal staining 
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Mouse embryos were dissected and fixed in 4% paraformaldehyde for 1hr at room temperature 
and then washed 3x 5 minutes in PBS.  Embryos were then stained overnight using 1mg/ml X-
Gal substrate (Gold Biotechnology) in PBS solution containing 5mM K3Fe(CN)6, K4Fe(CN)6, 
2mM MgCl2, 0.01% sodium deoxycholate, and 0.02% NP-40. Following staining, embryos were 
washed in PBS and post-fixed in 4% paraformaldehyde for 20 minutes at room temperature. 
Embryos were then cleared over night in PBS and photographed in PBS on a stereoscopic 
microscope (SMZ1500: Nikon) using a Nikon objective (type: HR Plan Apochromat; NA 0.13) 
with a camera (Digital Sight DS-Ri1; Nikon). Images were acquired using the NIS Elements 
software (Nikon).  
 
Mice 
Mice were housed in specific pathogen-free facilities of the University of Michigan 
Comprehensive Cancer Center. This study was approved by the University of Michigan 
University Committee on Use and Care of Animals guidelines.	   Gli1lacZ, Gli2lacZ, and Gli3lacZ 
mice were obtained from Dr. A. Joyner (MSKCC) and were maintained on a mixed C57BL/6 
and 129/SvJ genetic background. Kif17LacZ mice were obtained from Dr. J Besharse (Medical 
College of Wisconsin) and maintained on a mixed C57BL/6 background.	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3.8  Figures 
 
 
 
 
Figure 3.1. KIF17 co-localizes with endogenous GLI2 and GLI3 in NIH/3T3 cells. 
(A) Antibody detection of endogenous GLI2 in NIH/3T3 cells (top row; green) expressing HA-
tagged KIF17 (KIF17::HA, red). Primary cilia are identified using antibodies directed against 
Acetylated-tubulin (AcTub; grey). (B) Antibody detection of endogenous GLI3 in NIH/3T3 cells 
expressing HA-tagged KIF17 (KIF17::HA, red). Primary cilia are identified using antibodies 
directed against ARL13B (ARL13B; grey). DAPI denotes nuclei (blue). Insets represent high 
magnification images of primary cilia. Scale bar, 10µm. 
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Figure 3.2. KIF17 interacts with all mammalian GLI proteins. 
(A) Immunoprecipitation of MYC-tagged GLI2 (MYC::GLI2) from COS-7 cells expressing HA-
tagged KIF17 (KIF17::HA). (B) Immunoprecipitation of MYC::GLI1-3 from COS-7 cells co-
expressing KIF17::HA. Immunoprecipitates (IP) and whole cell lysates (WCL) were subjected to 
SDS-PAGE and western blot analysis (IB) using antibodies directed against MYC (α-MYC) and 
HA (α-HA). Antibody detection of Beta-Tubulin (α-Beta-Tubulin) was used to confirm equal 
loading across lanes. The molecular weights (in kDa) of protein standards are indicated at the left 
of each blot. 
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Figure 3.3. Endogenous GLI2 and GLI3 localize to primary cilia in NIH/3T3 cells 
expressing DNKIF17.(A) Antibody detection of endogenous GLI2 (red) in NIH/3T3 cells stably 
expressing KIF17::EGFP (top row), DNKIF17::EGFP (middle row), or DNKIF3A::EGFP 
(bottom row). DAPI denotes nuclei (blue) and an antibody directed against GFP is used to detect 
EGFP constructs (GFP; green). Primary cilia are identified using antibodies directed against 
Acetylated-tubulin (AcTub; grey). (B) Antibody detection of endogenous GLI3 (red) in NIH/3T3 
cells stably expressing KIF17::EGFP (top row), DNKIF17::EGFP (middle row), or 
DNKIF3A::EGFP (bottom row). Primary cilia are identified using antibodies directed against 
ARL13B (ARL13B; grey). DAPI denotes nuclei (blue) and an antibody directed against GFP 
was used to detect EGFP constructs (GFP; green). Insets represent high magnification images of 
primary cilia. Scale bar, 10µm. 
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Figure 3.4. DNKIF17 alters GLI1 expression, but does not affect GLI3 processing. 
(A) GLI1 protein expression in NIH/3T3 cells stably expressing KIF17::EGFP, 
DNKIF17::EGFP , or DNKIF3A::EGFP after 48 hr SAG treatment (+). GLI1 expression in the 
parental cell line (Parent) was cropped from same experimental blot used to visualize GLI1 
expression in stable cell lines in (A) (see lane 1). Whole cell lysates (WCL) were subjected to 
SDS-PAGE and western blot analysis (IB) using an antibody directed against GLI1 (α-GLI1) . 
Antibody detection of Beta-Tubulin (α-Beta-Tubulin) was used to confirm equal loading across 
lanes. The molecular weights (in kDa) of protein standards are indicated at the left of each blot. 
(B) Quantification of GLI1 signal intensity in parental vs. stable cell lines. Error bars  represent 
the mean +/- the standard error for three seperate experiments;  p-values are indicated above the 
relevant treatment groups (Student’s unpaired t-test); n.s., not significant (p>0.05). (C) GLI3 
protein expression in NIH/3T3 cells stably expressing KIF17::EGFP, DNKIF17::EGFP , or 
DNKIF3A::EGFP plus (+) or minus (-) 48 hr SAG treatment. Similar to (A), GLI3 expression in 
the parental cell line (Parent) was compared to GLI3 expression in the stable cell lines. GLI3 
full-length (GLI3FL) and GLI3 repressor (GLI3R) are labeled on the right of the blot. Asterick 
(*) denotes lower GLI3FL expression in the KIF17::EGFP expressing cell line. Whole cell 
lysates (WCL) were subjected to SDS-PAGE and western blot analysis (IB) using an antibody 
directed against GLI3 (α-GLI3). Antibody detection of Beta-Tubulin (α-Beta-Tubulin) was used 
to confirm equal loading across lanes. The molecular weights (in kDa) of protein standards are 
indicated at the left of each blot. 
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Figure 3.5. KIF17 is dispensable for HH-dependent neural patterning and not expressed in 
the early embryo. 
(A) Immunofluorescent analysis of neural patterning in E10.5 Kif17 +/- (left panels) and Kif17-/- 
(right panels) mouse forelimb sections.  FOXA2, NKX2.2, and OLIG2 (red, green, magenta, 
respectively) expression is detected in the top panels, and NKX6.1, DBX1, and PAX3 
(expression red, green, magenta, respectively) is detected in the bottom panels.  Scale bars: 100 
µm. (B)  Whole-mount X-Gal staining of E10.5 Kif17+/+, Kif17 +/-, and Kif17-/- mouse embryos.  
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Figure 3.6. KIF17 expressed in the developing mouse cerebellum. 
(A) Whole-mount X-Gal staining of Kif17 +/+ (left) and Kif17+/- (right) adult mouse brains. Cx, 
cerebral cortex; Cb, cerebellum; Th, thalamus. White asterisk (*) denotes non-specific X-Gal 
staining. Insets represent a high magnification the cerebellum denoted by black arrows. (B) 
Whole-mount X-Gal staining of mouse cerebellum from stages P4 to P21 in Kif17 +/+ (top row), 
Kif17+/- (middle row), and Kif17-/- (bottom row). Black Asterisks (*) denote X-Gal staining in the 
ependymal cell lining. Black arrows indicate initial X-Gal staining observed in cerebellum.   
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Figure 3.7. KIF17 expressed in the Purkinje cell layer of the cerebellum.  
(A) Whole-mount X-Gal staining on sagittal sections of Kif17+/+ (left panels) and Kif17-/- (right 
panels) P21 mouse cerebellum.  Bottom panels represent higher magnification images of lobules 
IX and X indicated by black arrows in the top panels. Purkinje cell layer (PCL); inner granule 
layer (IGL); external granule layer (EGL). (B) Immunofluorescent staining on sagittal sections of 
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Kif17+/+  (top panels) and Kif17-/- (bottom panels) P21 mouse cerebellum. Images represent high 
magnification of Lobe IX.  Purkinje cells are labeled using an antibody directed against LIM1/2 
(green); β-Gal (red) and DAPI (blue). Inset represents high magnification image of Purkinje cells 
indicated by white arrow. 
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Figure 3.8. KIF17 expression overlaps with GLI1 and GLI2 in the Purkinje cell layer of the 
cerebellum. (A) Whole-mount X-Gal staining on Kif17+/-, Gli1+/-, and Gli2+/- P21 cerebellum.  
Insets represent high magnifications of lobe X indicated by black arrows. Purkinje cell layer 
(PCL); inner granule layer (IGL); external granule layer (EGL); molecular cell layer (MCL). 
Dotted lines in insets denote the PCL. 
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Figure 3.9. Kif17-/- mice display decreased cerebellum size.  
(A) Whole-mount images of wildtype (top left) and Kif17-/- (top right) adult mouse brains.  
Dotted outlines highlight the difference in size between wiltdtype (bottom left) and Kif17-/- 
(bottom right) cerebellum. Scale bar, 1000 µm.    
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CHAPTER IV: 
 
Discussion and Future Directions 
 
4.1 Regulation of GLI protein function by the heterotrimeric kinesin-2 complex  
4.1.1 GLI proteins specifically interact with distinct members of the heterotrimeric kinesin-2 
complex 
 Despite their implication in HH signaling for more than a decade, in Chapter II I provide 
the first evidence that the heterotrimeric KIF3A/KIF3B/KAP3 complex physically interacts with 
all mammalian GLI proteins. Interestingly, I demonstrate that GLI2 specifically interacts with 
KIF3A, but not KIF3B, and I further detect synergistic interactions between GLI2, KIF3A and 
KAP3. These findings provide another example of how the heterotrimeric kinesin-2 motor 
complex interacts with specific protein cargos, an area that still remains poorly understood. Since 
it is largely accepted that KIF3A and KIF3B exist as a heterodimer(Yamazaki et al., 1995), it is 
interesting that GLI2 interacts with KIF3A and KAP3, but not KIF3B.  It will be important to 
determine whether this is the general mechanism by which the heterotrimeric kinesn-2 
complexes bind cargo, or whether this is distinct interaction with KIF3A and KAP3 is specific to 
GLI proteins. Further, it will also be important to test whether GLI1 and GLI3 also fail to 
interact with KIF3B.  Future biochemical studies with GLI proteins and additional protein cargos 
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will help define how the heterotrimeric kinesin-2 complex interacts with cargo and how these 
interactions regulate protein cargo function. 
  Anderson and colleagues eloquently showed that KIF7 lacks plus-end-directed 
microtubule trafficking capabilities (He et al., 2014); based on my findings in Chapter II,  I 
propose that the heterotrimeric kinesin-2 motor complex regulates GLI trafficking toward the 
plus-ends of microtubules. These findings are particularly interesting given that it is largely 
accepted that kinesin-2 cargo anterograde trafficking is mediated by IFT particles (Scholey, 
2003; Qin et al., 2004; Bhogaraju et al., 2013). Our findings are consistent with emerging reports 
showing that the heterotrimeric kinesin-2 complex directly interacts with and regulates 
anterograde trafficking of dynein motors independent of IFT proteins (Hao et al., 2011). 
Together these findings suggest a new paradigm where the heterotrimeric kinesin-2 complex 
interacts with protein cargo through interactions with distinct complex members independent of 
IFT particles to mediate plus-end-directed microtubule trafficking. While I provide evidence that 
GLI proteins interact with KAP3 in the absence of IFT particles using in vitro binding assays, it 
will be important to perform additional biochemical studies to determine whether IFT particles 
can also interact with GLI proteins to mediate both ciliary and non-ciliary trafficking.  
 Through extensive structure-function biochemical analyses, I demonstrate that KAP3 
binds a specific 47 amino-acid N-terminal sequence that is conserved between GLI2 and GLI3. 
While deleting this domain in full-length GLI2 and the C-terminally truncated GLI3 repressor 
(GLI3R) prevents KAP3 binding, GLI1 lacks the conserved 47 amino-acid N-terminal KAP3 
binding sequence but still robustly interacts with KAP3. Furthermore, fusing the conserved 47 
amino-acid KAP3 binding domain to the N-terminally truncated constitutive GLI activator 
(GLI2ΔN) is not sufficient to rescue the KAP3 interaction (Figure 4.1). Together these data 
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suggest that KAP3 may interact with GLI proteins through multiple motifs, but further 
biochemical studies are required to identify additional KAP3 binding domains. Similar mapping 
experiments that I used to identify the KAP3 binding domain within GLI2 are necessary to 
determine whether KIF3A interacts with GLI2 and GLI3 via the same motif as KAP3. In chapter 
II, I also showed that KAP3 interacts with GLI2 via it armadillo repeats and that the motor 
domain of KIF3A is dispensable for GLI2 interaction. It will be important to further map 
domains within both KAP3 and KIF3A that mediate interactions with GLI proteins. By 
identifying interaction domains within all three mammalian GLI proteins, KIF3A, and KAP3 that 
mediate complex formation, we will improve our understanding of how these kinesin-2 motor 
complexes dynamically interact with protein cargos, like GLI proteins.   
 In Chapter II, I show that GLI2 interacts with KIF3A and KAP3 units of the 
heterotrimeric kinesin-2 complex but a major unanswered question is where do these interactions 
take place within the cell. Further microscopy experiments are required to determine if the 
interactions between KIF3A, KAP3, and GLI proteins occur within primary cilia, cytoplasmic 
trafficking to and from the cilium, and/or during nuclear entry. One way to assess this would be 
to use CRISPR technologies (Singh et al., 2015) to generate mice that endogenously express both 
GFP-tagged GLI2 and mCherry-tagged KAP3 or KIF3A. Once generated, these provide 
excellent tools to assess co-localization of GLI2::GFP with KAP3::mCherry or KIF3A::mCherry 
in a wide range of HH responsive tissues, including the neural tube, using live cell imaging and 
confocal microscopy. These tools will not only aid in visualizing the subcellular co-localization 
of GLI2 with KAP3 and KIF3A, but will also provide information on how the heterotrimeric 
complex regulates ciliary and/or non-ciliary trafficking of GLI2.  
	  	  132	  
 Biochemical and functional assessment of the interactions between GLI proteins and 
heterotrimeric complex members were performed in the absence of HH pathway activation, 
largely due to the fact that in the absence of HH ligand GLI proteins still traffic between multiple 
subcellular compartments including the primary cilia. To determine whether the interaction 
between GLI proteins and KAP3 are altered in the presence of HH pathway activation, I would 
perform the same biochemical assays from Chapter II in a HH-responsive cell type (i.e. NIH/3T3 
cells) in the presence of HH ligand. Furthermore, whether primary cilia are required for the 
interaction between GLI2 and KIF3A and KIF3B has not been tested. Performing additional 
biochemical experiments in Ift88-/- mouse embryonic fibroblast (MEFs) that are defective in cilia 
formation, will determine whether cilia are necessary for these interactions. HH pathway 
activation promotes the dissociation of SUFU and GLI complexes and this dissociation requires 
primary cilia (Humke et al., 2010; Tukachinsky et al., 2010). The proposed experiments will test 
whether, like SUFU, the interactions between KAP3 and GLI proteins are altered by HH 
pathway activation and primary cilia. 
 
4.1.2 KAP3 interacts with GLI proteins and regulates GLI activator function 
 In addition to identifying physical interactions between GLI proteins and the 
heterotrimeric kinesin-2 complex, I further show in Chapter II that the interaction between KAP3 
and GLI proteins specifically regulates GLI2 activator, but not GLI3 repressor activity, 
suggesting that the interaction between GLI proteins and the kinesin-2 components are necessary 
for proper transcriptional activity of GLI proteins. While these findings suggest that the 
heterotrimeric kinesin-2 complex regulates GLI activator function, more work is required to 
determine the mechanism that underlies this regulation.  
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 Deleting the KAP3 binding domain from GLI2 and GLI3R results in an increase in GLI2 
transcriptional activity, but has no affect on GLI3 repressor activity. These findings are strikingly 
similar to those observed with SUFU (Wang et al., 2010). In these studies, SUFU interacts with 
both GLI2 and GLI3, however GLI3 repressor is able to rescue the ventralized neural tube 
phenotype in Sufu-/- embryos (Wang et al., 2010). It is interesting to speculate that, like SUFU, 
KAP3 may regulate GLI activator proteins as they traffic to the nucleus. Furthermore, 
immunoprecipitation of GLI2 from COS-7 cells transiently expressing GLI2 and either SUFU or 
KAP3 robustly co-immunoprecipitates SUFU and KAP3, respectively (Figure 4.2A lanes 5 and 
6). However, immunoprecipitating GLI2 from lysates transiently transfected with GLI2, SUFU, 
and KAP3 decreases the amount of KAP3 that co-immunoprecipitates with GLI2 (Figure 4.2A, 
lane 8). These results suggest that either GLI2 exists in a complex with KAP3 distinct from its 
complex with SUFU or that SUFU and KAP3 compete for the same GLI2 binding domain 
(Figure 4.2B).  One way to distinguish between these two possibilities is to immunoprecipitate 
SUFU from cells transiently expressing GLI2, SUFU, and KAP3 and assess whether KAP3 co-
immunoprecipitates with SUFU. In addition, it will be interesting to test whether the GLI2 
mutant lacking the KAP3 binding domain (GLI2Δ61-108) can interact with SUFU. While this 
site does not overlap with the published SYGH SUFU-binding motif (Dunaeva et al., 2003) it is 
possible that the close proximity of the SUFU and KAP3 binding sites may prevent simultaneous 
interactions of SUFU and KAP3 with GLI proteins. Similar to the in vitro binding assays in 
Chapter II used to assess direct interactions between KAP3 and GLI1, it will also be important to 
purify SUFU and GLI2 and perform in vitro binding assays to determine whether these 
interactions are also direct. In addition to the GFP-tagged GLI2 and mCherry-tagged KAP3 
described above, I would also propose utlizing CRISPR techniques to replace the endogenous 
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Gli2 locus with a GFP-tagged GLI2Δ61-108 allele that is deficient in KAP3 binding. Along with 
assessing the cellular distribution of GLI2Δ61-108, we could also gain insights into the function 
of this construct in HH-dependent tissue patterning.   
 Similar to SUFU, KIF7 interactions with GLI proteins both positively and negatively 
regulate their function (Maurya et al., 2013; Cheung et al., 2009). Further, KIF7 organizes the 
ciliary tip compartment through the regulation of microtubule dynamics (He et al., 2014). Like 
KAP3 and SUFU, KIF7 interacts with GLI proteins but these domains have not been precisely 
mapped (Marks and Kalderon, 2011). It is possible that KAP3 competes for KIF7 binding to GLI 
proteins, thus limiting dissociation of GLI-SUFU complexes and restricting GLI protein 
function. Moving forward, it will be important to identify the domains where KIF7 interacts with 
GLI2 and whether these sites are distinct or overlap with the KAP3 binding motif. Another 
possibility is that KAP3-GLI protein interactions are disrupted in Kif7 mutant cells due to the 
disorganized ciliary tip compartments. It will be particularly important to test these interactions 
in KIF7-deficient cells, and to assess the role of KIF7 in mediating kinesin-2 interactions with 
GLI proteins both in the presence and absence of HH pathway activation. More detailed 
biochemical mapping and live cell imaging will help decipher whether KAP3 is mediating GLI 
activator function through distinct or shared roles with SUFU and KIF7.  
 
4.2 Role of the homodimeric kinesin-2 complex in regulating GLI protein function  
4.2.1 KIF17 regulation of HH signaling through interactions with GLI proteins   
 Unlike the heterotrimeric KIF3A/KIF3B/KAP3 complex, the homodimeric KIF17 motor 
complex is dispensable for mammalian ciliogenesis and has not been implicated in HH signaling 
(Jenkins et al., 2006; Scholey, 2013). In Chapter III, I investigate the potential role for KIF17 in 
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HH signaling through interactions with GLI proteins. Here I show that, like KAP3, KIF17 
interacts with all three mammalian GLI proteins. These findings suggest that both homodimeric 
and heterotrimeric knesin-2 motor complexes regulate HH signaling, and that KIF17 may 
regulate GLI trafficking and function through physical interactions. Extensive biochemical 
experiments are necessary to map the domains in each of the GLI proteins that mediate 
interactions with KIF17. Furthermore, though it is suggested that KIF17 interacts with cargo via 
the C-terminal tail domain (Setou et al., 2000), it will also be important to determine whether 
GLI proteins also interact with KIF17 via the tail domain. It will also be important to test the 
functional consequences of these interactions using a combination of cell-based and in vivo 
functional assays similar to the ones performed with the KAP3 binding-deficient GLI2 mutant 
(GLI2Δ61-108) in Chapter II. 
 In Chapter III, I show that stable expression of a dominant-negative version of KIF17 that 
lacks the motor domain KIF17 (KIF17_466-1029) causes a decrease in GLI1 expression; 
however, GLI localization and GLI3 processing are not altered in these cells. In contrast to low-
level expression of a motorless version of KIF17, high-level expression of the KIF17 tail-domain 
(KIF17_801-1029) disrupts GLI2 localization, yet does not affect on HH signaling in cell-based 
luciferase assays (Figure 4.3). One explanation for normal GLI localization in the presence of 
low-level motorless KIF17 is that there is simply not enough mutant KIF17 present to exert a 
dominant negative effect on endogenous KIF17 motor function. Because not all cells were 
expressing the KIF17 tail domain due to transient transfections, I was unable to test whether the 
KIF17 tail domain alters GLI1 protein expression in whole cell lysates. Fortunately, the pCIG 
vector used to clone the KIF17 tail domain construct contains a nuclear GFP sequence and can 
be used to sort the cells expressing the dominant-negative KIF17 tail domain construct using 
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flow cytometry. By doing so, I will be able to determine whether GLI1 protein expression is 
similarly affected in high-expressing versus low-expressing dominant–negative KIF17 cells.  It 
will also be important to perform these experiments using the same dominant negative KIF17 
constructs. It is possible that the KIF17 tail domain construct, which lacks the motor domain and 
the coiled-coiled domain that is important in homodimerization (Setou et al., 2000), and the 
KIF17 construct that lacks only the motor domain may affect GLI localization and function 
differentially. While these findings implicate KIF17 as a potential regulator of GLI ciliary 
localization and HH target gene expression, more experiments are necessary to elucidate whether 
KIF17 regulates HH target gene expression directly through trafficking of GLI proteins or 
through additional mechanisms. For example, KIF17 stabilizes microtubules in epithelial cells 
and could be indirectly altering GLI activity and/or HH target gene expression by modulating 
microtubule dynamics (Jaulin and Kreitzer, 2010).   
  
4.2.2 Investigation of a role for KIF17 in regulating HH-dependent cerebellar proliferation  
 Examining KIF17 expression during pre- and postnatal development led to the exciting 
finding in Chapter III that KIF17 is expressed in the developing cerebellum. These findings 
support initial reports that characterized KIF17 as a “brain-specific” homodimeric kinesin-2 
motor complex (Setou et al., 2000). Further, the finding that KIF17 expression is largely 
restricted to postnatal neuronal tissues may explain how KIF17 could be playing a major role in 
regulating GLI protein trafficking and function, yet Kif17-/- mice are viable and display grossly 
normal body plans.  Based on my expression analysis of KIF17, the cerebellum is the only tissue 
where both KIF17 and GLI proteins are co-expressed together at high levels (our observations 
and (Corrales et al., 2004). These finding are particularly interesting since cerebellar 
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proliferation depends on proper HH signaling and GLI protein function (Wechsler-Reya and 
Scott, 1999; Corrales et al., 2004; 2006). Furthermore, we observe that Kif17-/- mice display 
smaller cerebella and that Kif17 co-localizes with Gli1 and Gli2 in the Purkinje cell layer (PCL) 
during cerebellum development. While these observations are interesting, further experiments 
are required to determine if KIF17 regulates HH-dependent cerebellar proliferation. SHH is 
secreted from Purkinje cells (PC) within the PCL and induces proliferation of granule progenitor 
cells (GCP) located with the external granule layer (EGL) (Wechsler-Reya and Scott, 1999; 
Dahmane and Ruiz i Altaba, 1999; Wallace and Raff, 1999). As a first step in determining 
whether KIF17 is required for HH-dependent cerebellar proliferation, I would assess GCP cell 
proliferation and apoptosis in wildtype versus Kif17-/- cerebella using markers for Ki67 and 
cleaved caspase-3, respectively. To further determine whether the defects in cerebellar 
proliferation observed in Kif17-/- mice are dependent on HH signaling, I would isolate GCPs and 
perform proliferation assays using recombinant SHH ligand (Izzi et al., 2011; Wechsler-Reya 
and Scott, 1999). 
 More in depth immunofluorescence experiments, including co-staining with additional 
PC and Bergman glia (BG) cell markers, will confirm whether Kif17 is expressed in PCs or in 
BGs within the PCL.  However, my preliminary co-staining experiments with the PC marker, 
LIM1/2, suggest that Kif17 is specifically expressed in PCs. This is particularly interesting 
because SHH is produced and secreted by PCs, where as Gli1 and Gli2 appear to be restricted to 
BGs during cerebellar proliferation (Corrales et al., 2004; Wechsler-Reya and Scott, 1999). BGs 
are intimately associated with PCs in the PCL and are important for regulating PC structure in 
the adult cerebellum (Yamada and Watanabe, 2002). While Glis do not appear to be highly 
expressed in PCs (Corrales et al., 2004), these results are unclear. Further experiments are 
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required to determine whether Glis, Shh, and Kif17 are present in the same or distinct cell types 
within the PCL. Interestingly, GLIs and Kif17 remain highly expressed in the PCL in adult mice 
yet it remains unclear whether HH signaling contributes to maintenance of the adult cerebellum. 
Future experiments are necessary to test this possibility and whether KIF17 regulates HH 
dependent cerebellar proliferation and/or maintenance of the adult cerebellum through direct 
interactions with GLI proteins. 
 
4.3 Conclusion 
 Here, I define novel interactions between the effector molecules of the HH signaling 
pathway, the GLI proteins, and kinesin-2 motors, namely the heterotrimeric 
KIF3A/KIF3B/KAP3 and homodimeric KIF17 motor complexes. In doing so, I improve our 
understanding of how GLI proteins are regulated by microtubule-based motor proteins; in 
addition, I provide details into how kinesin-2 motors interact with protein cargo. In particular, I 
map a novel domain within GLI2 and GLI3 that mediates KAP3 interaction and show that this 
interaction specifically regulating GLI activator function, but not GLI repressor function. It will 
be imperative to determine the subcellular location of the interactions between GLI proteins and 
kinesin-2 motors and to test whether these interactions require primary cilium.  In addition to 
KAP3, I show that GLI proteins interact with KIF3A and KIF17, yet how these interactions 
affect GLI transcriptional activity require further investigation. Future mapping experiments are 
necessary to determine whether kinesin-2 motor complexes interact with and regulate GLI 
proteins function through the same or distinct domains (Figure 4.4) Once a more complete map 
of GLI-kinesin-2 interactions is available, CRISPR technology can be used to generate mice 
replacing endogenous Gli2 with versions that are defective in interacting with specific or various 
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combinations of kinesin-2 motor proteins (Figure 4.4). Mouse mutants expressing Gli2 variants 
that selectively interact with distinct kinesin-2 motor proteins could be used to test the 
consequences of GLI and kinesin-2 interactions throughout vertebrate embryonic development 
and during adult tissue maintenance. Together, my experimental findings define novel 
interactions between GLI2 and kinesin-2 proteins thereby providing the framework for future 
studies aimed at elucidating the complex mechanisms by which kinesin-2 motor complexes 
regulate GLI protein trafficking and function. 
  
4.4 Materials and Methods 
DNA Constructs 
 To generate 6X MYC-tagged constructs hGli2, hGli2ΔN, cDNAs were cloned into 
pCDNA3 using standard molecular biology techniques. To generate a version of hGLI2 lacking 
amino acids 61-108 (hGli2∆61-108), we amplified hGli2 using forward  (5’-
TCTTGCCACCATTCCATGCGGCTGGCCCTGGGGAGTCCCC- 3’) and reverse (5’-	  
GGGGACTCCCCAGGGCCAGCCGCATGGAATGGTGGCAAGA-3’) mutagenesis primers. 
To generate a version of hGLI2∆N fused to amino acids 61-108 (61_108_hGli2∆N) we amplified 
hGli2 using forward  (5’-GGCTTTCCCCGCACCCGGCTATGGCCCTCACCTCCATCAA - 
3’) and reverse (5’-	  TTGATGGAGGTGAGGGCCATAGCCGGGTGCGGGGAAAGCC-3’) mutagenesis 
primers. Hemagglutinin (HA)-tagged hKIF17 construct and variants were generated from full-
length human KIF17 cDNA (provided by Kristen J. Verhey, University of Michigan Ann Arbor, 
MI).  Briefly, full-length hKIF17 (amino acids 1-1027) and DNKIF17 (amino acids 801-1027), 
were cloned into pGIG (Megason and McMahon, 2002) using standard molecular biology 
techniques. 
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Immunoprecipitation and Western Blot Analysis 
 COS-7 cells were transiently transfected with the relevant DNA constructs using 
Lipofectamine 2000 (Invitrogen, Cat. #11668). The cells were lysed 48 hr after transfection in 
HEPES lysis buffer (25mM HEPES pH 7.4, 115mM KOAc, 5mM NaOAc, 5mM MgCl2, 0.5mM 
EGTA, and 1% TX-100) containing protease inhibitor (Roche, Cat. #11836153001). Cell lysates 
were then subjected to centrifugation at 14,000 x g for 15 min to remove the insoluble fraction 
and protein concentrations were determined using a BCA Assay Kit (Pierce, Cat. #23225). Cell 
lysates (1mg) were then pre-cleared with Protein G agarose beads (Roche, Cat. #11719416001) 
for 1 hr at 4°C. MYC- or HA-tagged proteins were immunoprecipitated from pre-cleared lysates 
using either anti-MYC (1:150; Santa Cruz, Cat. #sc-40) or anti-HA (1:300; Covance, Cat. 
#MMS-101) antibodies for 2 hr at 4°C. Following immunoprecipitation, the lysates were 
incubated with Protein G agarose beads for 1 hr at 4°C. The Protein G agarose beads were 
washed 5 x 8 min in HEPES lysis buffer and re-suspended in 30 µl of 1x PBS and 6x Laemmli 
buffer. The samples were boiled for 10 minutes and proteins were separated using SDS-PAGE 
and analyzed by western blotting. Anti-MYC (1:1000), anti-FLAG (1:1000) and anti-HA 
(1:1000) primary antibodies, peroxidase-conjugated AffiniPure goat anti-mouse light chain 
secondary antibody (1:50,000; Jackson ImmunoResearch, Cat. # 115-035-174), and a Konica 
Minolta SRX-101A medical film processor were used to visualize tagged proteins.  
 
Immunofluorescence staining 
NIH/3T3 fibroblasts were seeded at a density of 1.5 x 105 cells/well in 6 well plates. Cells were 
transfected 24 hr later with either empty vector (pCIG) or with a DNA construct encoding 
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KIF17::HA or KIF17(801-1029) using Lipofectamine 2000. Cells were grown in low-serum 
media starting 8 hr after transfection, fixed 48 hr post-transfection in 4% paraformaldehyde for 
10 min at room temperature, and permeabilized with a 5 min incubation in 0.2% Triton X-100 in 
PBS. Immunostaining was performed using the following primary antibodies: mouse anti-
acetylated tubulin (1:2500; Sigma), mouse anti-HA (1:1000; Covance), guinea pig anti-GLI2 
(1:300; a gift from Dr. J.T. Eggenschwiler, University of Georgia). The following secondary 
antibodies were used at a dilution of 1:500:  Alexa 488 goat anti-guinea pig IgG, Alexa 555 goat 
anti-mouse IgG1, Alexa 633 goat anti-rabbit IgG2b. To visualize nuclei, DAPI (Invitrogen) was 
incubated for 5 min at a dilution of 1:30,000. Cells were imaged using a Leica Upright SP5X 
White Light Laser Confocal Microscope. Images were processed using Adobe Photoshop and 
Illustrator.  GLI2 fluorescence at the ciliary tip was quantified across multiple experiments using 
imageJ. 
 
Cell Culture and Luciferase Assays 
 NIH/3T3 cells were cultured at 37°C, 5% CO2, 95% humidity in Dulbecco’s modified 
eagle medium (DMEM; Gibco, Cat. #11965-092) containing 10% bovine calf serum (ATCC; 
Cat. #30-2030) and penicillin/streptomycin/glutamine (Gibco, Cat. #10378-016). Luciferase 
assays were performed by plating 2.5 x 104 cells/well in 24 well plates. The next day cells were 
co-transfected using Lipofectamine 2000 with the DNA constructs indicated in each experiment 
in addition to Ptc∆136-GL3 (Chen et al., 1999; Nybakken et al., 2005) and pSV-Beta-
galactosidase (Promega) constructs to report HH pathway activation and normalize transfections, 
respectively. Cells were changed to low-serum media (DMEM supplemented with 0.5% bovine 
calf serum and penicillin/streptomycin/glutamine) 48 hr after transfection and cultured at 37°C in 
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5%C02 for an additional 48 hr.  NSHH-conditioned medium was added immediately after low-
serum change where relevant to activate the HH pathway. Cells were harvested and luciferase 
and beta-galactosidase activities were measured using Luciferase Assay System (Promega Cat. # 
E1501) and BetaFluor β-gal assay kit (Novagen, Cat. #70979-3). Multiple assays were 
performed and each sample was assayed in triplicate. 
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4.5 Figures 
 
 
 
Figure 4.1. 61-108_GLI2ΔN does not rescue GLI2 interaction with KAP3A. 
(A) Graphic representation of full-length and truncated human GLI2 proteins. A 6X MYC 
epitope tag (purple) is present at the N-terminus of each GLI2 protein. Highly conserved GLI2 
protein sequences include a transcriptional repressor domain (red, absent from hGLI2ΔN), SUFU 
binding site (orange, absent from hGLI2ΔN), five zinc-finger DNA binding domains (dark blue), 
and a transcriptional activation domain (green). (B) Immunoprecipitation of MYC::GLI2, 
MYC::GLI2ΔN, MYC::GLI2Δ61_108, or MYC::61_108GLI2ΔN   from COS-7 cells co-
expressing KAP3A::HA. Immunoprecipitates (IP) and whole cell lysates (WCL) were subjected 
to SDS-PAGE and western blot analysis (IB) using antibodies directed against MYC (α-MYC) 
and HA (α-HA). Antibody detection of Beta-Tubulin (α-Beta-Tubulin) was used to confirm 
equal loading across lanes. The molecular weights (in kDa) of protein standards are indicated at 
the left of each blot 
	  	  144	  
 
 
 
 
 
 
Figure 4.2. SUFU and KAP3 form distinct complexes with GLI2. 
(A) Immunoprecipitation of MYC::GLI2  from COS-7 cells co-expressing KAP3A::HA and 
SUFU::FLAG. Immunoprecipitates (IP) subjected to SDS-PAGE and western blot analysis (IB) 
using antibodies directed against MYC (α-MYC) and HA (α-HA). The molecular weights (in 
kDa) of protein standards are indicated at the left of each blot (B) Graphic representation of two 
separate complexes containing GLI2.  (Left) GLI2 (orange) interacts with KAP3 (grey) and 
KIF3A (dark green) in a complex that also contains KIF3B.  (Right) GLI2 (orange) interacts with 
SUFU (blue) in a complex that does not include KAP3. 
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Figure 4.3. Transient transfection of DNKIF17 perturbs GLI2 cilia localization but does 
not affect HH signaling. (A) Antibody detection of endogenous GLI2 (green) in NIH/3T3 cells 
expressing HA-tagged KIF17 tail domain (KIF17_801-1029::HA; blue). Primary cilia are 
identified with antibodies against acetylated tubulin (ACTUB; red). White arrow denote cilia and 
insets represent high magnifications of cells transfected (left) and untransfected (right) with 
KIF17_801-1029::HA. (B) Quantification of GLI2 ciliary fluorescence intensity in cells in 
transfected and untransfected cells. Error bars represent the mean +/- the standard error across 
three separate experiments; p-values are indicated above the relevant treatment groups (Student’s 
unpaired t-test); n.s., not significant (p>0.05). Immunofluorescence experiments in (A) and 
quantification in (B) were performed by Lynne Blasius. (C) Luciferase activity readout of HH 
signaling following treatment of NIH/3T3 fibroblasts with NSHH (SHH) after transfection with 
either empty vector (No Treatment) or KIF17_801-1029::HA. HH pathway activity is measured 
as fold luciferase induction. Error bars represent the mean +/- S.D. for triplicate samples from a 
single experiment and are representative of three independent experiments; p-values are 
indicated above the relevant treatment groups (Student’s unpaired t-test).  
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Figure 4.4. Proposed model for defining novel kinesin-2 motor binding domains within 
GLI2. (A) Graphic illustration of a hypothetical full-length GLI2 protein containing deletions in 
mapped and unmapped kinesin-2 binding motifs. Highly conserved GLI2 protein sequences 
include a transcriptional repressor domain (red), SUFU binding site (orange), five zinc-finger 
DNA binding domains (dark blue), and a transcriptional activation domain (green). Putative 
kinesin-2 complexes including the heterotrimeric KIF3A/KIF3B/KAP3 complex, heterodimeric 
KIF3A/KIF3B complex, homodimeric KIF17 complex, and the heterotrimeric 
KIF3A/KIF3B/KAP3 complex are depicted below with black arrows indicating unmapped 
binding motifs with unknown function. Red arrow represents experimentally mapped domain 
required for KAP3 binding that negatively regulates GLI activator function. 
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APPENDIX I: 
Supplemental Materials 
 
A1.1 Assessment of endogenous interactions between GLI proteins and KAP3 
 To test whether endogenous GLI proteins and KAP3 interact, I performed 
immunoprecipitation experiments using commercially available antibodies against GLI1, GLI3 
and KAP3 in an attempt to co-precipitate endogenous GLI-KAP3 complexes (Figure A1.1).  I 
was able to successfully IP endogenous KAP3 from both wildtype and Gli2-/-;Gli3-/- MEFs, and 
could also specifically co-precipitate endogenous GLI3 in wildtype MEFs as determined by the 
absence of GLI3 protein in Gli2;Gli3 double mutant MEFs (Figure A1.1A). However, upon 
repeating this experiment with additional controls, I determined that endogenous GLI3 non-
specifically precipitates with beads alone (i.e. in the absence of KAP3 precipitation), nullifying 
our initial result. In addition, I performed the converse experiment, where I was able to 
immunoprecipitate endogenous GLI3; however, I did not detect the co-precipitation of 
endogenous KAP3 (Figure A1.1B). Further, the use of different lysis conditions did not alter this 
result (Figure A1.1B, top vs. bottom blots, data not shown). To attempt to enrich for GLI and 
KAP3 interactions, I performed similar experiments in Dync2h1lln/lln MEFs that are deficient in 
retrograde ciliary trafficking (Figure A1.1B, lane 3, top and bottom blots). However, I also failed 
to detect endogenous GLI and KAP3 interactions in this cell line.  
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 Further, I attempted immunoprecipitation experiments with KAP3 and GLI1 in wildtype 
MEFs in the presence of SAG, a Smoothened agonist that stimulates GLI1 expression 
downstream of Hedgehog pathway activation (Chen et al., 2002). While these experiments 
successfully up-regulated endogenous GLI1 that I could detect by western blot, and could also 
successfully immunoprecipitate, I failed to co-precipitate endogenous KAP3. The converse 
experiment also failed to co-precipitate endogenous GLI1 (Figure A1.1C, top and bottom blots).  
 It is important to note, however, that the failure to detect endogenous GLI-KAP3 
complexes biochemically is exactly what I would predict, especially given the limited amount of 
ciliary GLI protein within a cell at any given point in time. That is, current published estimates 
are that only 0.01% of total GLI3 protein is located within the primary cilium of Hedgehog-
responsive cells (Wen et al., 2010). Thus, even if this estimate is inaccurate by several orders of 
magnitude the likelihood of detecting endogenous GLI-KAP3 interactions biochemically is 
daunting at best. Further, the GLI-KAP3 interactions are likely to be transient, again limiting 
their detection by standard immunoprecipitation protocols. Additional biochemical experiments 
are required (i.e. cross-linking GLI-KAP3 complexes prior to immunoprecipitation) to detect 
endogenous GLI-KAP3 complexes   
  
A1.2 GLI proteins interact with KIF3A via a distinct domain from KAP3 
 In Chapter II, I show that GLI2 interacts KIF3A and KAP3, but not KIF3B. While I 
performed detailed mapping experiments to define the GLI2 motif required for KAP3 
interaction, where KIF3A interacts with GLI proteins was not reported. Here, I performed an 
additional biochemical experiment using the epitope-tagged GLI2 and KIF3A proteins generated 
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in Chapter II to narrow the domain within GLI2 required for interaction with KIF3A (Figure 
A1.2). 
Immunoprecipitation of full-length GLI2, but not GLI2∆N, co-immunoprecipitates KIF3A 
(Figure A1.2; lanes 3 and 4). Interestingly, and in contrast to what I observed in Chapter II with 
KAP3A, immunoprecipitation of GLI2∆61-108 also co-immunoprecipitates KIF3A (Figure A1.2; 
lane 5). Further, immunoprecipitation of GLI2108-1586 co-immunoprecipitates KIF3A, but this 
interaction is detected to a lesser degree when immunoprecipitating GLI2154-1586 and GLI2280-1586 
(Figure A1.2; lanes 6,7, and 8). Importantly, these results suggest that KIF3A interacts via a 
domain within GLI2 that is distinct from the KAP3A binding motif that I defined in Chapter II.  
While these experiments show that two members of the heterotrimeric kinesin-2 complex 
interact with GLI2 through distinct motifs, more biochemical experiments are required to 
precisely map the domain within GLI2 required for KIF3A interaction. 
 
A1.3 Full-length GLI3 lacking KAP3 binding motif interacts with KAP3 
 In Chapter II, I show that KAP3A interacts with a motif that is conserved between GLI2 
and GLI3. Deletion of the KAP3 binding motif in either GLI2 or GLI3R results in loss of KAP3 
binding. In contrast to GLI2 and GLI3R, deletion of the conserved KAP3 binding motif from 
full-length GLI3 does not perturb the interaction between GLI3 and KAP3 (Figure A1.3). This 
result suggests that additional motifs may exist within GLI3 that are important for interaction 
with KAP3. Interestingly, the finding that GLI1, which lacks the conserved KAP3 binding motif 
present in both GLI2 and GLI3, also interacts with KAP3 further supports the idea that GLI 
proteins interact with KAP3 via multiple binding motifs. Additional experiments are necessary to 
identify and test the functional consequence of these motifs on GLI protein activity. 
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A1.4 Mice lacking KIF17 display defects in cerebellum proliferation 
 In Chapter III, I show that Kif17-/- mice display smaller cerebella compared to Kif7+/+. To 
determine whether this difference is due to defects in proliferation, I performed additional 
immunofluorescence experiments using markers for proliferation (Ki67) and apoptosis (caspase-
3) (Figure A1.4). Strikingly, at P14, even at a time point when cerebellar proliferation has started 
to decrease (Espinosa and Luo, 2008), Ki67 staining is more abundantly distributed within the 
proliferative external granular layer (EGL) in Kif17+/+ compared to Kif17-/- embryos (Figure 
A1.4A, high magnification images in middle panel). In contrast, no discernable difference is 
observed between Kif17+/+ and Kif17-/- cerebella using an antibody against cleaved caspase-3 
(Figure A1.4B). These results suggest that the smaller sized cerebella in Kif17-/- mice is likely 
due to defects in granular cell proliferation and not cell death. It will be important to perform 
similar immunofluorescence experiments on P8 Kif17+/+ and Kif17-/- cerebella when granule cells 
are rapidly proliferating in response to the HH ligand (Corrales et al., 2004; Wechsler-Reya and 
Scott, 1999). Furthermore, isolating proliferating granular cells and performing proliferation 
assays using HH ligand will be required to determine whether the proliferation defect observed 
in Kif17-/- cerebella is due to a defect in HH signaling. 
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Figures 
 
 
Figure A1.1. Endogenous KAP3 does not co-immunoprecipitate with endogenous GLI3 and 
GLI1.  (A) Immunoprecipitation of endogenous KAP3 from Gli2-/-;Gli3-/- (-/-) and wildtype 
(WT) MEFs. (*) denotes a non-specific band detected in both WT and -/- tissue. (B) 
Immunoprecipitation of endogenous GLI3 from Gli2-/-;Gli3-/- (-/-), wildtype (WT), and Dynein 
(Dync2h1) mutant (Dyn-/-) MEFs. Whole cell lysates (WCL) were collected in either a high 
stringency RIPA lysis buffer (B, top) or a low stringency NP-40 lysis buffer (B, bottom). (C) 
Immunoprecipitation of either endogenous KAP3 (C, top) or GLI1 (C, bottom) from wildtype 
MEFs in the presence (+SAG) or absence (-SAG) of Smoothened agonist (SAG). 
Immunoprecipitates (IP) and whole cell lysates (WCL) were subjected to SDS-PAGE and 
western blot analysis (IB) using anti-KAP3, anti-GLI3, and/or anti-GLI1 antibodies. The 
molecular weights (in kDa) of protein standards are indicated at the left of each blot.   
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Figure A1.2. GLI2 interacts with KIF3A via a distinct domain from KAP3. 
(A) Immunoprecipitation of MYC::GLI2, MYC::GLI2ΔN, MYC::GLI2_Δ61-108, 
MYC::GLI2_108-1586, MYC:GLI2_154-1586, or MYC:GLI2_280-1586 from COS-7 cells 
expressing KIF3A::HA. Immunoprecipitates (IP) and whole cell lysates (WCL) were subjected 
to SDS-PAGE and western blot analysis (IB) using antibodies directed against MYC (α-MYC) 
and HA (α-HA). Antibody detection of Beta-Tubulin (α-Beta-Tubulin) was used to confirm 
equal loading across lanes. The molecular weights (in kDa) of protein standards are indicated at 
the left of each blot.   
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Figure A1.3. Full-length GLI3 lacking the KAP3 binding domain interacts with KAP3. 
(A) Graphic representation of full-length and mutant human GLI3 proteins. (B) 
Immunoprecipitation of MYC::GLI3 or MYC::GLI3∆134-182 from COS-7 cells expressing 
KAP3A::HA. Immunoprecipitates (IP) and whole cell lysates (WCL) were subjected to SDS-
PAGE and western blot analysis (IB) using antibodies directed against MYC (α-MYC) and HA 
(α-HA). Antibody detection of Beta-Tubulin (α-Beta-Tubulin) was used to confirm equal loading 
across lanes. The molecular weights (in kDa) of protein standards are indicated at the left of each 
blot. 
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Figure A1.4. Kif17-/- mice display defects in cerebellar proliferation. 
Immunofluorescence staining of Kif17+/+ and Kif17-/- P14 mouse cerebella stained with markers 
for (A) proliferation (Ki67, green) and (B) apoptosis [cleave caspase-3 (CC3), green]. Nuclei are 
stained with DAPI (blue). Arrows in (A) highlight cerebellar lobule VIII that is magnified in the 
middle panels to highlight differences in proliferation of cells within the external granular layer 
(EGL). 
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